<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1021/(ISSN)1520-6033" xmlns="http://purl.org/rss/1.0/"><title>Biotechnology Progress</title><description> Wiley Online Library : Biotechnology Progress</description><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2F%28ISSN%291520-6033</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Copyright © 2013 American Institute of Chemical Engineers</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">8756-7938</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1520-6033</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">March/April 2013</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">29</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">297</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">572</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1002/btpr.v29.2/asset/cover.gif?v=1&amp;s=28856f7868e1905d94729e09854898c92afa438b"/><items><rdf:Seq><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1754"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1755"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1753"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1752"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1750"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1751"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1748"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1749"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1747"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1746"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1740"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1741"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1742"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1743"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1745"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1744"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1734"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1732"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1733"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1730"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1728"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1731"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1729"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1726"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1727"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1725"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1724"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1722"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1723"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1721"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1720"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1719"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1718"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1717"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1716"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1715"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1714"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1713"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1748"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1703"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1704"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1747"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1746"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1740"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1743"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1739"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1744"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1745"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1742"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1741"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1736"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1738"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1737"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1735"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1734"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1726"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1723"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1729"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1728"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1727"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1733"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1732"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1731"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1730"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1725"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1724"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1719"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1718"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1716"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1713"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1702"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1722"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1715"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1721"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1720"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1717"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1714"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1710"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1712"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1708"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1709"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1711"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1706"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1693"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1688"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1677"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1690"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1679"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1696"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1700"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1701"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1676"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1678"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1684"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1695"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1680"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1705"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1667"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1681"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1685"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1686"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1687"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1698"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1674"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1682"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1689"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1691"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1692"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1675"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1683"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1699"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1694"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1697"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1707"/></rdf:Seq></items></channel><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1754" xmlns="http://purl.org/rss/1.0/"><title>Acquisition of thermotolerant yeast Saccharomyces cerevisiae by breeding via stepwise adaptation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1754</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Acquisition of thermotolerant yeast Saccharomyces cerevisiae by breeding via stepwise adaptation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Atsushi Satomura, Yoshiaki Katsuyama, Natsuko Miura, Kouichi Kuroda, Ayako Tomio, Takeshi Bamba, Eiichiro Fukusaki, Mitsuyoshi Ueda</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:46:29.900067-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1754</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1754</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1754</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>A thermotolerant <em>Saccharomyces cerevisiae</em> yeast strain, YK60-1, was bred from a parental strain, MT8-1, via stepwise adaptation. YK60-1 grew at 40<sup>o</sup>C, a temperature at which MT8-1 could not grow at all. YK60-1 exhibited faster growth than MT8-1 at 30<sup>o</sup>C. To investigate the mechanisms how MT8-1 acquired thermotolerance, DNA microarray analysis was performed. The analysis revealed that induction of stress-responsive genes such as those encoding heat shock proteins and trehalose biosynthetic enzymes in YK60-1. Furthermore, non-targeting metabolome analysis showed that YK60-1 accumulated more trehalose, a metabolite that contributes to stress tolerance in yeast, than MT8-1. In conclusion, <em>S. cerevisiae</em> MT8-1 acquired thermotolerance by induction of specific stress-responsive genes and enhanced intracellular trehalose levels. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

A thermotolerant Saccharomyces cerevisiae yeast strain, YK60-1, was bred from a parental strain, MT8-1, via stepwise adaptation. YK60-1 grew at 40oC, a temperature at which MT8-1 could not grow at all. YK60-1 exhibited faster growth than MT8-1 at 30oC. To investigate the mechanisms how MT8-1 acquired thermotolerance, DNA microarray analysis was performed. The analysis revealed that induction of stress-responsive genes such as those encoding heat shock proteins and trehalose biosynthetic enzymes in YK60-1. Furthermore, non-targeting metabolome analysis showed that YK60-1 accumulated more trehalose, a metabolite that contributes to stress tolerance in yeast, than MT8-1. In conclusion, S. cerevisiae MT8-1 acquired thermotolerance by induction of specific stress-responsive genes and enhanced intracellular trehalose levels. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1755" xmlns="http://purl.org/rss/1.0/"><title>New lipid-producing, cold-tolerant yellow-green alga isolated from the Rocky Mountains of Colorado</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1755</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">New lipid-producing, cold-tolerant yellow-green alga isolated from the Rocky Mountains of Colorado</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David R. Nelson, Sinafik Mengistu, Paul Ranum, Gail Celio, Mara Mashek, Douglas Mashek, Paul A. Lefebvre</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:21:07.90049-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1755</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1755</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1755</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>A new strain of yellow-green algae (<em>Xanthophyceae</em>, Heterokonta), tentatively named <em>Heterococcus sp. DN1 (</em>UTEX accession number UTEX ZZ885)<em>,</em> was discovered among snow fields in the Rocky Mountains. Axenic cultures of <em>H. sp. DN1</em> were isolated and their cellular morphology, growth, and composition of lipids were characterized. <em>H. sp. DN1</em> was found to grow at temperatures approaching freezing and to accumulate large intracellular stores of lipids. <em>H. sp. DN1</em> produces the highest quantity of lipids when grown undisturbed with high light in low temperatures<sub>.</sub> Of particular interest was the accumulation of eicosapentaenoic acid (EPA), known to be important for human nutrition, and palmitoleic acid (PA), known to improve biodiesel feedstock properties. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

A new strain of yellow-green algae (Xanthophyceae, Heterokonta), tentatively named Heterococcus sp. DN1 (UTEX accession number UTEX ZZ885), was discovered among snow fields in the Rocky Mountains. Axenic cultures of H. sp. DN1 were isolated and their cellular morphology, growth, and composition of lipids were characterized. H. sp. DN1 was found to grow at temperatures approaching freezing and to accumulate large intracellular stores of lipids. H. sp. DN1 produces the highest quantity of lipids when grown undisturbed with high light in low temperatures. Of particular interest was the accumulation of eicosapentaenoic acid (EPA), known to be important for human nutrition, and palmitoleic acid (PA), known to improve biodiesel feedstock properties. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1753" xmlns="http://purl.org/rss/1.0/"><title>Model-based identifiable parameter determination applied to a simultaneous saccharification and fermentation process model for bio-ethanol production</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1753</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Model-based identifiable parameter determination applied to a simultaneous saccharification and fermentation process model for bio-ethanol production</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Diana C. López C., Tilman Barz, Mariana Peñuela, Adriana Villegas, Silvia Ochoa, Günter Wozny</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T00:36:02.959926-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1753</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1753</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1753</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>In this work, a methodology for the Model-Based Identifiable Parameter Determination (MBIPD) is presented. This systematic approach is proposed to be used for structure and parameter identification of nonlinear models of biological reaction networks. Usually this kind of problems are over-parameterized with large correlations between parameters. Hence, the related inverse problems for parameter determination and analysis are mathematically ill-posed and numerically difficult to solve. The proposed MBIPD methodology comprises several tasks: i) model selection, ii) tracking of an adequate initial guess and iii) an iterative parameter estimation step which includes an identifiable parameter subset selection (SsS) algorithm and accuracy analysis of the estimated parameters. The SsS algorithm is based on the analysis of the sensitivity matrix by rank revealing factorization methods. Using this, a reduction of the parameter search space to a reasonable subset, which can be reliably and efficiently estimated from available measurements, is achieved. The Simultaneous Saccharification and Fermentation process for bio-ethanol production from cellulosic material is used as case study for testing the methodology. The successful application of MBIPD to the SSF process demonstrates a relatively large reduction in the identified parameter space. It is shown by a cross-validation that using the identified parameters (even though the reduction of the search space), the model is still able to predict the experimental data properly. Moreover, it is shown that the model is easily and efficiently adapted to new process conditions by solving reduced and well conditioned problems. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

In this work, a methodology for the Model-Based Identifiable Parameter Determination (MBIPD) is presented. This systematic approach is proposed to be used for structure and parameter identification of nonlinear models of biological reaction networks. Usually this kind of problems are over-parameterized with large correlations between parameters. Hence, the related inverse problems for parameter determination and analysis are mathematically ill-posed and numerically difficult to solve. The proposed MBIPD methodology comprises several tasks: i) model selection, ii) tracking of an adequate initial guess and iii) an iterative parameter estimation step which includes an identifiable parameter subset selection (SsS) algorithm and accuracy analysis of the estimated parameters. The SsS algorithm is based on the analysis of the sensitivity matrix by rank revealing factorization methods. Using this, a reduction of the parameter search space to a reasonable subset, which can be reliably and efficiently estimated from available measurements, is achieved. The Simultaneous Saccharification and Fermentation process for bio-ethanol production from cellulosic material is used as case study for testing the methodology. The successful application of MBIPD to the SSF process demonstrates a relatively large reduction in the identified parameter space. It is shown by a cross-validation that using the identified parameters (even though the reduction of the search space), the model is still able to predict the experimental data properly. Moreover, it is shown that the model is easily and efficiently adapted to new process conditions by solving reduced and well conditioned problems. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1752" xmlns="http://purl.org/rss/1.0/"><title>Investigation of vinegar production using a novel shaken repeated batch culture system</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1752</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Investigation of vinegar production using a novel shaken repeated batch culture system</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tino Schlepütz, Jochen Büchs</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-05T23:23:09.429754-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1752</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1752</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1752</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Nowadays, bioprocesses are developed or optimized on small sale. Also vinegar industry is motivated to reinvestigate the established repeated batch fermentation process. As yet, there is no small scale culture system for optimizing fermentation conditions for repeated batch bioprocesses. Thus, the aim of this study is to propose a new shaken culture system for parallel repeated batch vinegar fermentation. A new operation mode - the flushing repeated batch - was developed. Parallel repeated batch vinegar production could be established in shaken overflow vessels in a completely automated operation with only one pump per vessel. This flushing repeated batch was first theoretically investigated and then empirically tested. The ethanol concentration was on-line monitored during repeated batch fermentation by semiconductor gas sensors. It was shown that the switch from one ethanol substrate quality to different ethanol substrate qualities resulted in prolonged lag phases and durations of the first batches. In the subsequent batches the length of the fermentations decreased considerably. This decrease in the respective lag phases indicates an adaptation of the acetic acid bacteria mixed culture to the specific ethanol substrate quality. Consequently, flushing repeated batch fermentations on small scale are valuable for screening fermentation conditions and, thereby, improving industrial-scale bioprocesses such as vinegar production in terms of process robustness, stability and productivity. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

Nowadays, bioprocesses are developed or optimized on small sale. Also vinegar industry is motivated to reinvestigate the established repeated batch fermentation process. As yet, there is no small scale culture system for optimizing fermentation conditions for repeated batch bioprocesses. Thus, the aim of this study is to propose a new shaken culture system for parallel repeated batch vinegar fermentation. A new operation mode - the flushing repeated batch - was developed. Parallel repeated batch vinegar production could be established in shaken overflow vessels in a completely automated operation with only one pump per vessel. This flushing repeated batch was first theoretically investigated and then empirically tested. The ethanol concentration was on-line monitored during repeated batch fermentation by semiconductor gas sensors. It was shown that the switch from one ethanol substrate quality to different ethanol substrate qualities resulted in prolonged lag phases and durations of the first batches. In the subsequent batches the length of the fermentations decreased considerably. This decrease in the respective lag phases indicates an adaptation of the acetic acid bacteria mixed culture to the specific ethanol substrate quality. Consequently, flushing repeated batch fermentations on small scale are valuable for screening fermentation conditions and, thereby, improving industrial-scale bioprocesses such as vinegar production in terms of process robustness, stability and productivity. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1750" xmlns="http://purl.org/rss/1.0/"><title>Application of a non-radioactive method of measuring protein synthesis in industrially relevant Chinese hamster ovary cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1750</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Application of a non-radioactive method of measuring protein synthesis in industrially relevant Chinese hamster ovary cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nazanin Dadehbeigi, Alan James Dickson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T09:39:58.993525-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1750</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1750</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1750</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Due to the high medical and commercial value of recombinant proteins for clinical and diagnostic purposes, the protein synthesis machinery of mammalian host cells is the subject of extensive research by the biopharmaceutical industry. RNA translation and protein synthesis are steps that may determine the extent of growth and productivity of host cells. To address the problems of utilization of current radioisotope methods with proprietary media, we have focused on the application of an alternative method of measuring protein synthesis in recombinant Chinese hamster ovary (CHO) cells. This method employs puromycin as a nonradioactive label which incorporates into nascent polypeptide chains and is detectable by western blotting. This method, which is referred to as SUnSET, successfully demonstrated the expected changes in protein synthesis in conditions that inhibit and restore translation activity and was reproducibly quantifiable. The study of the effects of feed and sodium butyrate addition on protein synthesis by SUnSET revealed an increase following 1 hour feed supplementation while a high concentration of sodium butyrate was able to decrease translation during the same treatment period. Finally, SUnSET was used to compare protein synthesis activity during batch culture of the CHO cell line in relation to growth. The results indicate that as the cells approached the end of batch culture, the global rate of protein synthesis declined in parallel with the decreasing growth rate. In conclusion, this method can be used as a “snapshot” to directly monitor the effects of different culture conditions and treatments on translation in recombinant host cells. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Due to the high medical and commercial value of recombinant proteins for clinical and diagnostic purposes, the protein synthesis machinery of mammalian host cells is the subject of extensive research by the biopharmaceutical industry. RNA translation and protein synthesis are steps that may determine the extent of growth and productivity of host cells. To address the problems of utilization of current radioisotope methods with proprietary media, we have focused on the application of an alternative method of measuring protein synthesis in recombinant Chinese hamster ovary (CHO) cells. This method employs puromycin as a nonradioactive label which incorporates into nascent polypeptide chains and is detectable by western blotting. This method, which is referred to as SUnSET, successfully demonstrated the expected changes in protein synthesis in conditions that inhibit and restore translation activity and was reproducibly quantifiable. The study of the effects of feed and sodium butyrate addition on protein synthesis by SUnSET revealed an increase following 1 hour feed supplementation while a high concentration of sodium butyrate was able to decrease translation during the same treatment period. Finally, SUnSET was used to compare protein synthesis activity during batch culture of the CHO cell line in relation to growth. The results indicate that as the cells approached the end of batch culture, the global rate of protein synthesis declined in parallel with the decreasing growth rate. In conclusion, this method can be used as a “snapshot” to directly monitor the effects of different culture conditions and treatments on translation in recombinant host cells. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1751" xmlns="http://purl.org/rss/1.0/"><title>SO2-catalyzed steam explosion: The effects of different severity on digestibility, accessibility and crystallinity of lignocellulosic biomass</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1751</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">SO2-catalyzed steam explosion: The effects of different severity on digestibility, accessibility and crystallinity of lignocellulosic biomass</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yuzhi Kang, Prabuddha Bansal, Matthew J. Realff, Andreas S. Bommarius</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T06:47:33.786382-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1751</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1751</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1751</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Lignocellulosic biomass is the most promising feedstock for biofuels production. To enhance the efficiency of enzymatic hydrolysis, lignocellulosics needs to be pretreated to lower their recalcitrance. SO<sub>2</sub>-catalyzed steam explosion is an efficient and relatively cost-efficient pretreatment method for softwood. This work investigates the effects of steam explosion severity on the digestibility, accessibility, and crystallinity of Loblolly pine. Higher severity was found to increase the accessibility of the feedstock while also promoting nonselective degradation of carbohydrates. The adsorption behavior of Celluclast<sup>®</sup> enzymes on steam-exploded Loblolly pine (SELP) can be described by a Langmuir isotherm. Cellulose crystallinity was found to first increase and then decrease with increasing pretreatment severity. A linear relationship between initial hydrolysis rates and crystallinity index (CrI) of pretreated Loblolly pine was found; moreover, a strong correlation between X-ray diffraction intensities and initial rates was confirmed. The findings demonstrate the significance of CrI in enzymatic hydrolysis of pretreated lignocellulosic biomass. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Lignocellulosic biomass is the most promising feedstock for biofuels production. To enhance the efficiency of enzymatic hydrolysis, lignocellulosics needs to be pretreated to lower their recalcitrance. SO2-catalyzed steam explosion is an efficient and relatively cost-efficient pretreatment method for softwood. This work investigates the effects of steam explosion severity on the digestibility, accessibility, and crystallinity of Loblolly pine. Higher severity was found to increase the accessibility of the feedstock while also promoting nonselective degradation of carbohydrates. The adsorption behavior of Celluclast® enzymes on steam-exploded Loblolly pine (SELP) can be described by a Langmuir isotherm. Cellulose crystallinity was found to first increase and then decrease with increasing pretreatment severity. A linear relationship between initial hydrolysis rates and crystallinity index (CrI) of pretreated Loblolly pine was found; moreover, a strong correlation between X-ray diffraction intensities and initial rates was confirmed. The findings demonstrate the significance of CrI in enzymatic hydrolysis of pretreated lignocellulosic biomass. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1748" xmlns="http://purl.org/rss/1.0/"><title>Profiling the effects of process changes on residual host cell proteins in biotherapeutics by mass spectrometry</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1748</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Profiling the effects of process changes on residual host cell proteins in biotherapeutics by mass spectrometry</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Matthew R. Schenauer, Gregory C. Flynn, Andrew M. Goetze</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-12T04:09:14.919686-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1748</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1748</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1748</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>An advanced liquid chromatography/mass spectrometry (LC/MS) platform was used to identify and quantify residual <em>E. coli</em> host cell proteins (HCPs) in the drug substance (DS) of several peptibodies (Pbs). Significantly different HCP impurity profiles were observed among different biotherapeutic Pbs as well as one Pb purified via multiple processes. The results can be rationally interpreted in terms of differences among the purification processes, and demonstrate the power of this technique to sensitively monitor both the quantity and composition of residual HCPs in DS, where these may represent a safety risk to patients. The breadth of information obtained using MS is compared to traditional multi-product enzyme-linked immunosorbent assay (ELISA) values for total HCP in the same samples and shows that, in this case, the ELISA failed to detect multiple HCPs. The HCP composition of two upstream samples was also analyzed and used to demonstrate that HCPs that carry through purification processes to be detectable in DS are not always among those that are the most abundant upstream. Compared to ELISA, we demonstrate that MS can provide a more comprehensive, and accurate, characterization of DS HCPs, thereby facilitating process development as well as more rationally assessing potential safety risks posed by individual, identified HCPs. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

An advanced liquid chromatography/mass spectrometry (LC/MS) platform was used to identify and quantify residual E. coli host cell proteins (HCPs) in the drug substance (DS) of several peptibodies (Pbs). Significantly different HCP impurity profiles were observed among different biotherapeutic Pbs as well as one Pb purified via multiple processes. The results can be rationally interpreted in terms of differences among the purification processes, and demonstrate the power of this technique to sensitively monitor both the quantity and composition of residual HCPs in DS, where these may represent a safety risk to patients. The breadth of information obtained using MS is compared to traditional multi-product enzyme-linked immunosorbent assay (ELISA) values for total HCP in the same samples and shows that, in this case, the ELISA failed to detect multiple HCPs. The HCP composition of two upstream samples was also analyzed and used to demonstrate that HCPs that carry through purification processes to be detectable in DS are not always among those that are the most abundant upstream. Compared to ELISA, we demonstrate that MS can provide a more comprehensive, and accurate, characterization of DS HCPs, thereby facilitating process development as well as more rationally assessing potential safety risks posed by individual, identified HCPs. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1749" xmlns="http://purl.org/rss/1.0/"><title>A baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1749</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sánchez-Arreola PB, López-Uriarte S, Marichal-Gallardo PA, González-Vázquez JC, Pérez-Chavarría R, Soto-Vázquez P, López-Pacheco F, Ramírez-Medrano A, Rocha-Pizaña MR, Álvarez MM</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-12T04:09:12.012327-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1749</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1749</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1749</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The current commercial system for influenza vaccine production depends on the culture of virus in embryonated eggs—a strategy that is both costly and poorly scalable. Consequently, a sudden pandemic event with a demand for millions of vaccine doses in a short time could readily overwhelm the available world production capacity. In this communication, we present a process that uses <em>Escherichia coli</em> for scalable production of recombinant vaccine candidates against influenza. A monomeric and a dimeric fragment of hemagglutinin of the Influenza A H1N1/2009 virus were successfully expressed in a BL21 (DE3) pLysS variety of C41 <em>E. coli</em>. We present results from batch processes where induction is made with IPTG and from fed-batch experiments where expression is induced using lactose/glucose pulses. Concentrations in the range of 1.188 to 0.605 g/L of recombinant protein were observed in 2 L stirred tank bioreactors. The genetic construct included an N-terminal histidine tag sequence that facilitated recovery, purification, and proper refolding of the vaccine candidate by affinity chromatography in columns loaded with Ni<sup>+2</sup>. The proteins produced by this strategy selectively and specifically recognizes antibodies from patients diagnosed as positive to Influenza A H1N1/2009. Overall protein recovery yields between 30.0-34.7% were typically observed. Based on these yields, a production of 4.6X10<sup>3</sup> doses L<sup>-3</sup> day<sup>-1</sup> is feasible. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

The current commercial system for influenza vaccine production depends on the culture of virus in embryonated eggs—a strategy that is both costly and poorly scalable. Consequently, a sudden pandemic event with a demand for millions of vaccine doses in a short time could readily overwhelm the available world production capacity. In this communication, we present a process that uses Escherichia coli for scalable production of recombinant vaccine candidates against influenza. A monomeric and a dimeric fragment of hemagglutinin of the Influenza A H1N1/2009 virus were successfully expressed in a BL21 (DE3) pLysS variety of C41 E. coli. We present results from batch processes where induction is made with IPTG and from fed-batch experiments where expression is induced using lactose/glucose pulses. Concentrations in the range of 1.188 to 0.605 g/L of recombinant protein were observed in 2 L stirred tank bioreactors. The genetic construct included an N-terminal histidine tag sequence that facilitated recovery, purification, and proper refolding of the vaccine candidate by affinity chromatography in columns loaded with Ni+2. The proteins produced by this strategy selectively and specifically recognizes antibodies from patients diagnosed as positive to Influenza A H1N1/2009. Overall protein recovery yields between 30.0-34.7% were typically observed. Based on these yields, a production of 4.6X103 doses L-3 day-1 is feasible. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1747" xmlns="http://purl.org/rss/1.0/"><title>Comparative analysis of reference gene stability in human mesenchymal stromal cells during osteogenic differentiation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1747</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comparative analysis of reference gene stability in human mesenchymal stromal cells during osteogenic differentiation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Angela Jacobi, Juliane Rauh, Peter Bernstein, Cornelia Liebers, Xuenong Zou, Maik Stiehler</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-11T03:53:06.005991-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1747</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1747</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1747</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Mesenchymal stromal cells (MSCs) are one of the most frequently used cell sources for tissue engineering strategies. Cultivation of osteogenic MSCs is a prerequisite for cell-based concepts that aim at bone regeneration. Quantitative real time reverse transcription polymerase chain reaction (qRT-PCR) analysis is a commonly used method for the examination of mRNA expression levels. However, data on suitable reference genes for osteogenically cultivated MSCs is scarce. Hence, the aim of the study was to compare the regulation of different potential reference genes in osteogenically stimulated MSCs.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Human MSCs were isolated from bone marrow aspirates of N=6 haematologically healthy individuals, expanded by polystyrene-adherence, and maintained with and without osteogenic supplements for 14 days. Cellular proliferation and osteogenic differentiation were assessed by total DNA quantification, cell-specific alkaline phosphatase (ALP) activity and by qualitative staining for ALP and alizarin red, respectively. mRNA expression levels of N=32 potential reference genes were quantified using the human Endogenous Control TaqMan® assays. mRNA expression stability was calculated using geNorm.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The combined use of the most stable reference genes and DNA-damage-inducible alpha (GADD45A), Pumilio homolog 1 (PUM1) and large ribosomal protein P0 (RPLP0) significantly improved gene expression accuracy compared to the use of the commonly used reference genes beta actin (ACTB) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) during qRT-PCR-based target gene expression analysis of osteogenically stimulated MSCs. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

Mesenchymal stromal cells (MSCs) are one of the most frequently used cell sources for tissue engineering strategies. Cultivation of osteogenic MSCs is a prerequisite for cell-based concepts that aim at bone regeneration. Quantitative real time reverse transcription polymerase chain reaction (qRT-PCR) analysis is a commonly used method for the examination of mRNA expression levels. However, data on suitable reference genes for osteogenically cultivated MSCs is scarce. Hence, the aim of the study was to compare the regulation of different potential reference genes in osteogenically stimulated MSCs.
Human MSCs were isolated from bone marrow aspirates of N=6 haematologically healthy individuals, expanded by polystyrene-adherence, and maintained with and without osteogenic supplements for 14 days. Cellular proliferation and osteogenic differentiation were assessed by total DNA quantification, cell-specific alkaline phosphatase (ALP) activity and by qualitative staining for ALP and alizarin red, respectively. mRNA expression levels of N=32 potential reference genes were quantified using the human Endogenous Control TaqMan® assays. mRNA expression stability was calculated using geNorm.
The combined use of the most stable reference genes and DNA-damage-inducible alpha (GADD45A), Pumilio homolog 1 (PUM1) and large ribosomal protein P0 (RPLP0) significantly improved gene expression accuracy compared to the use of the commonly used reference genes beta actin (ACTB) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) during qRT-PCR-based target gene expression analysis of osteogenically stimulated MSCs. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1746" xmlns="http://purl.org/rss/1.0/"><title>Enzymatic digestion of alkaline-sulfite pretreated sugar cane bagasse and its correlation with the chemical and structural changes occurring during the pretreatment step</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1746</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Enzymatic digestion of alkaline-sulfite pretreated sugar cane bagasse and its correlation with the chemical and structural changes occurring during the pretreatment step</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fernanda M. Mendes, Debora F. Laurito, Mariana Bazzeggio, André Ferraz, Adriane M.F. Milagres</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-11T03:53:04.238716-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1746</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1746</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1746</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Sugar cane bagasse is recalcitrant to enzymatic digestion, which hinders the efficient conversion of its polysaccharides into fermentable sugars. Alkaline-sulfite pretreatment was used to overcome the sugar cane bagasse recalcitrance. Chemical and structural changes that occurred during the pretreatment were correlated with the efficiency of the enzymatic digestion of the polysaccharides. The first 30 min of pretreatment, which removed approximately half of the initial lignin and 30% of hemicellulose seemed responsible for a significant enhancement of the cellulose conversion level, which reached 64%. After the first 30 min of pretreatment, delignification increased slightly and hemicellulose removal was not enhanced, however, acid groups continued to be introduced into the residual lignin. Water retention values were 145% to the untreated bagasse and 210% to the bagasse pretreated for 120-min and fiber widths increased from 10.4 µm to 30 µm, respectively. These changes were responsible for an additional increase in the efficiency of enzymatic hydrolysis of the cellulose, which reached 92% with the 120-min pretreated sample. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

Sugar cane bagasse is recalcitrant to enzymatic digestion, which hinders the efficient conversion of its polysaccharides into fermentable sugars. Alkaline-sulfite pretreatment was used to overcome the sugar cane bagasse recalcitrance. Chemical and structural changes that occurred during the pretreatment were correlated with the efficiency of the enzymatic digestion of the polysaccharides. The first 30 min of pretreatment, which removed approximately half of the initial lignin and 30% of hemicellulose seemed responsible for a significant enhancement of the cellulose conversion level, which reached 64%. After the first 30 min of pretreatment, delignification increased slightly and hemicellulose removal was not enhanced, however, acid groups continued to be introduced into the residual lignin. Water retention values were 145% to the untreated bagasse and 210% to the bagasse pretreated for 120-min and fiber widths increased from 10.4 µm to 30 µm, respectively. These changes were responsible for an additional increase in the efficiency of enzymatic hydrolysis of the cellulose, which reached 92% with the 120-min pretreated sample. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1740" xmlns="http://purl.org/rss/1.0/"><title>Manipulation of kynurenine pathway for enhanced daptomycin production in Streptomyces roseosporus</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1740</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Manipulation of kynurenine pathway for enhanced daptomycin production in Streptomyces roseosporus</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Guojian Liao, Lei Wang, Qing Liu, Feifei Guan, Yuqi Huang, Changhu Hu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-04T02:33:20.570393-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1740</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1740</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1740</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Daptomycin is a cyclic lipopeptide natural product produced by Stretptomyces roseosporus, displaying good bactericidal activity against a wide range of Gram-positive pathogens. Daptomycin contains a 13 amino acid and kynurenine (Kyn) is essential for optimal activity of daptomycin. In this study, we characterized the Kyn pathway in S. roseosporus and investigated its role in supplying precursor for daptomycin biosynthesis. Two genes (dptJ and tdo) coding for tryptophan-2, 3-dioxgenase existed in the chromosome. dptJ is located in the daptomycin biosynthetic gene cluster, while tdo is in other locus. Disruption of dptJ or tdo resulted in reduced yield by approximately 50%. The introduction of an additional copy of dptJ but not tdo led to enhanced production of daptomycin by 110%. Furthermore, disruption of kyn encoding kynureninase showed improved daptomycin productivity by 30%. Our results demonstrated that the enhancement of Kyn supply through metabolic engineering approach is an efficient way to increase daptomycin production. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Daptomycin is a cyclic lipopeptide natural product produced by Stretptomyces roseosporus, displaying good bactericidal activity against a wide range of Gram-positive pathogens. Daptomycin contains a 13 amino acid and kynurenine (Kyn) is essential for optimal activity of daptomycin. In this study, we characterized the Kyn pathway in S. roseosporus and investigated its role in supplying precursor for daptomycin biosynthesis. Two genes (dptJ and tdo) coding for tryptophan-2, 3-dioxgenase existed in the chromosome. dptJ is located in the daptomycin biosynthetic gene cluster, while tdo is in other locus. Disruption of dptJ or tdo resulted in reduced yield by approximately 50%. The introduction of an additional copy of dptJ but not tdo led to enhanced production of daptomycin by 110%. Furthermore, disruption of kyn encoding kynureninase showed improved daptomycin productivity by 30%. Our results demonstrated that the enhancement of Kyn supply through metabolic engineering approach is an efficient way to increase daptomycin production. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1741" xmlns="http://purl.org/rss/1.0/"><title>Effect of glycosylation on the partition behavior of a human antibody in aqueous two-phase systems</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1741</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect of glycosylation on the partition behavior of a human antibody in aqueous two-phase systems</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J-W. Lee, D. Forciniti</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-04T02:33:19.082879-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1741</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1741</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1741</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Human proteins are expressed in some hosts wrongly glycosylated or non-glycosylated. Although it is accepted that glycosylation contributes to the stability of the protein in solution, the effect of glycosylation on the stability of human antibodies is not fully understood. In this work, we present solubility studies of two human antibodies that have the same primary structure but different glycosylation pattern. The studies were done by monitoring the partitioning behavior of both proteins in a series of aqueous two-phase systems at and away the isoelectric point of the proteins and at different temperatures. Our studies show that in the absence of direct electrostatic forces, the partitioning behavior of the antibodies depends on the presence or absence of the polysaccharide chains. Overall, the non-glycosylated protein is less soluble than the glycosylated one. The potential of aqueous two-phase systems for the separation of the glycosylated and non-glycosylated proteins was also explored. A simple series of extractions seems to be enough to separate the glycosylated variety from the non-glycosylated one at high purity but low yields. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Human proteins are expressed in some hosts wrongly glycosylated or non-glycosylated. Although it is accepted that glycosylation contributes to the stability of the protein in solution, the effect of glycosylation on the stability of human antibodies is not fully understood. In this work, we present solubility studies of two human antibodies that have the same primary structure but different glycosylation pattern. The studies were done by monitoring the partitioning behavior of both proteins in a series of aqueous two-phase systems at and away the isoelectric point of the proteins and at different temperatures. Our studies show that in the absence of direct electrostatic forces, the partitioning behavior of the antibodies depends on the presence or absence of the polysaccharide chains. Overall, the non-glycosylated protein is less soluble than the glycosylated one. The potential of aqueous two-phase systems for the separation of the glycosylated and non-glycosylated proteins was also explored. A simple series of extractions seems to be enough to separate the glycosylated variety from the non-glycosylated one at high purity but low yields. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1742" xmlns="http://purl.org/rss/1.0/"><title>Three-dimensional neural differentiation of embryonic stem cells with ACM induction in microfibrous matrices in bioreactors</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1742</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Three-dimensional neural differentiation of embryonic stem cells with ACM induction in microfibrous matrices in bioreactors</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ning Liu, Anli Ouyang, Yan Li, Shang-Tian Yang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-04T02:33:17.847957-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1742</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1742</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1742</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The clinical use of pluripotent stem cell (PSC)-derived neural cells requires an efficient differentiation process for mass production in a bioreactor. Toward this goal, neural differentiation of murine embryonic stem cells (ESCs) in three-dimensional (3-D) polyethylene terephthalate (PET) microfibrous matrices was investigated in this study. To streamline the process and provide a platform for process integration, the neural differentiation of ESCs was induced with astrocyte-conditioned medium (ACM) without the formation of embryoid bodies (EBs), starting from undifferentiated ESC aggregates expanded in a suspension bioreactor. The 3-D neural differentiation was able to generate a complex neural network in the matrices. Compared to 2-D differentiation, 3-D differentiation in microfibrous matrices resulted in a higher percentage of nestin-positive cells (68% <em>vs.</em> 54%) and up-regulated gene expressions of nestin, Nurr1, and tyrosine hydroxylase (TH). High purity of neural differentiation in 3-D microfibrous matrix was also demonstrated in a spinner bioreactor with 74% nestin+ cells. This study demonstrated the feasibility of a scalable process based on 3-D differentiation in microfibrous matrices for the production of ESC-derived neural cells. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

The clinical use of pluripotent stem cell (PSC)-derived neural cells requires an efficient differentiation process for mass production in a bioreactor. Toward this goal, neural differentiation of murine embryonic stem cells (ESCs) in three-dimensional (3-D) polyethylene terephthalate (PET) microfibrous matrices was investigated in this study. To streamline the process and provide a platform for process integration, the neural differentiation of ESCs was induced with astrocyte-conditioned medium (ACM) without the formation of embryoid bodies (EBs), starting from undifferentiated ESC aggregates expanded in a suspension bioreactor. The 3-D neural differentiation was able to generate a complex neural network in the matrices. Compared to 2-D differentiation, 3-D differentiation in microfibrous matrices resulted in a higher percentage of nestin-positive cells (68% vs. 54%) and up-regulated gene expressions of nestin, Nurr1, and tyrosine hydroxylase (TH). High purity of neural differentiation in 3-D microfibrous matrix was also demonstrated in a spinner bioreactor with 74% nestin+ cells. This study demonstrated the feasibility of a scalable process based on 3-D differentiation in microfibrous matrices for the production of ESC-derived neural cells. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1743" xmlns="http://purl.org/rss/1.0/"><title>The critical flux method for reduced filter membrane fouling when monitoring high-solids digesters</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1743</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The critical flux method for reduced filter membrane fouling when monitoring high-solids digesters</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stephan Tait, Christopher R. Carney, Damien J. Batstone</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-04T02:33:12.71096-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1743</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1743</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1743</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Membrane fouling currently makes filtration of high-solids anaerobic sludges difficult and this is discouraging online monitoring of volatile fatty acids and control of high-solids digesters. The present study tests the critical flux approach to reduce this membrane fouling. Filtration tests are performed on two sludges, filtered via a side-stream off two full-scale digesters. Sub-critical flux operating conditions (for minimal cake layer formation) are identified for each of the sludges and the filtration units are operated at these conditions to assess longer term performance. Results for one of the sludges (co-digested primary and secondary sludge) is found to be encouraging, showing that sufficient flux rates (up to 40L.m<sup>-2</sup>.h<sup>-1</sup>) can be readily sustained to allow longer term digester monitoring and control. Filtration performance for this sludge did not deteriorate significantly over the test period. Results for the other test sludge (digested thermally hydrolysed waste activated sludge) were not as favourable and indicated that application may be limited for very high solids digesters (&gt;5% total solids concentration). Differences in filtration behaviour for the two test sludges were ascribed to the presence of complex soluble organics and the concentration and particle size of the sludge solids. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Membrane fouling currently makes filtration of high-solids anaerobic sludges difficult and this is discouraging online monitoring of volatile fatty acids and control of high-solids digesters. The present study tests the critical flux approach to reduce this membrane fouling. Filtration tests are performed on two sludges, filtered via a side-stream off two full-scale digesters. Sub-critical flux operating conditions (for minimal cake layer formation) are identified for each of the sludges and the filtration units are operated at these conditions to assess longer term performance. Results for one of the sludges (co-digested primary and secondary sludge) is found to be encouraging, showing that sufficient flux rates (up to 40L.m-2.h-1) can be readily sustained to allow longer term digester monitoring and control. Filtration performance for this sludge did not deteriorate significantly over the test period. Results for the other test sludge (digested thermally hydrolysed waste activated sludge) were not as favourable and indicated that application may be limited for very high solids digesters (&gt;5% total solids concentration). Differences in filtration behaviour for the two test sludges were ascribed to the presence of complex soluble organics and the concentration and particle size of the sludge solids. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1745" xmlns="http://purl.org/rss/1.0/"><title>Enhancing operational stability and exhibition of enzyme activity by removing water in the immobilized lipase-catalyzed production of erythorbyl laurate</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1745</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Enhancing operational stability and exhibition of enzyme activity by removing water in the immobilized lipase-catalyzed production of erythorbyl laurate</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Da Eun Lee, Kyung Min Park, Seung Jun Choi, Jae-Hoon Shim, Pahn-Shick Chang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-04T02:33:11.330797-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1745</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1745</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1745</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Erythorbyl laurate was continuously synthesized by esterification in a packed-bed enzyme reactor with immobilized-lipase from <em>Candida antarctica</em>. Response surface methodology based on a five-level three-factor central composite design was adopted to optimize conditions for the enzymatic esterification. The reaction variables, such as reaction temperature (10–70°C), substrate molar ratio ([lauric acid]/[erythorbic acid], 5–15), and residence time (8–40 min) were evaluated and their optimum conditions were found to be 56.2°C, 14.3, and 24.2 min, respectively. Under the optimum conditions, the molar conversion yield was 83.4%, which was not significantly different (<em>p</em> &lt; 0.05) from the value predicted (84.4%). Especially, continuous water removal by adsorption on an ion-exchange resin in a packed-bed enzyme reactor improved operational stability, resulting in prolongation of half-life (2.02 times longer compared to the control without water-removal system). Furthermore, in the case of batch-type reactor, it exhibited significant increase in initial velocity of molar conversion from 1.58 to 2.04%/min. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Erythorbyl laurate was continuously synthesized by esterification in a packed-bed enzyme reactor with immobilized-lipase from Candida antarctica. Response surface methodology based on a five-level three-factor central composite design was adopted to optimize conditions for the enzymatic esterification. The reaction variables, such as reaction temperature (10–70°C), substrate molar ratio ([lauric acid]/[erythorbic acid], 5–15), and residence time (8–40 min) were evaluated and their optimum conditions were found to be 56.2°C, 14.3, and 24.2 min, respectively. Under the optimum conditions, the molar conversion yield was 83.4%, which was not significantly different (p &lt; 0.05) from the value predicted (84.4%). Especially, continuous water removal by adsorption on an ion-exchange resin in a packed-bed enzyme reactor improved operational stability, resulting in prolongation of half-life (2.02 times longer compared to the control without water-removal system). Furthermore, in the case of batch-type reactor, it exhibited significant increase in initial velocity of molar conversion from 1.58 to 2.04%/min. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1744" xmlns="http://purl.org/rss/1.0/"><title>Mass production of spores of lactic acid-producing Rhizopus oryzae NBRC 5384 on agar plate</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1744</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Mass production of spores of lactic acid-producing Rhizopus oryzae NBRC 5384 on agar plate</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tsuneo Yamane, Ryosuke Tanaka</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-04T02:33:06.883596-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1744</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1744</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1744</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Mass production of sporangiospores (spores) of Rhizopus oryzae NBRC 5384 (identical to NRRL 395 and ATCC 9363) on potato-dextrose-agar medium was studied aiming at starting its L(+)-lactic acid fermentation directly from spore inoculation. Various parameters including harvest time, sowed spore density, size of agar plate, height of air space and incubation mode of plate (agar-on-bottom or agar-on-top) were studied. Ordinarily used shallow Petri dishes were found out to be unsuitable for the full growth of R. oryzae sporangiophores. In a very wide range of the sowed spore density, the smaller it was, the greater the number of the harvested spores was. It was also interesting to find out that R. oryzae grown downward vertically with a deep air space in an agar-on-top mode gave larger amount of spores than in an agar-on-bottom mode at 30 °C for 7 day cultivation. Scale-up of the agar plate culture from 26.4 to 292 cm<sup>2</sup> was studied, resulting in the proportional relationship between the number of the harvested spores/plate and the plate area in the deep Petri dishes. The number of plates of 50 cm in diameter needed for 100 m<sup>3</sup> industrial submerged fermentation started directly from 2×10<sup>5</sup> spores/mL inoculum size was estimated as ca. 6, from which it was inferred that such a fermentation would be feasible. Designing a 50 cm plate and a method of spreading and collecting the spores were suggested. Bioprocess technological significance of the ‘full-scale industrial submerged fermentation started directly from spore inoculation omitting pre-culture’ has been discussed. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Mass production of sporangiospores (spores) of Rhizopus oryzae NBRC 5384 (identical to NRRL 395 and ATCC 9363) on potato-dextrose-agar medium was studied aiming at starting its L(+)-lactic acid fermentation directly from spore inoculation. Various parameters including harvest time, sowed spore density, size of agar plate, height of air space and incubation mode of plate (agar-on-bottom or agar-on-top) were studied. Ordinarily used shallow Petri dishes were found out to be unsuitable for the full growth of R. oryzae sporangiophores. In a very wide range of the sowed spore density, the smaller it was, the greater the number of the harvested spores was. It was also interesting to find out that R. oryzae grown downward vertically with a deep air space in an agar-on-top mode gave larger amount of spores than in an agar-on-bottom mode at 30 °C for 7 day cultivation. Scale-up of the agar plate culture from 26.4 to 292 cm2 was studied, resulting in the proportional relationship between the number of the harvested spores/plate and the plate area in the deep Petri dishes. The number of plates of 50 cm in diameter needed for 100 m3 industrial submerged fermentation started directly from 2×105 spores/mL inoculum size was estimated as ca. 6, from which it was inferred that such a fermentation would be feasible. Designing a 50 cm plate and a method of spreading and collecting the spores were suggested. Bioprocess technological significance of the ‘full-scale industrial submerged fermentation started directly from spore inoculation omitting pre-culture’ has been discussed. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1734" xmlns="http://purl.org/rss/1.0/"><title>Use of the mitochondria toxicity assay for quantifying the viable cell density of microencapsulated Jurkat cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1734</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Use of the mitochondria toxicity assay for quantifying the viable cell density of microencapsulated Jurkat cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Werner, K. Biss, V. Jérôme, F. Hilbrig, R. Freitag, K. Zambrano, H. Hübner, R. Buchholz, R. Mahou, C. Wandrey</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:12:19.331805-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1734</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1734</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1734</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The mitochondria toxicity assay (MTT assay) is an established method for monitoring cell viability based on mitochondrial activity. Here the MTT assay is proposed for the <em>in situ</em> quantification of the living cell density of microencapsulated Jurkat cells. Three systems were used to encapsulate the cells, namely a membrane consisting of an interpenetrating polyelectrolyte network of sodium cellulose sulphate/poly(diallyldimethylammonium chloride) (NaCS/PDADMAC), a calcium alginate hydrogel covered with poly(L-lysine) (Ca-alg-PLL), and a novel calcium alginate-poly(ethylene glycol) hybrid material (Ca-alg-PEG). MTT results were correlated to data obtained by the trypan blue exclusion assay after release of the cells from the NaCS/PDADMAC and Ca-alg-PLL capsules, while a resazurin-based assay was used for comparison in case of the Ca-alg-PEG material. Analysis by MTT assay allows quick and reliable determination of viable cell densities of encapsulated cells independent of the capsule material. The assay is highly reproducible with inter-assay relative standard deviations below 10 %. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

The mitochondria toxicity assay (MTT assay) is an established method for monitoring cell viability based on mitochondrial activity. Here the MTT assay is proposed for the in situ quantification of the living cell density of microencapsulated Jurkat cells. Three systems were used to encapsulate the cells, namely a membrane consisting of an interpenetrating polyelectrolyte network of sodium cellulose sulphate/poly(diallyldimethylammonium chloride) (NaCS/PDADMAC), a calcium alginate hydrogel covered with poly(L-lysine) (Ca-alg-PLL), and a novel calcium alginate-poly(ethylene glycol) hybrid material (Ca-alg-PEG). MTT results were correlated to data obtained by the trypan blue exclusion assay after release of the cells from the NaCS/PDADMAC and Ca-alg-PLL capsules, while a resazurin-based assay was used for comparison in case of the Ca-alg-PEG material. Analysis by MTT assay allows quick and reliable determination of viable cell densities of encapsulated cells independent of the capsule material. The assay is highly reproducible with inter-assay relative standard deviations below 10 %. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1732" xmlns="http://purl.org/rss/1.0/"><title>Chitinolytic enzymes: An appraisal as a product of commercial potential</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1732</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Chitinolytic enzymes: An appraisal as a product of commercial potential</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. B. Chavan, M. V. Deshpande</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:12:05.370333-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1732</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1732</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1732</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Chitin, its deacetylated form, chitosan and chitinolytic enzymes viz. endo-chitinase, <em>N</em>-acetylglucosaminidase, chitosanase, chitin deacetylase are gaining importance for their biotechnological applications. Presently chitin degrading enzymes constitute high-cost low-volume products in human health care and associated research. Indeed chitinases and chitin deacetylase-chitosanase complex possesss tremendous potential in agriculture to control plant pathogenic fungi and insects. The success in exploring chitinases especially for agriculture i.e. as a high-volume low-cost product, depends on the availability of highly active preparations with a reasonable cost. Therefore, a reconsideration in terms of understanding the roles of chitinolytic enzymes in applications, <em>e.g</em>. host-pathogen interaction for biocontrol, different mechanisms of chitin degradation, and identification of new enzymes with varying specificities, may make them more useful in a variety of commercial processes in the near future. The possible issues and challenges encountered in the translation of proof of concept into a commercial product will be appraised in this review. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

Chitin, its deacetylated form, chitosan and chitinolytic enzymes viz. endo-chitinase, N-acetylglucosaminidase, chitosanase, chitin deacetylase are gaining importance for their biotechnological applications. Presently chitin degrading enzymes constitute high-cost low-volume products in human health care and associated research. Indeed chitinases and chitin deacetylase-chitosanase complex possesss tremendous potential in agriculture to control plant pathogenic fungi and insects. The success in exploring chitinases especially for agriculture i.e. as a high-volume low-cost product, depends on the availability of highly active preparations with a reasonable cost. Therefore, a reconsideration in terms of understanding the roles of chitinolytic enzymes in applications, e.g. host-pathogen interaction for biocontrol, different mechanisms of chitin degradation, and identification of new enzymes with varying specificities, may make them more useful in a variety of commercial processes in the near future. The possible issues and challenges encountered in the translation of proof of concept into a commercial product will be appraised in this review. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1733" xmlns="http://purl.org/rss/1.0/"><title>Metabolic engineering of clostridium acetobutylicum for the enhanced production of isopropanol-butanol-ethanol fuel mixture</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1733</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Metabolic engineering of clostridium acetobutylicum for the enhanced production of isopropanol-butanol-ethanol fuel mixture</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yu-Sin Jang, Alok Malaviya, Joungmin Lee, Jung Ae Im, Sang Yup Lee, Julia Lee, Moon-Ho Eom, Jung-Hee Cho, Do Young Seung</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:12:00.964947-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1733</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1733</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1733</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Butanol is considered as a superior biofuel which is conventionally produced by clostridial acetone-butanol-ethanol (ABE) fermentation. Among ABE, only butanol and ethanol can be used as fuel alternatives. Co-production of acetone thus causes lower yield of fuel alcohols. Thus, this study aimed at developing an improved <em>Clostridium acetobutylicum</em> strain possessing enhanced fuel alcohol production capability. For this, a hyper ABE producing BKM19 strain we previously developed was further engineered to convert acetone into isopropanol. The BKM19 strain was transformed with the plasmid pIPA100 containing the <em>sadh</em> (primary/secondary alcohol dehydrogenase) and <em>hydG</em> (putative electron transfer protein) genes from the <em>Clostridium beijerinckii</em> NRRL B593 cloned under the control of the thiolase promoter. The resulting BKM19 (pIPA100) strain produced 27.9 g/L isopropanol-butanol-ethanol (IBE) as a fuel alcohols with negligible amount of acetone (0.4 g/L) from 97.8 g/L glucose in lab-scale (2 L) batch fermentation. Thus, this metabolically engineered strain was able to produce 99% of total solvent produced as fuel alcohols. The scalability and stability of BKM19 (pIPA100) were evaluated at 200 L pilot-scale fermentation, which showed that the fuel alcohol yield could be improved to 0.37 g/g as compared to 0.29 g/g obtained at lab-scale fermentation, while attaining a similar titer. To the best of our knowledge, this is the highest titer of IBE achieved and the first report on the large scale fermentation of <em>C. acetobutylicum</em> for IBE production. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

Butanol is considered as a superior biofuel which is conventionally produced by clostridial acetone-butanol-ethanol (ABE) fermentation. Among ABE, only butanol and ethanol can be used as fuel alternatives. Co-production of acetone thus causes lower yield of fuel alcohols. Thus, this study aimed at developing an improved Clostridium acetobutylicum strain possessing enhanced fuel alcohol production capability. For this, a hyper ABE producing BKM19 strain we previously developed was further engineered to convert acetone into isopropanol. The BKM19 strain was transformed with the plasmid pIPA100 containing the sadh (primary/secondary alcohol dehydrogenase) and hydG (putative electron transfer protein) genes from the Clostridium beijerinckii NRRL B593 cloned under the control of the thiolase promoter. The resulting BKM19 (pIPA100) strain produced 27.9 g/L isopropanol-butanol-ethanol (IBE) as a fuel alcohols with negligible amount of acetone (0.4 g/L) from 97.8 g/L glucose in lab-scale (2 L) batch fermentation. Thus, this metabolically engineered strain was able to produce 99% of total solvent produced as fuel alcohols. The scalability and stability of BKM19 (pIPA100) were evaluated at 200 L pilot-scale fermentation, which showed that the fuel alcohol yield could be improved to 0.37 g/g as compared to 0.29 g/g obtained at lab-scale fermentation, while attaining a similar titer. To the best of our knowledge, this is the highest titer of IBE achieved and the first report on the large scale fermentation of C. acetobutylicum for IBE production. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1730" xmlns="http://purl.org/rss/1.0/"><title>Chinese hamster ovary (CHO) K1 host cell enables stable cell line development for antibody molecules which are difficult to express in DUXB11-derived dihydrofolate reductase (DHFR) deficient host cell</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1730</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Chinese hamster ovary (CHO) K1 host cell enables stable cell line development for antibody molecules which are difficult to express in DUXB11-derived dihydrofolate reductase (DHFR) deficient host cell</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Zhilan Hu, Donglin Guo, Shirley S.M. Yip, Dejin Zhan, Shahram Misaghi, John C. Joly, Bradley R. Snedecor, Amy Y. Shen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:11:56.847813-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1730</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1730</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1730</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Therapeutic monoclonal antibodies (mAb) are often produced in Chinese hamster ovary (CHO) cells. Three commonly used CHO host cells for generating stable cell lines to produce therapeutic proteins are dihydrofolate reductase (DHFR) positive CHOK1, DHFR-deficient DG44, and DUXB11-based DHFR deficient CHO. Current Genentech commercial full-length antibody products have all been produced in the DUXB11-derived DHFR-deficient CHO host. However, it has been challenging to develop stable cell lines producing an appreciable amount of antibody proteins in the DUXB11-derived DHFR-deficient CHO host for some antibody molecules and the CHOK1 host has been explored as an alternative approach. In this work, stable cell lines were developed for three antibody molecules in both DUXB11-based and CHOK1 hosts. Results have shown that the best CHOK1 clones produce approximately 1 g/L for an antibody mAb1 and about 4 g/L for an antibody mAb2 in 14-day fed batch cultures in shake flasks. In contrast, the DUXB11-based host produced ~0.1 g/L for both antibodies in the same 14-day fed batch shake flask production experiments. For an antibody mAb3, both CHOK1 and DUXB11 host cells can generate stable cell lines with the best clone in each host producing approximately 2.5 g/L. Additionally, studies have shown that the CHOK1 host cell has a larger endoplasmic reticulum (ER) and higher mitochondrial mass. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

Therapeutic monoclonal antibodies (mAb) are often produced in Chinese hamster ovary (CHO) cells. Three commonly used CHO host cells for generating stable cell lines to produce therapeutic proteins are dihydrofolate reductase (DHFR) positive CHOK1, DHFR-deficient DG44, and DUXB11-based DHFR deficient CHO. Current Genentech commercial full-length antibody products have all been produced in the DUXB11-derived DHFR-deficient CHO host. However, it has been challenging to develop stable cell lines producing an appreciable amount of antibody proteins in the DUXB11-derived DHFR-deficient CHO host for some antibody molecules and the CHOK1 host has been explored as an alternative approach. In this work, stable cell lines were developed for three antibody molecules in both DUXB11-based and CHOK1 hosts. Results have shown that the best CHOK1 clones produce approximately 1 g/L for an antibody mAb1 and about 4 g/L for an antibody mAb2 in 14-day fed batch cultures in shake flasks. In contrast, the DUXB11-based host produced ~0.1 g/L for both antibodies in the same 14-day fed batch shake flask production experiments. For an antibody mAb3, both CHOK1 and DUXB11 host cells can generate stable cell lines with the best clone in each host producing approximately 2.5 g/L. Additionally, studies have shown that the CHOK1 host cell has a larger endoplasmic reticulum (ER) and higher mitochondrial mass. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1728" xmlns="http://purl.org/rss/1.0/"><title>Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1728</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Erik K. Read, Scott A. Bradley, Tim A. Smitka, Cyrus D. Agarabi, Scott C. Lute, Kurt A. Brorson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:11:51.327137-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1728</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1728</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1728</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Fermentanomics, or a global understanding of a culture state on the molecular level empowered by advanced techniques like NMR, was employed to show that a model hybridoma culture supplied with glutamine and glucose depletes aspartate, cysteine, methionine, tryptophan, and tyrosine during antibody production. Supplementation with these amino acids prevents depletion and improves culture performance. Furthermore, no significant changes were observed in the distribution of glycans attached to the IgG3 in cultures supplemented with specific amino acids, arguing that this strategy can be implemented without fear of impacts on important product quality attributes. In summary, a targeted strategy of quantifying media components and designing a supplementation strategy can improve bioprocess cell cultures when enpowered by fermentanomics tools. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

Fermentanomics, or a global understanding of a culture state on the molecular level empowered by advanced techniques like NMR, was employed to show that a model hybridoma culture supplied with glutamine and glucose depletes aspartate, cysteine, methionine, tryptophan, and tyrosine during antibody production. Supplementation with these amino acids prevents depletion and improves culture performance. Furthermore, no significant changes were observed in the distribution of glycans attached to the IgG3 in cultures supplemented with specific amino acids, arguing that this strategy can be implemented without fear of impacts on important product quality attributes. In summary, a targeted strategy of quantifying media components and designing a supplementation strategy can improve bioprocess cell cultures when enpowered by fermentanomics tools. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1731" xmlns="http://purl.org/rss/1.0/"><title>Cell-based screening of traditional chinese medicines for proliferation enhancers of mouse embryonic stem cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1731</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cell-based screening of traditional chinese medicines for proliferation enhancers of mouse embryonic stem cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ding Li, Sarah Isherwood, Andrew Motz, Ru Zang, Shang-Tian Yang, Jufang Wang, Xiaoning Wang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:10:35.896348-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1731</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1731</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1731</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>A high-throughput cell-based method was developed for screening traditional Chinese herbal medicines (TCHMs) for potential stem cell growth promoters. Mouse embryonic stem (mES) cells expressing enhanced green fluorescent protein (EGFP) were cultured in growth media supplemented with various TCHM extracts. The dosage-dependent effects of TCHM extracts on cell growth, including proliferation and cytotoxicity, were assessed via EGFP fluorescence measurement. Seven TCHMs were investigated, and among them <em>Panax notoginseng</em> (PN), <em>Rhizoma Atractylodis macrocephalae</em> (RAM), <em>Rhizoma chuanxiong</em> (RC) and <em>Ganoderma lucidum</em> spores (GLS) showed potential to improve mES cell proliferation. Eleven mixtures of these 4 TCHMs were then studied, and the results showed that the mixture of PN and GLS had the strongest growth promoting effect, increasing the specific growth rate of mES cells by 29.5% at a low dosage of 0.01% (w/v) PN/GLS (<em>p</em> &lt; 0.01) and 34.2% at 0.1% (w/v) PN/GLS (<em>p</em> &lt; 0.05) compared to the control. The growth promoting effect of PN/GLS was further confirmed with ES cells cultured in spinner flasks. A 29.3-fold increase in the total cell number was achieved in the medium supplemented with 0.01% PN/GLS after 5 days, while the control culture only gave a 16.8-fold increase. This cell-based screening method thus can provide an efficient and high-throughput way to explore potential stem cell growth promoters from TCHMs. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

A high-throughput cell-based method was developed for screening traditional Chinese herbal medicines (TCHMs) for potential stem cell growth promoters. Mouse embryonic stem (mES) cells expressing enhanced green fluorescent protein (EGFP) were cultured in growth media supplemented with various TCHM extracts. The dosage-dependent effects of TCHM extracts on cell growth, including proliferation and cytotoxicity, were assessed via EGFP fluorescence measurement. Seven TCHMs were investigated, and among them Panax notoginseng (PN), Rhizoma Atractylodis macrocephalae (RAM), Rhizoma chuanxiong (RC) and Ganoderma lucidum spores (GLS) showed potential to improve mES cell proliferation. Eleven mixtures of these 4 TCHMs were then studied, and the results showed that the mixture of PN and GLS had the strongest growth promoting effect, increasing the specific growth rate of mES cells by 29.5% at a low dosage of 0.01% (w/v) PN/GLS (p &lt; 0.01) and 34.2% at 0.1% (w/v) PN/GLS (p &lt; 0.05) compared to the control. The growth promoting effect of PN/GLS was further confirmed with ES cells cultured in spinner flasks. A 29.3-fold increase in the total cell number was achieved in the medium supplemented with 0.01% PN/GLS after 5 days, while the control culture only gave a 16.8-fold increase. This cell-based screening method thus can provide an efficient and high-throughput way to explore potential stem cell growth promoters from TCHMs. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1729" xmlns="http://purl.org/rss/1.0/"><title>Purification and biochemical characterization of feruloyl esterases from Aspergillus terreus MTCC 11096</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1729</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Purification and biochemical characterization of feruloyl esterases from Aspergillus terreus MTCC 11096</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Ganesh Kumar, Avijeet Kamle, Ahmed Kamal</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:10:30.673058-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1729</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1729</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1729</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Aspergillus terreus</em> MTCC 11096 isolated from the soils of agricultural fields cultivating sweet sorghum was previously identified to produce feruloyl esterases (FAE). The enzymes responsible for feruloyl esterase activity were purified to homogeneity and named as AtFAE-1, AtFAE-2 and AtFAE-3. The enzymes were monomeric having molecular masses of 74, 23 and 36 kDa, respectively. Active protein bands were identified by a developed pH-dependent zymogram on native PAGE. The three enzymes exhibited variation in pH tolerance ranging between pH 5-8 and thermostability of up to 55 °C. Inhibition studies revealed that the serine residue was essential for feruloyl esterase activity; moreover aspartyl and glutamyl residues are not totally involved at the active site. Metal ions such as Ca<sup>2+</sup>, K<sup>+</sup> and Mg<sup>2+</sup> stabilized the enzyme activity for all three feruloyl esterases. Kinetic data indicated that all three enzymes showed catalytic efficiencies (<em>k</em><sub>cat</sub> /<em>K</em><sub>m</sub>) against different synthesized alkyl and aryl esters indicating their broad substrate specificity. The peptide mass fingerprinting by MALDI/TOF-MS analysis and enzyme affinity towards methoxy and hydroxy substituents on the benzene ring revealed that the AtFAE-1 belonged to type A while AtFAE-2 and AtFAE-3 were type C feruloyl esterases. The FAEs could release 65% to 90% of ferulic acid from agro-waste substrates in the presence of xylanase. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

Aspergillus terreus MTCC 11096 isolated from the soils of agricultural fields cultivating sweet sorghum was previously identified to produce feruloyl esterases (FAE). The enzymes responsible for feruloyl esterase activity were purified to homogeneity and named as AtFAE-1, AtFAE-2 and AtFAE-3. The enzymes were monomeric having molecular masses of 74, 23 and 36 kDa, respectively. Active protein bands were identified by a developed pH-dependent zymogram on native PAGE. The three enzymes exhibited variation in pH tolerance ranging between pH 5-8 and thermostability of up to 55 °C. Inhibition studies revealed that the serine residue was essential for feruloyl esterase activity; moreover aspartyl and glutamyl residues are not totally involved at the active site. Metal ions such as Ca2+, K+ and Mg2+ stabilized the enzyme activity for all three feruloyl esterases. Kinetic data indicated that all three enzymes showed catalytic efficiencies (kcat /Km) against different synthesized alkyl and aryl esters indicating their broad substrate specificity. The peptide mass fingerprinting by MALDI/TOF-MS analysis and enzyme affinity towards methoxy and hydroxy substituents on the benzene ring revealed that the AtFAE-1 belonged to type A while AtFAE-2 and AtFAE-3 were type C feruloyl esterases. The FAEs could release 65% to 90% of ferulic acid from agro-waste substrates in the presence of xylanase. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1726" xmlns="http://purl.org/rss/1.0/"><title>Differential response in downstream processing of CHO cells grown under mild hypothermic conditions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1726</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Differential response in downstream processing of CHO cells grown under mild hypothermic conditions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A.S. Tait, R.D.R. Tarrant, M.L. Velez-Suberbie, D.I.R. Spencer, D.G. Bracewell</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:10:28.343733-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1726</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1726</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1726</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The manufacture of complex therapeutic proteins using mammalian cells is well established, with several strategies developed to improve productivity. The application of sustained mild hypothermic conditions during culture has been associated with increases in product titre and improved product quality. However, despite associated cell physiological effects, very few studies have investigated the impact on downstream processing (DSP).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Characterisation of cells grown under mild hypothermic conditions demonstrated that the stationary phase was prolonged by delaying the onset of apoptosis. This enabled cells to maintain viability for extended periods of time and increase volumetric productivity from 0.74 g L<sup>-1</sup> to 1.02 g L<sup>-1</sup>. However, host cell proteins, measured by ELISA, increased by ~50%, attributed to the extended time course and higher peak and harvest cell densities. The individual components making up this impurity, as determined by SELDI-TOF MS and 2D-PAGE, were shown to be largely comparable.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Under mild hypothermic conditions cells were less shear sensitive than those maintained at 37°C, enhancing the preliminary primary recovery step. Adaptive changes in membrane fluidity were further investigated by adopting a pronounced temperature shift immediately prior to primary recovery and the improvement observed suggests that such a strategy may be implementable when shear sensitivity is of concern. Early and late apoptotic cells were particularly susceptible to shear, at either temperature, even under the lowest shear rate investigated. These findings demonstrate the importance of considering the impact of cell culture strategies and cell physiology on DSP, by implementing a range of experimental methods for process characterisation. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

The manufacture of complex therapeutic proteins using mammalian cells is well established, with several strategies developed to improve productivity. The application of sustained mild hypothermic conditions during culture has been associated with increases in product titre and improved product quality. However, despite associated cell physiological effects, very few studies have investigated the impact on downstream processing (DSP).
Characterisation of cells grown under mild hypothermic conditions demonstrated that the stationary phase was prolonged by delaying the onset of apoptosis. This enabled cells to maintain viability for extended periods of time and increase volumetric productivity from 0.74 g L-1 to 1.02 g L-1. However, host cell proteins, measured by ELISA, increased by ~50%, attributed to the extended time course and higher peak and harvest cell densities. The individual components making up this impurity, as determined by SELDI-TOF MS and 2D-PAGE, were shown to be largely comparable.
Under mild hypothermic conditions cells were less shear sensitive than those maintained at 37°C, enhancing the preliminary primary recovery step. Adaptive changes in membrane fluidity were further investigated by adopting a pronounced temperature shift immediately prior to primary recovery and the improvement observed suggests that such a strategy may be implementable when shear sensitivity is of concern. Early and late apoptotic cells were particularly susceptible to shear, at either temperature, even under the lowest shear rate investigated. These findings demonstrate the importance of considering the impact of cell culture strategies and cell physiology on DSP, by implementing a range of experimental methods for process characterisation. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1727" xmlns="http://purl.org/rss/1.0/"><title>Feed rate control in fed-batch fermentations based on frequency content analysis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1727</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Feed rate control in fed-batch fermentations based on frequency content analysis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ola Johnsson, Jonas Andersson, Gunnar Lidén, Charlotta Johnsson, Tore Hägglund</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T05:10:22.756205-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1727</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1727</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1727</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>A new strategy for controlling substrate feed in the exponential growth phase of aerated fed-batch fermentations is presented. The challenge in this phase is typically to maximize specific growth rate while avoiding the accumulation of overflow metabolites which can occur at high substrate feed rates. In the new strategy, regular perturbations to the feed rate are applied and the proximity to overflow metabolism is continuously assessed from the frequency spectrum of the dissolved oxygen signal. The power spectral density for the frequency of the external perturbations is used as a control variable in a controller to regulate the substrate feed. The strategy was implemented in an industrial pilot scale fermentation set up and calibrated and verified using an amylase producing <em>Bacillus licheniformis</em> strain. It was shown that a higher biomass yield could be obtained without excessive accumulation of harmful overflow metabolites. The general applicability of the strategy was further demonstrated by implementing the controller in another process utilizing a <em>Bacillus licheniformis</em> strain currently used in industrial production processes. Also in this case a higher growth rate and decreased accumulation of overflow metabolites in the exponential growth phase was achieved in comparison to the reference controller. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog., <em>2013</em></p></div>
]]></content:encoded><description>

A new strategy for controlling substrate feed in the exponential growth phase of aerated fed-batch fermentations is presented. The challenge in this phase is typically to maximize specific growth rate while avoiding the accumulation of overflow metabolites which can occur at high substrate feed rates. In the new strategy, regular perturbations to the feed rate are applied and the proximity to overflow metabolism is continuously assessed from the frequency spectrum of the dissolved oxygen signal. The power spectral density for the frequency of the external perturbations is used as a control variable in a controller to regulate the substrate feed. The strategy was implemented in an industrial pilot scale fermentation set up and calibrated and verified using an amylase producing Bacillus licheniformis strain. It was shown that a higher biomass yield could be obtained without excessive accumulation of harmful overflow metabolites. The general applicability of the strategy was further demonstrated by implementing the controller in another process utilizing a Bacillus licheniformis strain currently used in industrial production processes. Also in this case a higher growth rate and decreased accumulation of overflow metabolites in the exponential growth phase was achieved in comparison to the reference controller. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1725" xmlns="http://purl.org/rss/1.0/"><title>Separation, antitumor activities and encapsulation of polypeptide from Chlorella pyrenoidosa</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1725</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Separation, antitumor activities and encapsulation of polypeptide from Chlorella pyrenoidosa</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Xiaoqin Wang, Xuewu Zhang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-13T04:00:55.809568-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1725</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1725</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1725</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Chlorella pyrenoidosa</em> is an unicellular green algae and has been a popular foodstuff worldwide. However, no reports on the antitumor peptides from such a microalgae are available in the literature. In this study, using low-temperature high-pressure extraction, enzymatic hydrolysis, ion exchange and gel filtration chromatography, we separated a polypeptide that exhibited inhibitory activity on human liver cancer HepG2 cells, and named the polypeptide CPAP (<em>Chlorella pyrenoidosa</em> antitumor polypeptide). Furthermore, the micro- and nanoencapsulation of CPAP were investigated by using two methods: complex coacervation and ionotropic gelation. The in vitro release tests revealed that CPAP was well preserved against gastric enzymatic degradation after micro/nanoencapsulation and the slowly-controlled release in the intestine could be potentially achieved. These results suggest that CPAP may be a useful ingredient in food, nutraceutical, and pharmaceutical applications. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

Chlorella pyrenoidosa is an unicellular green algae and has been a popular foodstuff worldwide. However, no reports on the antitumor peptides from such a microalgae are available in the literature. In this study, using low-temperature high-pressure extraction, enzymatic hydrolysis, ion exchange and gel filtration chromatography, we separated a polypeptide that exhibited inhibitory activity on human liver cancer HepG2 cells, and named the polypeptide CPAP (Chlorella pyrenoidosa antitumor polypeptide). Furthermore, the micro- and nanoencapsulation of CPAP were investigated by using two methods: complex coacervation and ionotropic gelation. The in vitro release tests revealed that CPAP was well preserved against gastric enzymatic degradation after micro/nanoencapsulation and the slowly-controlled release in the intestine could be potentially achieved. These results suggest that CPAP may be a useful ingredient in food, nutraceutical, and pharmaceutical applications. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1724" xmlns="http://purl.org/rss/1.0/"><title>Hemorheological implications of perfluorocarbon based oxygen carrier interaction with colloid plasma expanders and blood</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1724</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Hemorheological implications of perfluorocarbon based oxygen carrier interaction with colloid plasma expanders and blood</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Diana M. Vásquez, Daniel Ortiz, Oscar A. Alvarez, Juan C. Briceño, Pedro Cabrales</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-08T07:45:58.60212-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1724</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1724</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1724</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Perfluorocarbon (PFC) emulsion based oxygen carriers lack colloid osmotic pressure (COP) and must be administered with colloid-based plasma expanders (PEs). Although PFC emulsions have been widely studied, there is limited information about PFC emulsion interaction with PEs and blood. Their interaction forms aggregates due to electrostatic and rheological phenomena, and change blood rheology and blood flow. This study analyzes the effects of the interaction between PFC emulsions with blood in the presence of clinically-used PEs. The rheological behavior of the mixtures was analyzed in parallel with <em>in vivo</em> analysis of blood flow in microvessels using intravital microscopy when administered in a clinically relevant scenario. The interaction between the PFC emulsion and PE with blood produced PFC droplets and red blood cell (RBCs) aggregation, and increased blood viscosity. The PFC droplets formed aggregates when mixed with PEs containing electrolytes, and the aggregation increased with the electrolyte concentration. Mixtures of PFC with PEs that produced PFC aggregates also induced RCBs aggregation when mixed with blood, increasing blood viscosity at low shear rates. The more viscous suspension at low shear rates produced a blunted blood flow velocity profile in vivo relative to non-aggregating mixtures of PFC and PEs. For the PEs evaluated, albumin produced minimal to undetectable aggregation. PFC and PEs interaction with blood can affect sections of the microcirculation with low shear rate (e.g. arterioles, venules, and pulmonary circulation) because aggregates could cause capillary occlusion, decrease perfusion, pulmonary emboli, or focal ischemia. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

Perfluorocarbon (PFC) emulsion based oxygen carriers lack colloid osmotic pressure (COP) and must be administered with colloid-based plasma expanders (PEs). Although PFC emulsions have been widely studied, there is limited information about PFC emulsion interaction with PEs and blood. Their interaction forms aggregates due to electrostatic and rheological phenomena, and change blood rheology and blood flow. This study analyzes the effects of the interaction between PFC emulsions with blood in the presence of clinically-used PEs. The rheological behavior of the mixtures was analyzed in parallel with in vivo analysis of blood flow in microvessels using intravital microscopy when administered in a clinically relevant scenario. The interaction between the PFC emulsion and PE with blood produced PFC droplets and red blood cell (RBCs) aggregation, and increased blood viscosity. The PFC droplets formed aggregates when mixed with PEs containing electrolytes, and the aggregation increased with the electrolyte concentration. Mixtures of PFC with PEs that produced PFC aggregates also induced RCBs aggregation when mixed with blood, increasing blood viscosity at low shear rates. The more viscous suspension at low shear rates produced a blunted blood flow velocity profile in vivo relative to non-aggregating mixtures of PFC and PEs. For the PEs evaluated, albumin produced minimal to undetectable aggregation. PFC and PEs interaction with blood can affect sections of the microcirculation with low shear rate (e.g. arterioles, venules, and pulmonary circulation) because aggregates could cause capillary occlusion, decrease perfusion, pulmonary emboli, or focal ischemia. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1722" xmlns="http://purl.org/rss/1.0/"><title>Resilient immortals, characterizing and utilizing bax/bak deficient chinese hamster ovary (CHO) cells for high titer antibody production</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1722</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Resilient immortals, characterizing and utilizing bax/bak deficient chinese hamster ovary (CHO) cells for high titer antibody production</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shahram Misaghi, Yan Qu, Andrew Snowden, Jennifer Chang, Brad Snedecor</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-08T07:45:48.906941-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1722</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1722</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1722</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Cell death due to apoptosis is frequently observed in large-scale manufacturing of therapeutic proteins, and can reduce product accumulation in bioreactors. Several different strategies that involve over-expression of anti-apoptotic or down-regulation of pro-apoptotic proteins have been designed in attempt to curb this problem in Chinese hamster ovary (CHO) cell culture. However, each of these designs have their own shortcomings and limits, rendering them ineffective for large-scale protein production. Recently, we have reported generation of a Bax and Bak deficient dhfr<sup>-/-</sup> CHO cell line using zinc-finger nucleases. Here we demonstrate that puromycin, but not methotrexate, selection can be used to generate antibody-expressing Bax and Bak deficient clones that are not only resistant to apoptosis, but that can also achieve higher titers relative to parental CHO cells due to higher cell density. Additionally, we show that Bax and Bak deficient cells have more mitochondria with healthy membrane potential, an attribute that perhaps contributes to their more potent growth compared to parental cells. Bax and Bak deficient cells do not readily apoptose, as shown by the ability to withstand high concentrations of apoptosis inducing agents, such as sodium butyrate, without a reduction in viability, growth or titer. These traits render Bax and Bak deficient cells a potentially attractive host for production of therapeutic proteins at industrial scale. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

Cell death due to apoptosis is frequently observed in large-scale manufacturing of therapeutic proteins, and can reduce product accumulation in bioreactors. Several different strategies that involve over-expression of anti-apoptotic or down-regulation of pro-apoptotic proteins have been designed in attempt to curb this problem in Chinese hamster ovary (CHO) cell culture. However, each of these designs have their own shortcomings and limits, rendering them ineffective for large-scale protein production. Recently, we have reported generation of a Bax and Bak deficient dhfr-/- CHO cell line using zinc-finger nucleases. Here we demonstrate that puromycin, but not methotrexate, selection can be used to generate antibody-expressing Bax and Bak deficient clones that are not only resistant to apoptosis, but that can also achieve higher titers relative to parental CHO cells due to higher cell density. Additionally, we show that Bax and Bak deficient cells have more mitochondria with healthy membrane potential, an attribute that perhaps contributes to their more potent growth compared to parental cells. Bax and Bak deficient cells do not readily apoptose, as shown by the ability to withstand high concentrations of apoptosis inducing agents, such as sodium butyrate, without a reduction in viability, growth or titer. These traits render Bax and Bak deficient cells a potentially attractive host for production of therapeutic proteins at industrial scale. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1723" xmlns="http://purl.org/rss/1.0/"><title>Strictosidine-related enzymes involved in the alkaloid biosynthesis of Uncaria tomentosa root cultures grown under oxidative stress</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1723</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Strictosidine-related enzymes involved in the alkaloid biosynthesis of Uncaria tomentosa root cultures grown under oxidative stress</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ileana Vera-Reyes, Ariana A. Huerta-Heredia, Teresa Ponce-Noyola, Isvett Josefina Flores-Sanchez, Fernando Esparza-García, Carlos M. Cerda-García-Rojas, Gabriela Trejo-Tapia, Ana C. Ramos-Valdivia</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-08T07:45:45.827115-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1723</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1723</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1723</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The activity and gene expression of strictosidine-related enzymes in <em>Uncaria tomentosa</em> root cultures exposed to oxidative stress were studied. Elicitation with 0.2 mM hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) or a combination of 0.8 mM buthionine sulfoximine and 0.2 mM jasmonic acid (BSO-JA) increased peroxidase activities by 2-fold at day 8 and glutathione reductase by 1.4-fold at day 5 in H<sub>2</sub>O<sub>2</sub> elicited cultures respect to the control. Production of monoterpenoid oxindole alkaloids (MOA), 3α-dihydrocadambine, and dolichantoside was stimulated after H<sub>2</sub>O<sub>2</sub> elicitation, reaching levels of 886.4 ± 23.6, 847.7 ± 25.4, and 87.5 ± 7.2 µg/g DW, at day 8 which were 1.7-, 2.1- and 2.3-fold higher relative to control. BSO-JA elicited cultures produced ca. twice alkaloids than H<sub>2</sub>O<sub>2</sub> treated cultures, following a biphasic pattern with maxima at 0.5 and 8 days. Alkaloid production was preceded by increase in strictosidine synthase (STR) and strictosidine glucosidase (SGD) activities. After elicitation with H<sub>2</sub>O<sub>2</sub> or BSO-JA, the STR activity (pKat/mg protein) increased by 1.9-fold (93.8 ± 17.8 at 24 h) or 2.5-fold (102.4 ± 2.2 at 6 h) and the SGD activity (pKat/mg protein) by 2.8-fold (245.2 ± 14.4 at 6 h) or 4.2-fold (421.2 ± 1.8 at 18 h) relative to control. <em>STR</em> and <em>SGD</em> transcripts were upregulated after elicitation. H<sub>2</sub>O<sub>2</sub> treated roots showed higher levels of <em>STR</em> at 48-192 h and <em>SGD</em> at 24-48 h, while BSO-JA treatments showed <em>STR</em> increased at 12 h and <em>SGD</em> at 24 h. Also, LC/ESI-MS confirmed the biosynthesis of dolichantoside from <em>N</em>-ω-methyltryptamine and secologanin by <em>U. tomentosa</em> protein extracts. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.<em>, 2013</em></p></div>
]]></content:encoded><description>

The activity and gene expression of strictosidine-related enzymes in Uncaria tomentosa root cultures exposed to oxidative stress were studied. Elicitation with 0.2 mM hydrogen peroxide (H2O2) or a combination of 0.8 mM buthionine sulfoximine and 0.2 mM jasmonic acid (BSO-JA) increased peroxidase activities by 2-fold at day 8 and glutathione reductase by 1.4-fold at day 5 in H2O2 elicited cultures respect to the control. Production of monoterpenoid oxindole alkaloids (MOA), 3α-dihydrocadambine, and dolichantoside was stimulated after H2O2 elicitation, reaching levels of 886.4 ± 23.6, 847.7 ± 25.4, and 87.5 ± 7.2 µg/g DW, at day 8 which were 1.7-, 2.1- and 2.3-fold higher relative to control. BSO-JA elicited cultures produced ca. twice alkaloids than H2O2 treated cultures, following a biphasic pattern with maxima at 0.5 and 8 days. Alkaloid production was preceded by increase in strictosidine synthase (STR) and strictosidine glucosidase (SGD) activities. After elicitation with H2O2 or BSO-JA, the STR activity (pKat/mg protein) increased by 1.9-fold (93.8 ± 17.8 at 24 h) or 2.5-fold (102.4 ± 2.2 at 6 h) and the SGD activity (pKat/mg protein) by 2.8-fold (245.2 ± 14.4 at 6 h) or 4.2-fold (421.2 ± 1.8 at 18 h) relative to control. STR and SGD transcripts were upregulated after elicitation. H2O2 treated roots showed higher levels of STR at 48-192 h and SGD at 24-48 h, while BSO-JA treatments showed STR increased at 12 h and SGD at 24 h. Also, LC/ESI-MS confirmed the biosynthesis of dolichantoside from N-ω-methyltryptamine and secologanin by U. tomentosa protein extracts. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1721" xmlns="http://purl.org/rss/1.0/"><title>Microplates as a microreactor platform for microalgae research</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1721</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Microplates as a microreactor platform for microalgae research</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adriana Pacheco, Ileana Hernández-Mireles, Cecilia García-Martínez, Mario M. Álvarez</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:27:41.873277-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1721</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1721</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1721</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>High-throughput platforms for microalgae screening are not yet commercially available. In this study, the feasibility of 96-well microplates was analyzed for microalgae research. Equivalence among wells, as culture microreactors, was investigated in controlled high CO<sub>2</sub> conditions. Specific growth rates of two microalgae species, <em>Scenedesmus</em> sp. UTEX 1589 and an environmental isolate, were significantly higher in border wells than in internal positions. Furthermore, growth rate gradients analyzed as contours throughout the platform were observed for <em>Scenedesmus</em> sp. However, the output variable exhibited high precision associated with a low coefficient of variation (CV), between 6.8-7.8%. In a demonstrative experiment to determine the effect of culture media dilution on six microalgae species, treatments were randomized in the central subset of a microplate. Results were consistent and statistically sound (CV 9.4-12.9%), and showed that microalgae species could grow with no detrimental effect in 50% (v/v) dilution of the culture medium. Provided border wells exclusion and a randomized design, 96-well microplates are a practical and statistical robust platform for microalgae research. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

High-throughput platforms for microalgae screening are not yet commercially available. In this study, the feasibility of 96-well microplates was analyzed for microalgae research. Equivalence among wells, as culture microreactors, was investigated in controlled high CO2 conditions. Specific growth rates of two microalgae species, Scenedesmus sp. UTEX 1589 and an environmental isolate, were significantly higher in border wells than in internal positions. Furthermore, growth rate gradients analyzed as contours throughout the platform were observed for Scenedesmus sp. However, the output variable exhibited high precision associated with a low coefficient of variation (CV), between 6.8-7.8%. In a demonstrative experiment to determine the effect of culture media dilution on six microalgae species, treatments were randomized in the central subset of a microplate. Results were consistent and statistically sound (CV 9.4-12.9%), and showed that microalgae species could grow with no detrimental effect in 50% (v/v) dilution of the culture medium. Provided border wells exclusion and a randomized design, 96-well microplates are a practical and statistical robust platform for microalgae research. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1720" xmlns="http://purl.org/rss/1.0/"><title>Improving of red colorants production by a new Penicillium purpurogenum strain in submerged culture and the effect of different parameters in their stability</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1720</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Improving of red colorants production by a new Penicillium purpurogenum strain in submerged culture and the effect of different parameters in their stability</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Valéria Carvalho Santos-Ebinuma, Inês Conceição Roberto, Maria Francisca Simas Teixeira, Adalberto Pessoa</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:27:33.69586-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1720</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1720</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1720</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>There is a worldwide interest in the development of processes for colorants production from natural sources such as microorganism. The aim of this study was to optimize red colorants production by <em>Penicillium purpurogenum</em> DPUA 1275 and to evaluate the effect of pH, temperature, salts and polymers on the stability of these colorants. Under optimized conditions, a 78% increase in red colorants production was achieved. The best pH and temperature conditions were obtained at pH 8.0 and 70 °C, respectively. In the presence of salts NaCl and Na<sub>2</sub>SO<sub>4</sub>, at concentrations of 0.1 and 0.5 M, respectively, in Mcllvaine buffer (pH 8.0), the red colorants showed good stability. In the presence of both polymers Polyethylene Glycol (PEG) and Sodium Polyacrylate (NaPA), the red colorants kept their color intensity. Thus, the present study presents characteristics of red colorants produced by <em>P. purpurogenum</em> that can be applied in different industries after toxicological examination. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

There is a worldwide interest in the development of processes for colorants production from natural sources such as microorganism. The aim of this study was to optimize red colorants production by Penicillium purpurogenum DPUA 1275 and to evaluate the effect of pH, temperature, salts and polymers on the stability of these colorants. Under optimized conditions, a 78% increase in red colorants production was achieved. The best pH and temperature conditions were obtained at pH 8.0 and 70 °C, respectively. In the presence of salts NaCl and Na2SO4, at concentrations of 0.1 and 0.5 M, respectively, in Mcllvaine buffer (pH 8.0), the red colorants showed good stability. In the presence of both polymers Polyethylene Glycol (PEG) and Sodium Polyacrylate (NaPA), the red colorants kept their color intensity. Thus, the present study presents characteristics of red colorants produced by P. purpurogenum that can be applied in different industries after toxicological examination. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1719" xmlns="http://purl.org/rss/1.0/"><title>Case study: An accelerated 8-day monoclonal antibody production process based on high seeding densities</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1719</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Case study: An accelerated 8-day monoclonal antibody production process based on high seeding densities</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ishai Padawer, Wai Lam W. Ling, Yunling Bai</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:26:57.486853-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1719</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1719</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1719</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This study describes the development work to shorten the monoclonal antibody (mAb) production time in CHO cell cultures from 14 days to 8 days without impacting mAb titer or product quality. The proposed process increases cell inoculation densities up to 25X higher than a typical seeding density in the final production bioreactor, with the implementation of an ATF™ perfusion system in the N-1 stage. Similar antibody titer and N-glycosylation profiles were reached in 8 days using the 25X seed condition, as in 14 days using the 1X seed condition. Acidic variants in the 25X seed condition were 12-20% lower than the 1X seed condition. These results indicate that an accelerated 8-day antibody production process utilizing a 25X seeding strategy has the potential of achieving similar product quality and titer as the 1X seeding condition in a 14-day production process. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

This study describes the development work to shorten the monoclonal antibody (mAb) production time in CHO cell cultures from 14 days to 8 days without impacting mAb titer or product quality. The proposed process increases cell inoculation densities up to 25X higher than a typical seeding density in the final production bioreactor, with the implementation of an ATF™ perfusion system in the N-1 stage. Similar antibody titer and N-glycosylation profiles were reached in 8 days using the 25X seed condition, as in 14 days using the 1X seed condition. Acidic variants in the 25X seed condition were 12-20% lower than the 1X seed condition. These results indicate that an accelerated 8-day antibody production process utilizing a 25X seeding strategy has the potential of achieving similar product quality and titer as the 1X seeding condition in a 14-day production process. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1718" xmlns="http://purl.org/rss/1.0/"><title>Multi-pronged approach to managing beta-glucan contaminants in the downstream process: Control of raw materials and filtration with charge-modified nylon 6, 6 membrane filters</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1718</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multi-pronged approach to managing beta-glucan contaminants in the downstream process: Control of raw materials and filtration with charge-modified nylon 6, 6 membrane filters</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eva Gefroh, Art Hewig, Ganesh Vedantham, Megan McClure, Alla Krivosheyeva, Ajay Lajmi|, Yuefeng Lu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:26:48.558039-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1718</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1718</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1718</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>(1→3)-β-D-glucans (beta-glucans) have been found in raw materials used in the manufacture of recombinant therapeutics. Because of their biological activity, beta-glucans are considered process contaminants and consequently their level in the product needs to be controlled. While beta-glucans introduced into the cell culture process can readily be removed by bind-and-elute chromatography process steps, beta-glucans can also be introduced into the purification process through raw materials containing beta-glucans as well as leachables from filters made from cellulose. This paper reports a multi-pronged approach to managing the beta-glucan contamination in the downstream process. Raw material screening and selection can be used to effectively limit the level of beta-glucan introduced into the downstream process. Placement of a cellulosic filter upstream of the last bind-and-elute column step or effective pre-use flushing can also limit the level of contaminant introduced. More importantly, this paper reports the active removal of beta-glucan from the downstream process when necessary. It was discovered that the Posidyne<sup>®</sup> filter, a charge-modified Nylon 6,6 membrane filter, was able to effectively remove beta-glucans from buffers at relatively low pH and salt concentrations. An approach of using low beta-glucan buffer components combined with filtration of the buffer with a Posidyne membrane has been successfully demonstrated at preparative scale. Additionally, the feasibility of active removal of beta-glucan from in-process product pools by Posidyne membrane filtration has also been demonstrated. Based on the data presented, a mechanism for binding is proposed, as well as a systematic approach for sizing of the Posidyne filter. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

(1→3)-β-D-glucans (beta-glucans) have been found in raw materials used in the manufacture of recombinant therapeutics. Because of their biological activity, beta-glucans are considered process contaminants and consequently their level in the product needs to be controlled. While beta-glucans introduced into the cell culture process can readily be removed by bind-and-elute chromatography process steps, beta-glucans can also be introduced into the purification process through raw materials containing beta-glucans as well as leachables from filters made from cellulose. This paper reports a multi-pronged approach to managing the beta-glucan contamination in the downstream process. Raw material screening and selection can be used to effectively limit the level of beta-glucan introduced into the downstream process. Placement of a cellulosic filter upstream of the last bind-and-elute column step or effective pre-use flushing can also limit the level of contaminant introduced. More importantly, this paper reports the active removal of beta-glucan from the downstream process when necessary. It was discovered that the Posidyne® filter, a charge-modified Nylon 6,6 membrane filter, was able to effectively remove beta-glucans from buffers at relatively low pH and salt concentrations. An approach of using low beta-glucan buffer components combined with filtration of the buffer with a Posidyne membrane has been successfully demonstrated at preparative scale. Additionally, the feasibility of active removal of beta-glucan from in-process product pools by Posidyne membrane filtration has also been demonstrated. Based on the data presented, a mechanism for binding is proposed, as well as a systematic approach for sizing of the Posidyne filter. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1717" xmlns="http://purl.org/rss/1.0/"><title>Separation of nonfucosylated antibodies with immobilized FcγRIII receptors</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1717</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Separation of nonfucosylated antibodies with immobilized FcγRIII receptors</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Glen R. Bolton, Margaret E. Ackerman, Austin W. Boesch</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:26:22.284447-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1717</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1717</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1717</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Post-translational modifications can dramatically impact protein activity, but identifying such structure:function relationships, as well as capitalizing on functionally enhanced variants, is a significant challenge. Here, affinity chromatography resins that contained immobilized FcγRIII receptors were used to enrich nonfucosylated antibodies 6-9 fold, offering what may be a tractable method for both the identification of post-translational modifications that affect function, as well as a means to enrich variants with enhanced activity. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Post-translational modifications can dramatically impact protein activity, but identifying such structure:function relationships, as well as capitalizing on functionally enhanced variants, is a significant challenge. Here, affinity chromatography resins that contained immobilized FcγRIII receptors were used to enrich nonfucosylated antibodies 6-9 fold, offering what may be a tractable method for both the identification of post-translational modifications that affect function, as well as a means to enrich variants with enhanced activity. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1716" xmlns="http://purl.org/rss/1.0/"><title>Use of perfluorocarbons to enhance the performance of perfused three-dimensional hepatic cultures</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1716</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Use of perfluorocarbons to enhance the performance of perfused three-dimensional hepatic cultures</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gengbei Shi, Robin N. Coger</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:26:01.865306-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1716</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1716</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1716</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Bioartificial liver devices (BALs) are extracorporeal systems designed to temporarily bridge patients until a suitable donated liver is available for transplantation and also have value for pharmaceutical testing applications. Yet critical issues exist that limit the functional performance of their current designs. One of these concerns scale up issues connected to oxygen (O<sub>2</sub>) delivery to the cells housed within their three-dimensional (3D) configurations, and its consequences to device performance. As primary blood substitute candidates with extraordinarily high O<sub>2</sub> capacity, perfluorocarbons (PFCs) offer hope as one strategy for addressing the O<sub>2</sub> delivery issue encountered when scaling up the tissue space of current BAL designs. This study utilizes a PFC-based second-generation O<sub>2</sub> carrier OXYCYTE<sup>®</sup>, as an additive to regular nutrient medium, for augmenting O<sub>2</sub> delivery in a customized 3D tissue assembly system. The results demonstrate that the addition of PFCs significantly increases the O<sub>2</sub> capacity of regular medium and that net cytochrome P450 activity levels are considerably increased under flow in PFC-treated systems, as compared to controls. This work thus clarifies the benefits of using PFCs to enhance the functional performance of 3D liver systems. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Bioartificial liver devices (BALs) are extracorporeal systems designed to temporarily bridge patients until a suitable donated liver is available for transplantation and also have value for pharmaceutical testing applications. Yet critical issues exist that limit the functional performance of their current designs. One of these concerns scale up issues connected to oxygen (O2) delivery to the cells housed within their three-dimensional (3D) configurations, and its consequences to device performance. As primary blood substitute candidates with extraordinarily high O2 capacity, perfluorocarbons (PFCs) offer hope as one strategy for addressing the O2 delivery issue encountered when scaling up the tissue space of current BAL designs. This study utilizes a PFC-based second-generation O2 carrier OXYCYTE®, as an additive to regular nutrient medium, for augmenting O2 delivery in a customized 3D tissue assembly system. The results demonstrate that the addition of PFCs significantly increases the O2 capacity of regular medium and that net cytochrome P450 activity levels are considerably increased under flow in PFC-treated systems, as compared to controls. This work thus clarifies the benefits of using PFCs to enhance the functional performance of 3D liver systems. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1715" xmlns="http://purl.org/rss/1.0/"><title>Production of humic acids from oil palm empty fruit bunch by submerged fermentation with Trichoderma viride: Cellulosic substrates and nitrogen sources</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1715</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Production of humic acids from oil palm empty fruit bunch by submerged fermentation with Trichoderma viride: Cellulosic substrates and nitrogen sources</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Motta FL, Santana MHA</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:25:58.625919-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1715</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1715</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1715</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The novelty of this study was to produce humic acids by submerged fermentation of empty fruit bunch (EFB) with <em>Trichoderma viride</em> and to investigate the effects of the cellulosic substrates and the organic sources of nitrogen on the biotechnological production of these acids. The results obtained indicate the potential application of EFB, a waste of oil palm processing, for humic acids production. Because EFB contains cellulose, hemicellulose and lignin, fermentations were also performed using these polymers as carbon sources, separately or in combination. After 120 hours of fermentation, significant production of humic acids was observed only in cultures containing either EFB or a mixture of the three polymers. Use of either potato peptone or yeast extract as a nitrogen source yielded nearly identical patterns of fungal growth and production of humic acids. The data obtained from microscopic imaging of <em>Trichoderma viride</em> growth and sporulation in EFB, coupled with the determined rates of production of humic acids indicated that the production of these acids is related to <em>Trichoderma viride</em> sporulation. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

The novelty of this study was to produce humic acids by submerged fermentation of empty fruit bunch (EFB) with Trichoderma viride and to investigate the effects of the cellulosic substrates and the organic sources of nitrogen on the biotechnological production of these acids. The results obtained indicate the potential application of EFB, a waste of oil palm processing, for humic acids production. Because EFB contains cellulose, hemicellulose and lignin, fermentations were also performed using these polymers as carbon sources, separately or in combination. After 120 hours of fermentation, significant production of humic acids was observed only in cultures containing either EFB or a mixture of the three polymers. Use of either potato peptone or yeast extract as a nitrogen source yielded nearly identical patterns of fungal growth and production of humic acids. The data obtained from microscopic imaging of Trichoderma viride growth and sporulation in EFB, coupled with the determined rates of production of humic acids indicated that the production of these acids is related to Trichoderma viride sporulation. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1714" xmlns="http://purl.org/rss/1.0/"><title>Multispectral image analysis for algal biomass quantification</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1714</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multispectral image analysis for algal biomass quantification</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Thomas E. Murphy, Keith Macon, Halil Berberoglu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:25:40.831135-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1714</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1714</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1714</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This paper reports a novel multispectral image processing technique for rapid, non-invasive quantification of biomass concentration in attached and suspended algae cultures. Monitoring the biomass concentration is critical for efficient production of biofuel feedstocks, food supplements, and bioactive chemicals. Particularly, non-invasive and rapid detection techniques can significantly aid in providing delay-free process control feedback in large scale cultivation platforms. In this technique, three-band spectral images of <em>Anabaena variabilis</em> cultures were acquired and separated into their red, green, and blue components. A correlation between the magnitude of the green component and the areal biomass concentration was generated. The correlation predicted the biomass concentrations of independently prepared attached and suspended cultures with errors of 7% and 15%, respectively, and the effect of varying lighting conditions and background color were investigated. This method can provide necessary feedback for dilution and harvesting strategies for optimal photosynthetic conversion efficiency in large scale operation. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

This paper reports a novel multispectral image processing technique for rapid, non-invasive quantification of biomass concentration in attached and suspended algae cultures. Monitoring the biomass concentration is critical for efficient production of biofuel feedstocks, food supplements, and bioactive chemicals. Particularly, non-invasive and rapid detection techniques can significantly aid in providing delay-free process control feedback in large scale cultivation platforms. In this technique, three-band spectral images of Anabaena variabilis cultures were acquired and separated into their red, green, and blue components. A correlation between the magnitude of the green component and the areal biomass concentration was generated. The correlation predicted the biomass concentrations of independently prepared attached and suspended cultures with errors of 7% and 15%, respectively, and the effect of varying lighting conditions and background color were investigated. This method can provide necessary feedback for dilution and harvesting strategies for optimal photosynthetic conversion efficiency in large scale operation. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1713" xmlns="http://purl.org/rss/1.0/"><title>Polyethylene glycol-based low generation dendrimers functionalized with β-cyclodextrin as cryo- and dehydro-protectant of catalase formulations</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1713</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Polyethylene glycol-based low generation dendrimers functionalized with β-cyclodextrin as cryo- and dehydro-protectant of catalase formulations</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Patricio R. Santagapita, M. Florencia Mazzobre, Ariel García Cruz, Horacio R. Corti, Reynaldo Villalonga, M. Pilar Buera</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T03:25:28.841183-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1021/btpr.1713</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1021/btpr.1713</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1021%2Fbtpr.1713</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Polyethylene glycol (PEG)-based low generation dendrimers are analyzed as single excipient or combined with trehalose in relation to their structure and efficiency as enzyme stabilizers during freeze-thawing, freeze-drying and thermal treatment. A novel functional dendrimer (DG<sub>o</sub>-CD) based on the known PEG's ability as cryo-protector and β-CD as supramolecular stabilizing agent is presented. During freeze-thawing, PEG and β-CD failed to prevent catalase denaturation, while dendrimers, and especially DG<sub>o</sub>-CD, offered the better protection of the enzyme. During freeze-drying, trehalose was the best protective additive but DG<sub>o</sub>-CD provided also an adequate catalase stability showing a synergistic behavior in comparison to the activities recovered employing PEG or β-CD as unique additives. Although all the studied dendrimers improved the enzyme remaining activity during thermal treatment of freeze-dried formulations, the presence of amorphous trehalose was critical to enhance enzyme stability. The crystallinity of the protective matrix, either of PEG derivatives or of trehalose, negatively affected catalase stability in the freeze-dried systems. When humidified at 52% of relative humidity, the dendrimers delayed trehalose crystallization in the combined matrices, allowing extending the protection at those conditions in which normally trehalose fails. The results show how a relatively simple covalent combination of a polymer such as PEG with β-CD could significantly affect the properties of the individual components. Also, results provide further insights about the role played by polymer-enzyme supramolecular interactions (host-guest crosslink, hydrogen bonding and hydrophobic interactions) on enzyme stability in dehydrated models, being the effect on the stabilization also influenced by the physical state of the matrix. <em>© 2013 American Institute of Chemical Engineers</em> Biotechnol. Prog.,<em>, 2013</em></p></div>
]]></content:encoded><description>

Polyethylene glycol (PEG)-based low generation dendrimers are analyzed as single excipient or combined with trehalose in relation to their structure and efficiency as enzyme stabilizers during freeze-thawing, freeze-drying and thermal treatment. A novel functional dendrimer (DGo-CD) based on the known PEG's ability as cryo-protector and β-CD as supramolecular stabilizing agent is presented. During freeze-thawing, PEG and β-CD failed to prevent catalase denaturation, while dendrimers, and especially DGo-CD, offered the better protection of the enzyme. During freeze-drying, trehalose was the best protective additive but DGo-CD provided also an adequate catalase stability showing a synergistic behavior in comparison to the activities recovered employing PEG or β-CD as unique additives. Although all the studied dendrimers improved the enzyme remaining activity during thermal treatment of freeze-dried formulations, the presence of amorphous trehalose was critical to enhance enzyme stability. The crystallinity of the protective matrix, either of PEG derivatives or of trehalose, negatively affected catalase stability in the freeze-dried systems. When humidified at 52% of relative humidity, the dendrimers delayed trehalose crystallization in the combined matrices, allowing extending the protection at those conditions in which normally trehalose fails. The results show how a relatively simple covalent combination of a polymer such as PEG with β-CD could significantly affect the properties of the individual components. Also, results provide further insights about the role played by polymer-enzyme supramolecular interactions (host-guest crosslink, hydrogen bonding and hydrophobic interactions) on enzyme stability in dehydrated models, being the effect on the stabilization also influenced by the physical state of the matrix. © 2013 American Institute of Chemical Engineers Biotechnol. Prog.,, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1748" xmlns="http://purl.org/rss/1.0/"><title>Profiling the effects of process changes on residual host cell proteins in biotherapeutics by mass spectrometry</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1748</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Profiling the effects of process changes on residual host cell proteins in biotherapeutics by mass spectrometry</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Matthew R. Schenauer, Gregory C. Flynn, Andrew M. Goetze</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-21T02:28:05.231916-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1748</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1748</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1748</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>An advanced liquid chromatography/mass spectrometry (MS) platform was used to identify and quantify residual <em>Escherichia coli</em> host cell proteins (HCPs) in the drug substance (DS) of several peptibodies (Pbs). Significantly different HCP impurity profiles were observed among different biotherapeutic Pbs as well as one Pb purified via multiple processes. The results can be rationally interpreted in terms of differences among the purification processes, and demonstrate the power of this technique to sensitively monitor both the quantity and composition of residual HCPs in DS, where these may represent a safety risk to patients. The breadth of information obtained using MS is compared to traditional multiproduct enzyme-linked immunosorbent assay (ELISA) values for total HCP in the same samples and shows that, in this case, the ELISA failed to detect multiple HCPs. The HCP composition of two upstream samples was also analyzed and used to demonstrate that HCPs that carry through purification processes to be detectable in DS are not always among those that are the most abundant upstream. Compared to ELISA, we demonstrate that MS can provide a more comprehensive, and accurate, characterization of DS HCPs, thereby facilitating process development as well as more rationally assessing potential safety risks posed by individual, identified HCPs.  © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
An advanced liquid chromatography/mass spectrometry (MS) platform was used to identify and quantify residual Escherichia coli host cell proteins (HCPs) in the drug substance (DS) of several peptibodies (Pbs). Significantly different HCP impurity profiles were observed among different biotherapeutic Pbs as well as one Pb purified via multiple processes. The results can be rationally interpreted in terms of differences among the purification processes, and demonstrate the power of this technique to sensitively monitor both the quantity and composition of residual HCPs in DS, where these may represent a safety risk to patients. The breadth of information obtained using MS is compared to traditional multiproduct enzyme-linked immunosorbent assay (ELISA) values for total HCP in the same samples and shows that, in this case, the ELISA failed to detect multiple HCPs. The HCP composition of two upstream samples was also analyzed and used to demonstrate that HCPs that carry through purification processes to be detectable in DS are not always among those that are the most abundant upstream. Compared to ELISA, we demonstrate that MS can provide a more comprehensive, and accurate, characterization of DS HCPs, thereby facilitating process development as well as more rationally assessing potential safety risks posed by individual, identified HCPs.  © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1703" xmlns="http://purl.org/rss/1.0/"><title>Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE bioreactor™—part II: Applications for antibody production and cryopreservation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1703</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE bioreactor™—part II: Applications for antibody production and cryopreservation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marie-Françoise Clincke, Carin Mölleryd, Puneeth K Samani, Eva Lindskog, Eric Fäldt, Kieron Walsh, Véronique Chotteau</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-21T02:27:50.503767-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1703</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1703</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1703</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A high cell density perfusion process of monoclonal antibody (MAb) producing <em>Chinese</em> hamster ovary (CHO) cells was developed in disposable WAVE Bioreactor™ using external hollow fiber (HF) filter as cell separation device. Tangential flow filtration (TFF) and alternating tangential flow (ATF) systems were compared and process applications of high cell density perfusion were studied here: MAb production and cryopreservation. Operations by perfusion using microfiltration (MF) or ultrafiltration (UF) with ATF or TFF and by fed-batch were compared. Cell densities higher than 10<sup>8</sup> cells/mL were obtained using UF TFF or UF ATF. The cells produced comparable amounts of MAb in perfusion by ATF or TFF, MF or UF. MAbs were partially retained by the MF using ATF or TFF but more severely using TFF. Consequently, MAbs were lost when cell broth was discarded from the bioreactor in the daily bleeds. The MAb cell-specific productivity was comparable at cell densities up to 1.3 × 10<sup>8</sup> cells/mL in perfusion and was comparable or lower in fed-batch. After 12 days, six times more MAbs were harvested using perfusion by ATF or TFF with MF or UF, compared to fed-batch and 28× more in a 1-month perfusion at 10<sup>8</sup> cells/mL density. Pumping at a recirculation rate up to 2.75 L/min did not damage the cells with the present TFF settings with HF short circuited. Cell cryopreservation at 0.5 × 10<sup>8</sup> and 10<sup>8</sup> cells/mL was performed using cells from a perfusion run at 10<sup>8</sup> cells/mL density. Cell resuscitation was very successful, showing that this system was a reliable process for cell bank manufacturing. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
A high cell density perfusion process of monoclonal antibody (MAb) producing Chinese hamster ovary (CHO) cells was developed in disposable WAVE Bioreactor™ using external hollow fiber (HF) filter as cell separation device. Tangential flow filtration (TFF) and alternating tangential flow (ATF) systems were compared and process applications of high cell density perfusion were studied here: MAb production and cryopreservation. Operations by perfusion using microfiltration (MF) or ultrafiltration (UF) with ATF or TFF and by fed-batch were compared. Cell densities higher than 108 cells/mL were obtained using UF TFF or UF ATF. The cells produced comparable amounts of MAb in perfusion by ATF or TFF, MF or UF. MAbs were partially retained by the MF using ATF or TFF but more severely using TFF. Consequently, MAbs were lost when cell broth was discarded from the bioreactor in the daily bleeds. The MAb cell-specific productivity was comparable at cell densities up to 1.3 × 108 cells/mL in perfusion and was comparable or lower in fed-batch. After 12 days, six times more MAbs were harvested using perfusion by ATF or TFF with MF or UF, compared to fed-batch and 28× more in a 1-month perfusion at 108 cells/mL density. Pumping at a recirculation rate up to 2.75 L/min did not damage the cells with the present TFF settings with HF short circuited. Cell cryopreservation at 0.5 × 108 and 108 cells/mL was performed using cells from a perfusion run at 108 cells/mL density. Cell resuscitation was very successful, showing that this system was a reliable process for cell bank manufacturing. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1704" xmlns="http://purl.org/rss/1.0/"><title>Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1704</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marie-Françoise Clincke, Carin Mölleryd, Ye Zhang, Eva Lindskog, Kieron Walsh, Véronique Chotteau</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-21T02:27:07.25018-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1704</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1704</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1704</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>High cell density perfusion process of antibody producing CHO cells was developed in disposable WAVE Bioreactor™ using external hollow fiber filter as cell separation device. Both “classical” tangential flow filtration (TFF) and alternating tangential flow system (ATF) equipment were used and compared. Consistency of both TFF- and ATF-based cultures was shown at 20–35 × 10<sup>6</sup> cells/mL density stabilized by cell bleeds. To minimize the nutrients deprivation and by-product accumulation, a perfusion rate correlated to the cell density was applied. The cells were maintained by cell bleeds at density 0.9–1.3 × 10<sup>8</sup> cells/mL in growing state and at high viability for more than 2 weeks. Finally, with the present settings, maximal cell densities of 2.14 × 10<sup>8</sup> cells/mL, achieved for the first time in a wave-induced bioreactor, and 1.32 × 10<sup>8</sup> cells/mL were reached using TFF and ATF systems, respectively. Using TFF, the cell density was limited by the membrane capacity for the encountered high viscosity and by the pCO<sub>2</sub> level. Using ATF, the cell density was limited by the vacuum capacity failing to pull the highly viscous fluid. Thus, the TFF system allowed reaching higher cell densities. The TFF inlet pressure was highly correlated to the viscosity leading to the development of a model of this pressure, which is a useful tool for hollow fiber design of TFF and ATF. At very high cell density, the viscosity introduced physical limitations. This led us to recommend cell densities under 1.46 × 10<sup>8</sup> cell/mL based on the analysis of the theoretical distance between the cells for the present cell line. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
High cell density perfusion process of antibody producing CHO cells was developed in disposable WAVE Bioreactor™ using external hollow fiber filter as cell separation device. Both “classical” tangential flow filtration (TFF) and alternating tangential flow system (ATF) equipment were used and compared. Consistency of both TFF- and ATF-based cultures was shown at 20–35 × 106 cells/mL density stabilized by cell bleeds. To minimize the nutrients deprivation and by-product accumulation, a perfusion rate correlated to the cell density was applied. The cells were maintained by cell bleeds at density 0.9–1.3 × 108 cells/mL in growing state and at high viability for more than 2 weeks. Finally, with the present settings, maximal cell densities of 2.14 × 108 cells/mL, achieved for the first time in a wave-induced bioreactor, and 1.32 × 108 cells/mL were reached using TFF and ATF systems, respectively. Using TFF, the cell density was limited by the membrane capacity for the encountered high viscosity and by the pCO2 level. Using ATF, the cell density was limited by the vacuum capacity failing to pull the highly viscous fluid. Thus, the TFF system allowed reaching higher cell densities. The TFF inlet pressure was highly correlated to the viscosity leading to the development of a model of this pressure, which is a useful tool for hollow fiber design of TFF and ATF. At very high cell density, the viscosity introduced physical limitations. This led us to recommend cell densities under 1.46 × 108 cell/mL based on the analysis of the theoretical distance between the cells for the present cell line. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1747" xmlns="http://purl.org/rss/1.0/"><title>Comparative analysis of reference gene stability in human mesenchymal stromal cells during osteogenic differentiation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1747</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comparative analysis of reference gene stability in human mesenchymal stromal cells during osteogenic differentiation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Angela Jacobi, Juliane Rauh, Peter Bernstein, Cornelia Liebers, Xuenong Zou, Maik Stiehler</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T01:00:48.153999-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1747</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1747</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1747</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Mesenchymal stromal cells (MSCs) are one of the most frequently used cell sources for tissue engineering strategies. Cultivation of osteogenic MSCs is a prerequisite for cell-based concepts that aim at bone regeneration. Quantitative real time reverse transcription polymerase chain reaction (qRT-PCR) analysis is a commonly used method for the examination of mRNA expression levels. However, data on suitable reference genes for osteogenically cultivated MSCs is scarce. Hence, the aim of the study was to compare the regulation of different potential reference genes in osteogenically stimulated MSCs. Human MSCs were isolated from bone marrow aspirates of N = 6 hematologically healthy individuals, expanded by polystyrene-adherence, and maintained with and without osteogenic supplements for 14 days. Cellular proliferation and osteogenic differentiation were assessed by total DNA quantification, cell-specific alkaline phosphatase (ALP) activity and by qualitative staining for ALP and alizarin red, respectively. mRNA expression levels of N = 32 potential reference genes were quantified using the human Endogenous Control TaqMan® assays. mRNA expression stability was calculated using geNorm. The combined use of the most stable reference genes and DNA-damage-inducible alpha, Pumilio homolog 1, and large ribosomal protein P0 significantly improved gene expression accuracy as compared to the use of the commonly used reference genes beta actin and glyceraldehyde-3-phosphate dehydrogenase during qRT-PCR-based target gene expression analysis of osteogenically stimulated MSCs. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Mesenchymal stromal cells (MSCs) are one of the most frequently used cell sources for tissue engineering strategies. Cultivation of osteogenic MSCs is a prerequisite for cell-based concepts that aim at bone regeneration. Quantitative real time reverse transcription polymerase chain reaction (qRT-PCR) analysis is a commonly used method for the examination of mRNA expression levels. However, data on suitable reference genes for osteogenically cultivated MSCs is scarce. Hence, the aim of the study was to compare the regulation of different potential reference genes in osteogenically stimulated MSCs. Human MSCs were isolated from bone marrow aspirates of N = 6 hematologically healthy individuals, expanded by polystyrene-adherence, and maintained with and without osteogenic supplements for 14 days. Cellular proliferation and osteogenic differentiation were assessed by total DNA quantification, cell-specific alkaline phosphatase (ALP) activity and by qualitative staining for ALP and alizarin red, respectively. mRNA expression levels of N = 32 potential reference genes were quantified using the human Endogenous Control TaqMan® assays. mRNA expression stability was calculated using geNorm. The combined use of the most stable reference genes and DNA-damage-inducible alpha, Pumilio homolog 1, and large ribosomal protein P0 significantly improved gene expression accuracy as compared to the use of the commonly used reference genes beta actin and glyceraldehyde-3-phosphate dehydrogenase during qRT-PCR-based target gene expression analysis of osteogenically stimulated MSCs. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1746" xmlns="http://purl.org/rss/1.0/"><title>Enzymatic digestion of alkaline-sulfite pretreated sugar cane bagasse and its correlation with the chemical and structural changes occurring during the pretreatment step</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1746</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Enzymatic digestion of alkaline-sulfite pretreated sugar cane bagasse and its correlation with the chemical and structural changes occurring during the pretreatment step</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fernanda M. Mendes, Debora F. Laurito, Mariana Bazzeggio, André Ferraz, Adriane M. F. Milagres</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-11T08:56:05.314398-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1746</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1746</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1746</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Sugar cane bagasse is recalcitrant to enzymatic digestion, which hinders the efficient conversion of its polysaccharides into fermentable sugars. Alkaline-sulfite pretreatment was used to overcome the sugar cane bagasse recalcitrance. Chemical and structural changes that occurred during the pretreatment were correlated with the efficiency of the enzymatic digestion of the polysaccharides. The first 30 min of pretreatment, which removed approximately half of the initial lignin and 30% of hemicellulose seemed responsible for a significant enhancement of the cellulose conversion level, which reached 64%. After the first 30 min of pretreatment, delignification increased slightly, and hemicellulose removal was not enhanced; however, acid groups continued to be introduced into the residual lignin. Water retention values were 145% to the untreated bagasse and 210% to the bagasse pretreated for 120 min and fiber widths increased from 10.4 to 30 μm, respectively. These changes were responsible for an additional increase in the efficiency of enzymatic hydrolysis of the cellulose, which reached 92% with the 120 min pretreated sample. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Sugar cane bagasse is recalcitrant to enzymatic digestion, which hinders the efficient conversion of its polysaccharides into fermentable sugars. Alkaline-sulfite pretreatment was used to overcome the sugar cane bagasse recalcitrance. Chemical and structural changes that occurred during the pretreatment were correlated with the efficiency of the enzymatic digestion of the polysaccharides. The first 30 min of pretreatment, which removed approximately half of the initial lignin and 30% of hemicellulose seemed responsible for a significant enhancement of the cellulose conversion level, which reached 64%. After the first 30 min of pretreatment, delignification increased slightly, and hemicellulose removal was not enhanced; however, acid groups continued to be introduced into the residual lignin. Water retention values were 145% to the untreated bagasse and 210% to the bagasse pretreated for 120 min and fiber widths increased from 10.4 to 30 μm, respectively. These changes were responsible for an additional increase in the efficiency of enzymatic hydrolysis of the cellulose, which reached 92% with the 120 min pretreated sample. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1740" xmlns="http://purl.org/rss/1.0/"><title>Manipulation of kynurenine pathway for enhanced daptomycin production in Streptomyces roseosporus</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1740</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Manipulation of kynurenine pathway for enhanced daptomycin production in Streptomyces roseosporus</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Guojian Liao, Lei Wang, Qing Liu, Feifei Guan, Yuqi Huang, Changhu Hu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-11T08:43:00.324352-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1740</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1740</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1740</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Daptomycin is a cyclic lipopeptide natural product produced by <em>Stretptomyces roseosporus</em>, displaying good bactericidal activity against a wide range of gram-positive pathogens. Daptomycin contains a 13 amino acid and kynurenine (Kyn) is essential for optimal activity of daptomycin. In this study, we characterized the Kyn pathway in <em>S. roseosporus</em> and investigated its role in supplying precursor for daptomycin biosynthesis. Two genes (dptJ and tdo) coding for tryptophan-2,3-dioxgenase existed in the chromosome. dptJ is located in the daptomycin biosynthetic gene cluster, while tdo is in other locus. Disruption of dptJ or tdo resulted in reduced yield by ∼50%. The introduction of an additional copy of dptJ but not tdo led to enhanced production of daptomycin by 110%. Furthermore, disruption of kyn encoding kynureninase showed improved daptomycin productivity by 30%. Our results demonstrated that the enhancement of Kyn supply through metabolic engineering approach is an efficient way to increase daptomycin production. <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Daptomycin is a cyclic lipopeptide natural product produced by Stretptomyces roseosporus, displaying good bactericidal activity against a wide range of gram-positive pathogens. Daptomycin contains a 13 amino acid and kynurenine (Kyn) is essential for optimal activity of daptomycin. In this study, we characterized the Kyn pathway in S. roseosporus and investigated its role in supplying precursor for daptomycin biosynthesis. Two genes (dptJ and tdo) coding for tryptophan-2,3-dioxgenase existed in the chromosome. dptJ is located in the daptomycin biosynthetic gene cluster, while tdo is in other locus. Disruption of dptJ or tdo resulted in reduced yield by ∼50%. The introduction of an additional copy of dptJ but not tdo led to enhanced production of daptomycin by 110%. Furthermore, disruption of kyn encoding kynureninase showed improved daptomycin productivity by 30%. Our results demonstrated that the enhancement of Kyn supply through metabolic engineering approach is an efficient way to increase daptomycin production. Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1743" xmlns="http://purl.org/rss/1.0/"><title>The critical flux method for reduced filter membrane fouling when monitoring high-solids digesters</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1743</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The critical flux method for reduced filter membrane fouling when monitoring high-solids digesters</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stephan Tait, Christopher R. Carney, Damien J. Batstone</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-11T08:42:13.21074-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1743</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1743</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1743</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Membrane fouling currently makes filtration of high-solids anaerobic sludges difficult and this is discouraging online monitoring of volatile fatty acids and control of high-solids digesters. The present study tests the critical flux approach to reduce membrane fouling. Filtration tests are performed on two sludges, filtered via a side-stream off two full-scale digesters. Sub-critical flux operating conditions (for minimal cake layer formation) are identified for each of the sludges and the filtration units are operated at these conditions to assess longer term performance. Results for one of the sludges (co-digested primary and secondary sludge) is found to be encouraging, showing that sufficient flux rates (up to 40 L m<sup>−2</sup> h<sup>−1</sup>) can be readily sustained to allow longer term digester monitoring and control. Filtration performance for this sludge did not deteriorate significantly over the test period. Results for the other test sludge (digested thermally hydrolyzed waste activated sludge) were not as favorable and indicated that application may be limited for very high solids digesters (&gt;5% total solids concentration). Differences in filtration behavior for the two test sludges were ascribed to the presence of complex soluble organics, the concentration of sludge solids and their particle size. <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Membrane fouling currently makes filtration of high-solids anaerobic sludges difficult and this is discouraging online monitoring of volatile fatty acids and control of high-solids digesters. The present study tests the critical flux approach to reduce membrane fouling. Filtration tests are performed on two sludges, filtered via a side-stream off two full-scale digesters. Sub-critical flux operating conditions (for minimal cake layer formation) are identified for each of the sludges and the filtration units are operated at these conditions to assess longer term performance. Results for one of the sludges (co-digested primary and secondary sludge) is found to be encouraging, showing that sufficient flux rates (up to 40 L m−2 h−1) can be readily sustained to allow longer term digester monitoring and control. Filtration performance for this sludge did not deteriorate significantly over the test period. Results for the other test sludge (digested thermally hydrolyzed waste activated sludge) were not as favorable and indicated that application may be limited for very high solids digesters (&gt;5% total solids concentration). Differences in filtration behavior for the two test sludges were ascribed to the presence of complex soluble organics, the concentration of sludge solids and their particle size. Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1739" xmlns="http://purl.org/rss/1.0/"><title>Improvement of mammalian cell culture performance through surfactant enabled concentrated feed media</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1739</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Improvement of mammalian cell culture performance through surfactant enabled concentrated feed media</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Patrick Hossler, Sean McDermott, Christopher Racicot, John C. H. Fann</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-11T08:42:09.961681-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1739</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1739</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1739</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The design of basal and feed media in mammalian cell culture is paramount towards ensuring acceptable upstream process performance in various operation modes, especially fed-batch culture. Mammalian cell culture media designs have evolved from the classical formulations designed by Eagle and Ham, to today's formulations designed from continuous improvement and statistical frameworks. Feed media is especially important for ensuring robust cell growth, productivity, and ensuring the product quality of recombinant therapeutics are within acceptable ranges. Numerous studies have highlighted the benefit of various media designs, supplements, and feed addition strategies towards the resulting cell culture process. In this work we highlight the use of a top-down level approach towards feed media design enabled by the use of select surfactants for the targeted enrichment of a chemically defined feed media. The use of the enriched media was able to improve product titers at g/L levels, without adversely impacting the growth of multiple Chinese Hamster Ovary cell lines or the product quality of multiple recombinant antibodies. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The design of basal and feed media in mammalian cell culture is paramount towards ensuring acceptable upstream process performance in various operation modes, especially fed-batch culture. Mammalian cell culture media designs have evolved from the classical formulations designed by Eagle and Ham, to today's formulations designed from continuous improvement and statistical frameworks. Feed media is especially important for ensuring robust cell growth, productivity, and ensuring the product quality of recombinant therapeutics are within acceptable ranges. Numerous studies have highlighted the benefit of various media designs, supplements, and feed addition strategies towards the resulting cell culture process. In this work we highlight the use of a top-down level approach towards feed media design enabled by the use of select surfactants for the targeted enrichment of a chemically defined feed media. The use of the enriched media was able to improve product titers at g/L levels, without adversely impacting the growth of multiple Chinese Hamster Ovary cell lines or the product quality of multiple recombinant antibodies. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1744" xmlns="http://purl.org/rss/1.0/"><title>Mass production of spores of lactic acid-producing Rhizopus oryzae NBRC 5384 on agar plate</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1744</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Mass production of spores of lactic acid-producing Rhizopus oryzae NBRC 5384 on agar plate</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tsuneo Yamane, Ryosuke Tanaka</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T00:21:36.836205-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1744</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1744</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1744</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Mass production of sporangiospores (spores) of Rhizopus oryzae NBRC 5384 (identical to NRRL 395 and ATCC 9363) on potato-dextrose-agar medium was studied aiming at starting its <span class="smallCaps">L</span>(+)-lactic acid fermentation directly from spore inoculation. Various parameters including harvest time, sowed spore density, size of agar plate, height of air space, and incubation mode of plate (agar-on-bottom or agar-on-top) were studied. Ordinarily used shallow Petri dishes were found out to be unsuitable for the full growth of <em>R. oryzae</em> sporangiophores. In a very wide range of the sowed spore density, the smaller it was, the greater the number of the harvested spores was. It was also interesting to find out that <em>R. oryzae</em> grown downward vertically with a deep air space in an agar-on-top mode gave larger amount of spores than in an agar-on-bottom mode at 30°C for 7-day cultivation. Scale-up of the agar plate culture from 26.4 to 292 cm<sup>2</sup> was studied, resulting in the proportional relationship between the number of the harvested spores/plate and the plate area in the deep Petri dishes. The number of plates of 50 cm in diameter needed for 100 m<sup>3</sup> industrial submerged fermentation started directly from 2 × 10<sup>5</sup> spores/mL inoculum size was estimated as about 6, from which it was inferred that such a fermentation would be feasible. Designing a 50 cm plate and a method of spreading and collecting the spores were suggested. Bioprocess technological significance of the “full-scale industrial submerged fermentation started directly from spore inoculation omitting pre-culture” has been discussed. <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Mass production of sporangiospores (spores) of Rhizopus oryzae NBRC 5384 (identical to NRRL 395 and ATCC 9363) on potato-dextrose-agar medium was studied aiming at starting its L(+)-lactic acid fermentation directly from spore inoculation. Various parameters including harvest time, sowed spore density, size of agar plate, height of air space, and incubation mode of plate (agar-on-bottom or agar-on-top) were studied. Ordinarily used shallow Petri dishes were found out to be unsuitable for the full growth of R. oryzae sporangiophores. In a very wide range of the sowed spore density, the smaller it was, the greater the number of the harvested spores was. It was also interesting to find out that R. oryzae grown downward vertically with a deep air space in an agar-on-top mode gave larger amount of spores than in an agar-on-bottom mode at 30°C for 7-day cultivation. Scale-up of the agar plate culture from 26.4 to 292 cm2 was studied, resulting in the proportional relationship between the number of the harvested spores/plate and the plate area in the deep Petri dishes. The number of plates of 50 cm in diameter needed for 100 m3 industrial submerged fermentation started directly from 2 × 105 spores/mL inoculum size was estimated as about 6, from which it was inferred that such a fermentation would be feasible. Designing a 50 cm plate and a method of spreading and collecting the spores were suggested. Bioprocess technological significance of the “full-scale industrial submerged fermentation started directly from spore inoculation omitting pre-culture” has been discussed. Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1745" xmlns="http://purl.org/rss/1.0/"><title>Enhancing operational stability and exhibition of enzyme activity by removing water in the immobilized lipase-catalyzed production of erythorbyl laurate</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1745</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Enhancing operational stability and exhibition of enzyme activity by removing water in the immobilized lipase-catalyzed production of erythorbyl laurate</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Da Eun Lee, Kyung Min Park, Seung Jun Choi, Jae-Hoon Shim, Pahn-Shick Chang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T00:21:34.416787-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1745</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1745</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1745</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Erythorbyl laurate was continuously synthesized by esterification in a packed-bed enzyme reactor with immobilized lipase from <em>Candida antarctica</em>. Response surface methodology based on a five-level three-factor central composite design was adopted to optimize conditions for the enzymatic esterification. The reaction variables, such as reaction temperature (10–70°C), substrate molar ratio ([lauric acid]/[erythorbic acid], 5–15), and residence time (8–40 min) were evaluated and their optimum conditions were found to be 56.2°C, 14.3, and 24.2 min, respectively. Under the optimum conditions, the molar conversion yield was 83.4%, which was not significantly different (<em>P</em> &lt; 0.05) from the value predicted (84.4%). Especially, continuous water removal by adsorption on an ion-exchange resin in a packed-bed enzyme reactor improved operational stability, resulting in prolongation of half-life (2.02 times longer compared to the control without water-removal system). Furthermore, in the case of batch-type reactor, it exhibited significant increase in initial velocity of molar conversion from 1.58% to 2.04%/min. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog.,</em> 2013</p></div>
]]></content:encoded><description>
Erythorbyl laurate was continuously synthesized by esterification in a packed-bed enzyme reactor with immobilized lipase from Candida antarctica. Response surface methodology based on a five-level three-factor central composite design was adopted to optimize conditions for the enzymatic esterification. The reaction variables, such as reaction temperature (10–70°C), substrate molar ratio ([lauric acid]/[erythorbic acid], 5–15), and residence time (8–40 min) were evaluated and their optimum conditions were found to be 56.2°C, 14.3, and 24.2 min, respectively. Under the optimum conditions, the molar conversion yield was 83.4%, which was not significantly different (P &lt; 0.05) from the value predicted (84.4%). Especially, continuous water removal by adsorption on an ion-exchange resin in a packed-bed enzyme reactor improved operational stability, resulting in prolongation of half-life (2.02 times longer compared to the control without water-removal system). Furthermore, in the case of batch-type reactor, it exhibited significant increase in initial velocity of molar conversion from 1.58% to 2.04%/min. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1742" xmlns="http://purl.org/rss/1.0/"><title>Three-dimensional neural differentiation of embryonic stem cells with ACM induction in microfibrous matrices in bioreactors</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1742</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Three-dimensional neural differentiation of embryonic stem cells with ACM induction in microfibrous matrices in bioreactors</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ning Liu, Anli Ouyang, Yan Li, Shang-Tian Yang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T00:20:49.270017-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1742</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1742</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1742</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The clinical use of pluripotent stem cell (PSC)-derived neural cells requires an efficient differentiation process for mass production in a bioreactor. Toward this goal, neural differentiation of murine embryonic stem cells (ESCs) in three-dimensional (3D) polyethylene terephthalate microfibrous matrices was investigated in this study. To streamline the process and provide a platform for process integration, the neural differentiation of ESCs was induced with astrocyte-conditioned medium without the formation of embryoid bodies, starting from undifferentiated ESC aggregates expanded in a suspension bioreactor. The 3D neural differentiation was able to generate a complex neural network in the matrices. When compared to 2D differentiation, 3D differentiation in microfibrous matrices resulted in a higher percentage of nestin-positive cells (68% vs. 54%) and upregulated gene expressions of nestin, Nurr1, and tyrosine hydroxylase. High purity of neural differentiation in 3D microfibrous matrix was also demonstrated in a spinner bioreactor with 74% nestin + cells. This study demonstrated the feasibility of a scalable process based on 3D differentiation in microfibrous matrices for the production of ESC-derived neural cells. <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The clinical use of pluripotent stem cell (PSC)-derived neural cells requires an efficient differentiation process for mass production in a bioreactor. Toward this goal, neural differentiation of murine embryonic stem cells (ESCs) in three-dimensional (3D) polyethylene terephthalate microfibrous matrices was investigated in this study. To streamline the process and provide a platform for process integration, the neural differentiation of ESCs was induced with astrocyte-conditioned medium without the formation of embryoid bodies, starting from undifferentiated ESC aggregates expanded in a suspension bioreactor. The 3D neural differentiation was able to generate a complex neural network in the matrices. When compared to 2D differentiation, 3D differentiation in microfibrous matrices resulted in a higher percentage of nestin-positive cells (68% vs. 54%) and upregulated gene expressions of nestin, Nurr1, and tyrosine hydroxylase. High purity of neural differentiation in 3D microfibrous matrix was also demonstrated in a spinner bioreactor with 74% nestin + cells. This study demonstrated the feasibility of a scalable process based on 3D differentiation in microfibrous matrices for the production of ESC-derived neural cells. Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1741" xmlns="http://purl.org/rss/1.0/"><title>Effect of glycosylation on the partition behavior of a human antibody in aqueous two-phase systems</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1741</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect of glycosylation on the partition behavior of a human antibody in aqueous two-phase systems</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J.-W. Lee, D. Forciniti</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T00:20:44.089069-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1741</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1741</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1741</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Human proteins are expressed in some hosts wrongly glycosylated or nonglycosylated. Although it is accepted that glycosylation contributes to the stability of the protein in solution, the effect of glycosylation on the stability of human antibodies is not fully understood. In this work, we present solubility studies of two human antibodies that have the same primary structure but different glycosylation pattern. The studies were done by monitoring the partitioning behavior of both proteins in a series of aqueous two-phase systems at and away the isoelectric point of the proteins and at different temperatures. Our studies show that in the absence of direct electrostatic forces, the partitioning behavior of the antibodies depends on the presence or absence of the polysaccharide chains. Overall, the nonglycosylated protein is less soluble than the glycosylated one. The potential of aqueous two-phase systems for the separation of the glycosylated and nonglycosylated proteins was also explored. A simple series of extractions seems to be enough to separate the glycosylated variety from the nonglycosylated one at high purity but low yields. <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Human proteins are expressed in some hosts wrongly glycosylated or nonglycosylated. Although it is accepted that glycosylation contributes to the stability of the protein in solution, the effect of glycosylation on the stability of human antibodies is not fully understood. In this work, we present solubility studies of two human antibodies that have the same primary structure but different glycosylation pattern. The studies were done by monitoring the partitioning behavior of both proteins in a series of aqueous two-phase systems at and away the isoelectric point of the proteins and at different temperatures. Our studies show that in the absence of direct electrostatic forces, the partitioning behavior of the antibodies depends on the presence or absence of the polysaccharide chains. Overall, the nonglycosylated protein is less soluble than the glycosylated one. The potential of aqueous two-phase systems for the separation of the glycosylated and nonglycosylated proteins was also explored. A simple series of extractions seems to be enough to separate the glycosylated variety from the nonglycosylated one at high purity but low yields. Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1736" xmlns="http://purl.org/rss/1.0/"><title>Computational fluid modeling and performance analysis of a bidirectional rotating perfusion culture system</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1736</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Computational fluid modeling and performance analysis of a bidirectional rotating perfusion culture system</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chang-Wei Kang, Yan Wang, Marshella Tania, Huancheng Zhou, Yi Gao, Te Ba, Guo-Dong Sean Tan, Sangho Kim, Hwa Liang Leo</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T00:20:32.470501-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1736</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1736</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1736</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A myriad of bioreactor configurations have been investigated as extracorporeal medical support systems for temporary replacement of vital organ functions. In recent years, studies have demonstrated that the rotating bioreactors have the potential to be utilized as bioartificial liver assist devices (BLADs) owing to their advantage of ease of scalability of cell-culture volume. However, the fluid movement in the rotating chamber will expose the suspended cells to unwanted flow structures with abnormally high shear conditions that may result in poor cell stability and in turn lower the efficacy of the bioreactor system. In this study, we compared the hydrodynamic performance of our modified rotating bioreactor design with that of an existing rotating bioreactor design. Computational fluid dynamic analysis coupled with experimental results were employed in the optimization process for the development of the modified bioreactor design. Our simulation results showed that the modified bioreactor had lower fluid induced shear stresses and more uniform flow conditions within its rotating chamber than the conventional design. Experimental results revealed that the cells within the modified bioreactor also exhibited better cell-carrier attachment, higher metabolic activity, and cell viability compared to those in the conventional design. In conclusion, this study was able to provide important insights into the flow physics within the rotating bioreactors, and help enhanced the hydrodynamic performance of an existing rotating bioreactor for BLAD applications. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
A myriad of bioreactor configurations have been investigated as extracorporeal medical support systems for temporary replacement of vital organ functions. In recent years, studies have demonstrated that the rotating bioreactors have the potential to be utilized as bioartificial liver assist devices (BLADs) owing to their advantage of ease of scalability of cell-culture volume. However, the fluid movement in the rotating chamber will expose the suspended cells to unwanted flow structures with abnormally high shear conditions that may result in poor cell stability and in turn lower the efficacy of the bioreactor system. In this study, we compared the hydrodynamic performance of our modified rotating bioreactor design with that of an existing rotating bioreactor design. Computational fluid dynamic analysis coupled with experimental results were employed in the optimization process for the development of the modified bioreactor design. Our simulation results showed that the modified bioreactor had lower fluid induced shear stresses and more uniform flow conditions within its rotating chamber than the conventional design. Experimental results revealed that the cells within the modified bioreactor also exhibited better cell-carrier attachment, higher metabolic activity, and cell viability compared to those in the conventional design. In conclusion, this study was able to provide important insights into the flow physics within the rotating bioreactors, and help enhanced the hydrodynamic performance of an existing rotating bioreactor for BLAD applications. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1738" xmlns="http://purl.org/rss/1.0/"><title>Interaction between abscisic acid and nitric oxide in PB90-induced catharanthine biosynthesis of catharanthus roseus cell suspension cultures</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1738</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Interaction between abscisic acid and nitric oxide in PB90-induced catharanthine biosynthesis of catharanthus roseus cell suspension cultures</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Qian Chen, Zunwei Chen, Li Lu, Haihong Jin, Lina Sun, Qin Yu, Hongke Xu, Fengxia Yang, Mengna Fu, Shengchao Li, Huizhong Wang, Maojun Xu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-02T04:59:24.106621-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1738</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1738</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1738</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Elicitations are considered to be an important strategy to improve production of secondary metabolites of plant cell cultures. However, mechanisms responsible for the elicitor-induced production of secondary metabolites of plant cells have not yet been fully elucidated. Here, we report that treatment of <em>Catharanthus roseus</em> cell suspension cultures with PB90, a protein elicitor from <em>Phytophthora boehmeriae</em>, induced rapid increases of abscisic acid (ABA) and nitric oxide (NO), subsequently followed by the enhancement of catharanthine production and up-regulation of <em>Str</em> and <em>Tdc</em>, two important genes in catharanthine biosynthesis. PB90-induced catharanthine production and the gene expression were suppressed by the ABA inhibitor and NO scavenger respectively, showing that ABA and NO are essential for the elicitor-induced catharanthine biosynthesis. The relationship between ABA and NO in mediating catharanthine biosynthesis was further investigated. Treatment of the cells with ABA triggered NO accumulation and induced catharanthine production and up-regulation of <em>Str</em> and <em>Tdc</em>. ABA-induced catharanthine production and gene expressions were suppressed by the NO scavenger. Conversely, exogenous application of NO did not stimulate ABA generation and treatment with ABA inhibitor did not suppress NO-induced catharanthine production and gene expressions. Together, the results showed that both NO and ABA were involved in PB90-induced catharanthine biosynthesis of <em>C. roseus</em> cells. Furthermore, our data demonstrated that ABA acted upstream of NO in the signaling cascade leading to PB90-induced catharanthine biosynthesis of <em>C. roseus</em> cells. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Elicitations are considered to be an important strategy to improve production of secondary metabolites of plant cell cultures. However, mechanisms responsible for the elicitor-induced production of secondary metabolites of plant cells have not yet been fully elucidated. Here, we report that treatment of Catharanthus roseus cell suspension cultures with PB90, a protein elicitor from Phytophthora boehmeriae, induced rapid increases of abscisic acid (ABA) and nitric oxide (NO), subsequently followed by the enhancement of catharanthine production and up-regulation of Str and Tdc, two important genes in catharanthine biosynthesis. PB90-induced catharanthine production and the gene expression were suppressed by the ABA inhibitor and NO scavenger respectively, showing that ABA and NO are essential for the elicitor-induced catharanthine biosynthesis. The relationship between ABA and NO in mediating catharanthine biosynthesis was further investigated. Treatment of the cells with ABA triggered NO accumulation and induced catharanthine production and up-regulation of Str and Tdc. ABA-induced catharanthine production and gene expressions were suppressed by the NO scavenger. Conversely, exogenous application of NO did not stimulate ABA generation and treatment with ABA inhibitor did not suppress NO-induced catharanthine production and gene expressions. Together, the results showed that both NO and ABA were involved in PB90-induced catharanthine biosynthesis of C. roseus cells. Furthermore, our data demonstrated that ABA acted upstream of NO in the signaling cascade leading to PB90-induced catharanthine biosynthesis of C. roseus cells. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1737" xmlns="http://purl.org/rss/1.0/"><title>Effect of enzyme dehydration on alcalase-catalyzed dipeptide synthesis in near-anhydrous organic media</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1737</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect of enzyme dehydration on alcalase-catalyzed dipeptide synthesis in near-anhydrous organic media</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Petra Vossenberg, Rik Beeftink, Martien Cohen Stuart, Hans Tramper</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-02T04:59:20.294884-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1737</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1737</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1737</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The effect of enzyme dehydration by molecular sieves on the coupling of phenylalanine amide and the carbamoylmethyl ester of N-protected phenylalanine in near-anhydrous tetrahydrofuran was investigated. This coupling was catalyzed by Alcalase covalently immobilized onto macroporous acrylic beads (Cov); these immobilized enzymes were hydrated prior to use. The dehydration kinetics of Cov by molecular sieve powder were determined by incubating Cov with different amounts of molecular sieve powder for different periods of time (0–80 h). Subsequently, the remaining coupling activity of Cov was measured. Dehydration-induced inactivation of Cov by molecular sieve powder was found to occur in three phases: (1) an initial, rapid, major dehydration-induced inactivation that takes place during the first activity measurement, (2) a phase of first-order inactivation, and (3) a plateau phase in activity. These dehydration kinetics were incorporated into a previously found reaction kinetics model. The resulting model was then used to fit progress curve data of the coupling in the presence of different amounts of molecular sieve powder. Upon establishment of parameter values, the model was used to predict independent data sets and found to work well. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The effect of enzyme dehydration by molecular sieves on the coupling of phenylalanine amide and the carbamoylmethyl ester of N-protected phenylalanine in near-anhydrous tetrahydrofuran was investigated. This coupling was catalyzed by Alcalase covalently immobilized onto macroporous acrylic beads (Cov); these immobilized enzymes were hydrated prior to use. The dehydration kinetics of Cov by molecular sieve powder were determined by incubating Cov with different amounts of molecular sieve powder for different periods of time (0–80 h). Subsequently, the remaining coupling activity of Cov was measured. Dehydration-induced inactivation of Cov by molecular sieve powder was found to occur in three phases: (1) an initial, rapid, major dehydration-induced inactivation that takes place during the first activity measurement, (2) a phase of first-order inactivation, and (3) a plateau phase in activity. These dehydration kinetics were incorporated into a previously found reaction kinetics model. The resulting model was then used to fit progress curve data of the coupling in the presence of different amounts of molecular sieve powder. Upon establishment of parameter values, the model was used to predict independent data sets and found to work well. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1735" xmlns="http://purl.org/rss/1.0/"><title>Experimental and theoretical investigation of multistage extraction of 1,3-propanediol using the extraction system phosphate/1-butyl-3-methylimidazolium trifluoromethanesulfonate/water</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1735</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Experimental and theoretical investigation of multistage extraction of 1,3-propanediol using the extraction system phosphate/1-butyl-3-methylimidazolium trifluoromethanesulfonate/water</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anja Müller, Philip Lutze, Andrzej Górak</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-02T04:59:07.910585-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1735</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1735</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1735</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The separation of 1,3-propanediol from fermentation broth is a challenging and energy-demanding step using conventional unit operations. One alternative process is the use of an aqueous two-phase system incorporating ionic liquids to use synergy effects of both technologies. Within this manuscript, the technical feasibility of the extraction of 1,3-propanediol using the aqueous two-phase system phosphate (salt)/1-butyl-3-methylimidazolium trifluoromethanesulfonate (ionic liquid)/water in a continuously operated process in pilot-scale is presented. The extraction was performed in a multistage mixer–settler unit and successfully modeled with an equilibrium-stage model and correlations to describe the liquid–liquid equilibrium of the salt/ionic liquid/water two-phase system. The developed and validated model was used for a further investigation of the influence of different process parameters in the determined operating window. Theses parameters include the number of stages, the phase ratio, the pH, and the mass fraction of the involved components. The results prove that the phosphate and 1-butyl-3-methylimidazolium trifluoromethanesulfonate mass fraction, the phase ratio, and the number of stages have a considerable influence on the recovery of 1,3-propanediol, whereas the pH value has only a smaller impact. Those results can be used for optimization of the system as well as for targeting future research within this area. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The separation of 1,3-propanediol from fermentation broth is a challenging and energy-demanding step using conventional unit operations. One alternative process is the use of an aqueous two-phase system incorporating ionic liquids to use synergy effects of both technologies. Within this manuscript, the technical feasibility of the extraction of 1,3-propanediol using the aqueous two-phase system phosphate (salt)/1-butyl-3-methylimidazolium trifluoromethanesulfonate (ionic liquid)/water in a continuously operated process in pilot-scale is presented. The extraction was performed in a multistage mixer–settler unit and successfully modeled with an equilibrium-stage model and correlations to describe the liquid–liquid equilibrium of the salt/ionic liquid/water two-phase system. The developed and validated model was used for a further investigation of the influence of different process parameters in the determined operating window. Theses parameters include the number of stages, the phase ratio, the pH, and the mass fraction of the involved components. The results prove that the phosphate and 1-butyl-3-methylimidazolium trifluoromethanesulfonate mass fraction, the phase ratio, and the number of stages have a considerable influence on the recovery of 1,3-propanediol, whereas the pH value has only a smaller impact. Those results can be used for optimization of the system as well as for targeting future research within this area. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1734" xmlns="http://purl.org/rss/1.0/"><title>Use of the mitochondria toxicity assay for quantifying the viable cell density of microencapsulated jurkat cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1734</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Use of the mitochondria toxicity assay for quantifying the viable cell density of microencapsulated jurkat cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Werner, K. Biss, V. Jérôme, F. Hilbrig, R. Freitag, K. Zambrano, H. Hübner, R. Buchholz, R. Mahou, C. Wandrey</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-02T04:58:45.357485-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1734</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1734</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1734</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The mitochondria toxicity assay (MTT assay) is an established method for monitoring cell viability based on mitochondrial activity. Here the MTT assay is proposed for the <em>in situ</em> quantification of the living cell density of microencapsulated Jurkat cells. Three systems were used to encapsulate the cells, namely a membrane consisting of an interpenetrating polyelectrolyte network of sodium cellulose sulphate/poly(diallyldimethylammonium chloride) (NaCS/PDADMAC), a calcium alginate hydrogel covered with poly(<span class="smallCaps">L</span>-lysine) (Ca-alg-PLL), and a novel calcium alginate-poly(ethylene glycol) hybrid material (Ca-alg-PEG). MTT results were correlated to data obtained by the trypan blue exclusion assay after release of the cells from the NaCS/PDADMAC and Ca-alg-PLL capsules, while a resazurin-based assay was used for comparison in case of the Ca-alg-PEG material. Analysis by MTT assay allows quick and reliable determination of viable cell densities of encapsulated cells independent of the capsule material. The assay is highly reproducible with inter-assay relative standard deviations below 10%.  © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The mitochondria toxicity assay (MTT assay) is an established method for monitoring cell viability based on mitochondrial activity. Here the MTT assay is proposed for the in situ quantification of the living cell density of microencapsulated Jurkat cells. Three systems were used to encapsulate the cells, namely a membrane consisting of an interpenetrating polyelectrolyte network of sodium cellulose sulphate/poly(diallyldimethylammonium chloride) (NaCS/PDADMAC), a calcium alginate hydrogel covered with poly(L-lysine) (Ca-alg-PLL), and a novel calcium alginate-poly(ethylene glycol) hybrid material (Ca-alg-PEG). MTT results were correlated to data obtained by the trypan blue exclusion assay after release of the cells from the NaCS/PDADMAC and Ca-alg-PLL capsules, while a resazurin-based assay was used for comparison in case of the Ca-alg-PEG material. Analysis by MTT assay allows quick and reliable determination of viable cell densities of encapsulated cells independent of the capsule material. The assay is highly reproducible with inter-assay relative standard deviations below 10%.  © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1726" xmlns="http://purl.org/rss/1.0/"><title>Differential response in downstream processing of CHO cells grown under mild hypothermic conditions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1726</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Differential response in downstream processing of CHO cells grown under mild hypothermic conditions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andrew S. Tait, Richard D. R. Tarrant, M. Lourdes Velez-Suberbie, Daniel I. R. Spencer, Daniel G. Bracewell</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-02T04:58:40.082327-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1726</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1726</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1726</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The manufacture of complex therapeutic proteins using mammalian cells is well established, with several strategies developed to improve productivity. The application of sustained mild hypothermic conditions during culture has been associated with increases in product titer and improved product quality. However, despite associated cell physiological effects, very few studies have investigated the impact on downstream processing (DSP). Characterization of cells grown under mild hypothermic conditions demonstrated that the stationary phase was prolonged by delaying the onset of apoptosis. This enabled cells to maintain viability for extended periods and increase volumetric productivity from 0.74 to 1.02 g L<sup>−1</sup>. However, host cell proteins, measured by ELISA, increased by ∼50%, attributed to the extended time course and higher peak and harvest cell densities. The individual components making up this impurity, as determined by SELDI-TOF MS and 2D-PAGE, were shown to be largely comparable. Under mild hypothermic conditions, cells were less shear sensitive than those maintained at 37°C, enhancing the preliminary primary recovery step. Adaptive changes in membrane fluidity were further investigated by adopting a pronounced temperature shift immediately prior to primary recovery and the improvement observed suggests that such a strategy may be implementable when shear sensitivity is of concern. Early and late apoptotic cells were particularly susceptible to shear, at either temperature, even under the lowest shear rate investigated. These findings demonstrate the importance of considering the impact of cell culture strategies and cell physiology on DSP, by implementing a range of experimental methods for process characterization. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The manufacture of complex therapeutic proteins using mammalian cells is well established, with several strategies developed to improve productivity. The application of sustained mild hypothermic conditions during culture has been associated with increases in product titer and improved product quality. However, despite associated cell physiological effects, very few studies have investigated the impact on downstream processing (DSP). Characterization of cells grown under mild hypothermic conditions demonstrated that the stationary phase was prolonged by delaying the onset of apoptosis. This enabled cells to maintain viability for extended periods and increase volumetric productivity from 0.74 to 1.02 g L−1. However, host cell proteins, measured by ELISA, increased by ∼50%, attributed to the extended time course and higher peak and harvest cell densities. The individual components making up this impurity, as determined by SELDI-TOF MS and 2D-PAGE, were shown to be largely comparable. Under mild hypothermic conditions, cells were less shear sensitive than those maintained at 37°C, enhancing the preliminary primary recovery step. Adaptive changes in membrane fluidity were further investigated by adopting a pronounced temperature shift immediately prior to primary recovery and the improvement observed suggests that such a strategy may be implementable when shear sensitivity is of concern. Early and late apoptotic cells were particularly susceptible to shear, at either temperature, even under the lowest shear rate investigated. These findings demonstrate the importance of considering the impact of cell culture strategies and cell physiology on DSP, by implementing a range of experimental methods for process characterization. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1723" xmlns="http://purl.org/rss/1.0/"><title>Strictosidine-related enzymes involved in the alkaloid biosynthesis of Uncaria tomentosa root cultures grown under oxidative stress</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1723</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Strictosidine-related enzymes involved in the alkaloid biosynthesis of Uncaria tomentosa root cultures grown under oxidative stress</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ileana Vera-Reyes, Ariana A. Huerta-Heredia, Teresa Ponce-Noyola, Isvett Josefina Flores-Sanchez, Fernando Esparza-García, Carlos M. Cerda-García-Rojas, Gabriela Trejo-Tapia, Ana C. Ramos-Valdivia</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T05:29:54.139619-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1723</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1723</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1723</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The activity and gene expression of strictosidine-related enzymes in <em>Uncaria tomentosa</em> root cultures exposed to oxidative stress were studied. Elicitation with 0.2 mM hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) or a combination of 0.8 mM buthionine sulfoximine and 0.2 mM jasmonic acid (BSO-JA) increased peroxidase activities by twofold at Day 8 and glutathione reductase by 1.4-fold at Day 5 in H<sub>2</sub>O<sub>2</sub> elicited cultures respect to the control. Production of monoterpenoid oxindole alkaloids (MOA), 3α-dihydrocadambine, and dolichantoside was stimulated after H<sub>2</sub>O<sub>2</sub> elicitation, reaching levels of 886.4 ± 23.6, 847.7 ± 25.4, and 87.5 ± 7.2 µg/g DW, at Day 8 which were 1.7-, 2.1-, and 2.3-fold higher relative to control. BSO-JA elicited cultures produced about twice alkaloids than H<sub>2</sub>O<sub>2</sub>-treated cultures, following a biphasic pattern with maxima at 0.5 and 8 days. Alkaloid production was preceded by increase in strictosidine synthase (STR) and strictosidine glucosidase (SGD) activities. After elicitation with H<sub>2</sub>O<sub>2</sub> or BSO-JA, the STR activity (pKat/mg protein) increased by 1.9-fold (93.8 ± 17.8 at 24 h) or 2.5-fold (102.4 ± 2.2 at 6 h) and the SGD activity (pKat/mg protein) by 2.8-fold (245.2 ± 14.4 at 6 h) or 4.2-fold (421.2 ± 1.8 at 18 h) relative to control. <em>STR</em> and <em>SGD</em> transcripts were upregulated after elicitation. H<sub>2</sub>O<sub>2</sub>-treated roots showed higher levels of <em>STR</em> at 48–192 h and <em>SGD</em> at 24–48 h, while BSO-JA treatments showed <em>STR</em> increased at 12 h and <em>SGD</em> at 24 h. Also, LC/ESI-MS confirmed the biosynthesis of dolichantoside from <em>N</em>-ω-methyltryptamine and secologanin by <em>U. tomentosa</em> protein extracts. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The activity and gene expression of strictosidine-related enzymes in Uncaria tomentosa root cultures exposed to oxidative stress were studied. Elicitation with 0.2 mM hydrogen peroxide (H2O2) or a combination of 0.8 mM buthionine sulfoximine and 0.2 mM jasmonic acid (BSO-JA) increased peroxidase activities by twofold at Day 8 and glutathione reductase by 1.4-fold at Day 5 in H2O2 elicited cultures respect to the control. Production of monoterpenoid oxindole alkaloids (MOA), 3α-dihydrocadambine, and dolichantoside was stimulated after H2O2 elicitation, reaching levels of 886.4 ± 23.6, 847.7 ± 25.4, and 87.5 ± 7.2 µg/g DW, at Day 8 which were 1.7-, 2.1-, and 2.3-fold higher relative to control. BSO-JA elicited cultures produced about twice alkaloids than H2O2-treated cultures, following a biphasic pattern with maxima at 0.5 and 8 days. Alkaloid production was preceded by increase in strictosidine synthase (STR) and strictosidine glucosidase (SGD) activities. After elicitation with H2O2 or BSO-JA, the STR activity (pKat/mg protein) increased by 1.9-fold (93.8 ± 17.8 at 24 h) or 2.5-fold (102.4 ± 2.2 at 6 h) and the SGD activity (pKat/mg protein) by 2.8-fold (245.2 ± 14.4 at 6 h) or 4.2-fold (421.2 ± 1.8 at 18 h) relative to control. STR and SGD transcripts were upregulated after elicitation. H2O2-treated roots showed higher levels of STR at 48–192 h and SGD at 24–48 h, while BSO-JA treatments showed STR increased at 12 h and SGD at 24 h. Also, LC/ESI-MS confirmed the biosynthesis of dolichantoside from N-ω-methyltryptamine and secologanin by U. tomentosa protein extracts. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1729" xmlns="http://purl.org/rss/1.0/"><title>Purification and biochemical characterization of feruloyl esterases from Aspergillus terreus MTCC 11096</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1729</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Purification and biochemical characterization of feruloyl esterases from Aspergillus terreus MTCC 11096</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Ganesh Kumar, Avijeet Kamle, Ahmed Kamal</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T05:29:47.921125-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1729</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1729</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1729</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Aspergillus terreus</em> MTCC 11096 isolated from the soils of agricultural fields cultivating sweet sorghum was previously identified to produce feruloyl esterases (FAEs). The enzymes responsible for feruloyl esterase activity were purified to homogeneity and named as AtFAE-1, AtFAE-2, and AtFAE-3. The enzymes were monomeric having molecular masses of 74, 23 and 36 kDa, respectively. Active protein bands were identified by a developed pH-dependent zymogram on native PAGE. The three enzymes exhibited variation in pH tolerance ranging between pH 5–8 and thermostability of up to 55°C. Inhibition studies revealed that the serine residue was essential for feruloyl esterase activity; moreover aspartyl and glutamyl residues are not totally involved at the active site. Metal ions such as Ca<sup>2+</sup>, K<sup>+</sup>, and Mg<sup>2+</sup> stabilized the enzyme activity for all three FAEs. Kinetic data indicated that all three enzymes showed catalytic efficiencies (<em>k</em><sub>cat</sub>/<em>K</em><sub>m</sub>) against different synthesized alkyl and aryl esters indicating their broad substrate specificity. The peptide mass fingerprinting by MALDI/TOF-MS analysis and enzyme affinity toward methoxy and hydroxy substituents on the benzene ring revealed that the AtFAE-1 belonged to type A while AtFAE-2 and AtFAE-3 were type C FAE. The FAEs could release 65 to 90% of ferulic acid from agrowaste substrates in the presence of xylanase. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Aspergillus terreus MTCC 11096 isolated from the soils of agricultural fields cultivating sweet sorghum was previously identified to produce feruloyl esterases (FAEs). The enzymes responsible for feruloyl esterase activity were purified to homogeneity and named as AtFAE-1, AtFAE-2, and AtFAE-3. The enzymes were monomeric having molecular masses of 74, 23 and 36 kDa, respectively. Active protein bands were identified by a developed pH-dependent zymogram on native PAGE. The three enzymes exhibited variation in pH tolerance ranging between pH 5–8 and thermostability of up to 55°C. Inhibition studies revealed that the serine residue was essential for feruloyl esterase activity; moreover aspartyl and glutamyl residues are not totally involved at the active site. Metal ions such as Ca2+, K+, and Mg2+ stabilized the enzyme activity for all three FAEs. Kinetic data indicated that all three enzymes showed catalytic efficiencies (kcat/Km) against different synthesized alkyl and aryl esters indicating their broad substrate specificity. The peptide mass fingerprinting by MALDI/TOF-MS analysis and enzyme affinity toward methoxy and hydroxy substituents on the benzene ring revealed that the AtFAE-1 belonged to type A while AtFAE-2 and AtFAE-3 were type C FAE. The FAEs could release 65 to 90% of ferulic acid from agrowaste substrates in the presence of xylanase. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1728" xmlns="http://purl.org/rss/1.0/"><title>Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1728</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Erik K. Read, Scott A. Bradley, Tim A. Smitka, Cyrus D. Agarabi, Scott C. Lute, Kurt A. Brorson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T05:15:12.972882-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1728</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1728</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1728</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Fermentanomics, or a global understanding of a culture state on the molecular level empowered by advanced techniques like NMR, was employed to show that a model hybridoma culture supplied with glutamine and glucose depletes aspartate, cysteine, methionine, tryptophan, and tyrosine during antibody production. Supplementation with these amino acids prevents depletion and improves culture performance. Furthermore, no significant changes were observed in the distribution of glycans attached to the IgG3 in cultures supplemented with specific amino acids, arguing that this strategy can be implemented without fear of impact on important product quality attributes. In summary, a targeted strategy of quantifying media components and designing a supplementation strategy can improve bioprocess cell cultures when enpowered by fermentanomics tools. Published 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Fermentanomics, or a global understanding of a culture state on the molecular level empowered by advanced techniques like NMR, was employed to show that a model hybridoma culture supplied with glutamine and glucose depletes aspartate, cysteine, methionine, tryptophan, and tyrosine during antibody production. Supplementation with these amino acids prevents depletion and improves culture performance. Furthermore, no significant changes were observed in the distribution of glycans attached to the IgG3 in cultures supplemented with specific amino acids, arguing that this strategy can be implemented without fear of impact on important product quality attributes. In summary, a targeted strategy of quantifying media components and designing a supplementation strategy can improve bioprocess cell cultures when enpowered by fermentanomics tools. Published 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1727" xmlns="http://purl.org/rss/1.0/"><title>Feed rate control in fed-batch fermentations based on frequency content analysis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1727</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Feed rate control in fed-batch fermentations based on frequency content analysis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ola Johnsson, Jonas Andersson, Gunnar Lidén, Charlotta Johnsson, Tore Hägglund</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T05:14:57.495196-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1727</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1727</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1727</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A new strategy for controlling substrate feed in the exponential growth phase of aerated fed-batch fermentations is presented. The challenge in this phase is typically to maximize specific growth rate while avoiding the accumulation of overflow metabolites which can occur at high substrate feed rates. In the new strategy, regular perturbations to the feed rate are applied and the proximity to overflow metabolism is continuously assessed from the frequency spectrum of the dissolved oxygen signal. The power spectral density for the frequency of the external perturbations is used as a control variable in a controller to regulate the substrate feed. The strategy was implemented in an industrial pilot scale fermentation set up and calibrated and verified using an amylase producing <em>Bacillus licheniformis</em> strain. It was shown that a higher biomass yield could be obtained without excessive accumulation of harmful overflow metabolites. The general applicability of the strategy was further demonstrated by implementing the controller in another process using a <em>Bacillus licheniformis</em> strain currently used in industrial production processes. In addition, in this case a higher growth rate and decreased accumulation of overflow metabolites in the exponential growth phase was achieved in comparison to the reference controller. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
A new strategy for controlling substrate feed in the exponential growth phase of aerated fed-batch fermentations is presented. The challenge in this phase is typically to maximize specific growth rate while avoiding the accumulation of overflow metabolites which can occur at high substrate feed rates. In the new strategy, regular perturbations to the feed rate are applied and the proximity to overflow metabolism is continuously assessed from the frequency spectrum of the dissolved oxygen signal. The power spectral density for the frequency of the external perturbations is used as a control variable in a controller to regulate the substrate feed. The strategy was implemented in an industrial pilot scale fermentation set up and calibrated and verified using an amylase producing Bacillus licheniformis strain. It was shown that a higher biomass yield could be obtained without excessive accumulation of harmful overflow metabolites. The general applicability of the strategy was further demonstrated by implementing the controller in another process using a Bacillus licheniformis strain currently used in industrial production processes. In addition, in this case a higher growth rate and decreased accumulation of overflow metabolites in the exponential growth phase was achieved in comparison to the reference controller. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1733" xmlns="http://purl.org/rss/1.0/"><title>Metabolic engineering of Clostridium acetobutylicum for the enhanced production of isopropanol-butanol-ethanol fuel mixture</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1733</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Metabolic engineering of Clostridium acetobutylicum for the enhanced production of isopropanol-butanol-ethanol fuel mixture</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yu-Sin Jang, Alok Malaviya, Joungmin Lee, Jung Ae Im, Sang Yup Lee, Julia Lee, Moon-Ho Eom, Jung-Hee Cho, Do Young Seung</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T08:47:52.652625-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1733</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1733</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1733</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Butanol is considered as a superior biofuel, which is conventionally produced by clostridial acetone-butanol-ethanol (ABE) fermentation. Among ABE, only butanol and ethanol can be used as fuel alternatives. Coproduction of acetone thus causes lower yield of fuel alcohols. Thus, this study aimed at developing an improved <em>Clostridium acetobutylicum</em> strain possessing enhanced fuel alcohol production capability. For this, we previously developed a hyper ABE producing BKM19 strain was further engineered to convert acetone into isopropanol. The BKM19 strain was transformed with the plasmid pIPA100 containing the <em>sadh</em> (primary/secondary alcohol dehydrogenase) and <em>hydG</em> (putative electron transfer protein) genes from the <em>Clostridium beijerinckii</em> NRRL B593 cloned under the control of the thiolase promoter. The resulting BKM19 (pIPA100) strain produced 27.9 g/l isopropanol-butanol-ethanol (IBE) as a fuel alcohols with negligible amount of acetone (0.4 g/l) from 97.8 g/l glucose in lab-scale (2 l) batch fermentation. Thus, this metabolically engineered strain was able to produce 99% of total solvent produced as fuel alcohols. The scalability and stability of BKM19 (pIPA100) were evaluated at 200 l pilot-scale fermentation, which showed that the fuel alcohol yield could be improved to 0.37 g/g as compared to 0.29 g/g obtained at lab-scale fermentation, while attaining a similar titer. To the best of our knowledge, this is the highest titer of IBE achieved and the first report on the large scale fermentation of <em>C. acetobutylicum</em> for IBE production. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Butanol is considered as a superior biofuel, which is conventionally produced by clostridial acetone-butanol-ethanol (ABE) fermentation. Among ABE, only butanol and ethanol can be used as fuel alternatives. Coproduction of acetone thus causes lower yield of fuel alcohols. Thus, this study aimed at developing an improved Clostridium acetobutylicum strain possessing enhanced fuel alcohol production capability. For this, we previously developed a hyper ABE producing BKM19 strain was further engineered to convert acetone into isopropanol. The BKM19 strain was transformed with the plasmid pIPA100 containing the sadh (primary/secondary alcohol dehydrogenase) and hydG (putative electron transfer protein) genes from the Clostridium beijerinckii NRRL B593 cloned under the control of the thiolase promoter. The resulting BKM19 (pIPA100) strain produced 27.9 g/l isopropanol-butanol-ethanol (IBE) as a fuel alcohols with negligible amount of acetone (0.4 g/l) from 97.8 g/l glucose in lab-scale (2 l) batch fermentation. Thus, this metabolically engineered strain was able to produce 99% of total solvent produced as fuel alcohols. The scalability and stability of BKM19 (pIPA100) were evaluated at 200 l pilot-scale fermentation, which showed that the fuel alcohol yield could be improved to 0.37 g/g as compared to 0.29 g/g obtained at lab-scale fermentation, while attaining a similar titer. To the best of our knowledge, this is the highest titer of IBE achieved and the first report on the large scale fermentation of C. acetobutylicum for IBE production. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1732" xmlns="http://purl.org/rss/1.0/"><title>Chitinolytic enzymes: An appraisal as a product of commercial potential</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1732</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Chitinolytic enzymes: An appraisal as a product of commercial potential</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. B. Chavan, M. V. Deshpande</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T08:47:42.601321-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1732</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1732</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1732</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Chitin, its deacetylated form, chitosan and chitinolytic enzymes viz. endo-chitinase, <em>N</em>-acetylglucosaminidase, chitosanase, chitin deacetylase (CDA) are gaining importance for their biotechnological applications. Presently, chitin degrading enzymes constitute high-cost low-volume products in human health care and associated research. Indeed chitinases and CDA-chitosanase complex possesss tremendous potential in agriculture to control plant pathogenic fungi and insects. The success in exploring chitinases especially for agriculture, i.e. as a high-volume low-cost product, depends on the availability of highly active preparations with a reasonable cost. Therefore, a reconsideration in terms of understanding the roles of chitinolytic enzymes in applications, e.g. host–pathogen interaction for biocontrol, different mechanisms of chitin degradation, and identification of new enzymes with varying specificities, may make them more useful in a variety of commercial processes in the near future. The possible issues and challenges encountered in the translation of proof of concept into a commercial product will be appraised in this review. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Chitin, its deacetylated form, chitosan and chitinolytic enzymes viz. endo-chitinase, N-acetylglucosaminidase, chitosanase, chitin deacetylase (CDA) are gaining importance for their biotechnological applications. Presently, chitin degrading enzymes constitute high-cost low-volume products in human health care and associated research. Indeed chitinases and CDA-chitosanase complex possesss tremendous potential in agriculture to control plant pathogenic fungi and insects. The success in exploring chitinases especially for agriculture, i.e. as a high-volume low-cost product, depends on the availability of highly active preparations with a reasonable cost. Therefore, a reconsideration in terms of understanding the roles of chitinolytic enzymes in applications, e.g. host–pathogen interaction for biocontrol, different mechanisms of chitin degradation, and identification of new enzymes with varying specificities, may make them more useful in a variety of commercial processes in the near future. The possible issues and challenges encountered in the translation of proof of concept into a commercial product will be appraised in this review. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1731" xmlns="http://purl.org/rss/1.0/"><title>Cell-based screening of traditional chinese medicines for proliferation enhancers of mouse embryonic stem cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1731</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cell-based screening of traditional chinese medicines for proliferation enhancers of mouse embryonic stem cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ding Li, Sarah Isherwood, Andrew Motz, Ru Zang, Shang-Tian Yang, Jufang Wang, Xiaoning Wang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T08:47:27.312003-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1731</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1731</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1731</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A high-throughput cell-based method was developed for screening traditional Chinese herbal medicines (TCHMs) for potential stem cell growth promoters. Mouse embryonic stem (mES) cells expressing enhanced green fluorescent protein (EGFP) were cultured in growth media supplemented with various TCHM extracts. The dosage-dependent effects of TCHM extracts on cell growth, including proliferation and cytotoxicity, were assessed via EGFP fluorescence measurement. Seven TCHMs were investigated, and among them <em>Panax notoginseng</em> (PN), <em>Rhizoma Atractylodis macrocephalae</em>, <em>Rhizoma chuanxiong</em>, and <em>Ganoderma lucidum</em> spores (GLS) showed potential to improve mES cell proliferation. Eleven mixtures of these four TCHMs were then studied, and the results showed that the mixture of PN and GLS had the strongest growth promoting effect, increasing the specific growth rate of mES cells by 29.5% at a low dosage of 0.01% (wt/vol) PN/GLS (<em>P</em> &lt; 0.01) and 34.2% at 0.1% (wt/vol) PN/GLS (<em>P</em> &lt; 0.05) compared to the control. The growth promoting effect of PN/GLS was further confirmed with ES cells cultured in spinner flasks. A 29.3-fold increase in the total cell number was achieved in the medium supplemented with 0.01% PN/GLS after 5 days, while the control culture only gave a 16.8-fold increase. This cell-based screening method thus can provide an efficient and high-throughput way to explore potential stem cell growth promoters from TCHMs. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
A high-throughput cell-based method was developed for screening traditional Chinese herbal medicines (TCHMs) for potential stem cell growth promoters. Mouse embryonic stem (mES) cells expressing enhanced green fluorescent protein (EGFP) were cultured in growth media supplemented with various TCHM extracts. The dosage-dependent effects of TCHM extracts on cell growth, including proliferation and cytotoxicity, were assessed via EGFP fluorescence measurement. Seven TCHMs were investigated, and among them Panax notoginseng (PN), Rhizoma Atractylodis macrocephalae, Rhizoma chuanxiong, and Ganoderma lucidum spores (GLS) showed potential to improve mES cell proliferation. Eleven mixtures of these four TCHMs were then studied, and the results showed that the mixture of PN and GLS had the strongest growth promoting effect, increasing the specific growth rate of mES cells by 29.5% at a low dosage of 0.01% (wt/vol) PN/GLS (P &lt; 0.01) and 34.2% at 0.1% (wt/vol) PN/GLS (P &lt; 0.05) compared to the control. The growth promoting effect of PN/GLS was further confirmed with ES cells cultured in spinner flasks. A 29.3-fold increase in the total cell number was achieved in the medium supplemented with 0.01% PN/GLS after 5 days, while the control culture only gave a 16.8-fold increase. This cell-based screening method thus can provide an efficient and high-throughput way to explore potential stem cell growth promoters from TCHMs. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1730" xmlns="http://purl.org/rss/1.0/"><title>Chinese hamster ovary K1 host cell enables stable cell line development for antibody molecules which are difficult to express in DUXB11-derived dihydrofolate reductase deficient host cell</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1730</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Chinese hamster ovary K1 host cell enables stable cell line development for antibody molecules which are difficult to express in DUXB11-derived dihydrofolate reductase deficient host cell</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Zhilan Hu, Donglin Guo, Shirley S.M. Yip, Dejin Zhan, Shahram Misaghi, John C. Joly, Bradley R. Snedecor, Amy Y. Shen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T08:47:10.494322-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1730</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1730</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1730</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Therapeutic monoclonal antibodies (mAb) are often produced in Chinese hamster ovary (CHO) cells. Three commonly used CHO host cells for generating stable cell lines to produce therapeutic proteins are dihydrofolate reductase (DHFR) positive CHOK1, DHFR-deficient DG44, and DUXB11-based DHFR deficient CHO. Current Genentech commercial full-length antibody products have all been produced in the DUXB11-derived DHFR-deficient CHO host. However, it has been challenging to develop stable cell lines producing an appreciable amount of antibody proteins in the DUXB11-derived DHFR-deficient CHO host for some antibody molecules and the CHOK1 host has been explored as an alternative approach. In this work, stable cell lines were developed for three antibody molecules in both DUXB11-based and CHOK1 hosts. Results have shown that the best CHOK1 clones produce about 1 g/l for an antibody mAb1 and about 4 g/l for an antibody mAb2 in 14-day fed batch cultures in shake flasks. In contrast, the DUXB11-based host produced ∼0.1 g/l for both antibodies in the same 14-day fed batch shake flask production experiments. For an antibody mAb3, both CHOK1 and DUXB11 host cells can generate stable cell lines with the best clone in each host producing ∼2.5 g/l. Additionally, studies have shown that the CHOK1 host cell has a larger endoplasmic reticulum and higher mitochondrial mass. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Therapeutic monoclonal antibodies (mAb) are often produced in Chinese hamster ovary (CHO) cells. Three commonly used CHO host cells for generating stable cell lines to produce therapeutic proteins are dihydrofolate reductase (DHFR) positive CHOK1, DHFR-deficient DG44, and DUXB11-based DHFR deficient CHO. Current Genentech commercial full-length antibody products have all been produced in the DUXB11-derived DHFR-deficient CHO host. However, it has been challenging to develop stable cell lines producing an appreciable amount of antibody proteins in the DUXB11-derived DHFR-deficient CHO host for some antibody molecules and the CHOK1 host has been explored as an alternative approach. In this work, stable cell lines were developed for three antibody molecules in both DUXB11-based and CHOK1 hosts. Results have shown that the best CHOK1 clones produce about 1 g/l for an antibody mAb1 and about 4 g/l for an antibody mAb2 in 14-day fed batch cultures in shake flasks. In contrast, the DUXB11-based host produced ∼0.1 g/l for both antibodies in the same 14-day fed batch shake flask production experiments. For an antibody mAb3, both CHOK1 and DUXB11 host cells can generate stable cell lines with the best clone in each host producing ∼2.5 g/l. Additionally, studies have shown that the CHOK1 host cell has a larger endoplasmic reticulum and higher mitochondrial mass. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1725" xmlns="http://purl.org/rss/1.0/"><title>Separation, antitumor activities, and encapsulation of polypeptide from Chlorella pyrenoidosa</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1725</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Separation, antitumor activities, and encapsulation of polypeptide from Chlorella pyrenoidosa</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Xiaoqin Wang, Xuewu Zhang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T08:46:55.600873-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1725</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1725</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1725</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Chlorella pyrenoidosa is a unicellular green algae and has been a popular foodstuff worldwide. However, no reports on the antitumor peptides from such a microalgae are available in the literature. In this study, using low-temperature high-pressure extraction, enzymatic hydrolysis, ion exchange, and gel filtration chromatography, we separated a polypeptide that exhibited inhibitory activity on human liver cancer HepG2 cells, and named the polypeptide CPAP (C. pyrenoidosa antitumor polypeptide). Furthermore, the micro- and nanoencapsulation of CPAP were investigated by using two methods: complex coacervation and ionotropic gelation. The in vitro release tests revealed that CPAP was well preserved against gastric enzymatic degradation after micro/nanoencapsulation and the slowly controlled release in the intestine could be potentially achieved. These results suggest that CPAP may be a useful ingredient in food, nutraceutical, and pharmaceutical applications. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Chlorella pyrenoidosa is a unicellular green algae and has been a popular foodstuff worldwide. However, no reports on the antitumor peptides from such a microalgae are available in the literature. In this study, using low-temperature high-pressure extraction, enzymatic hydrolysis, ion exchange, and gel filtration chromatography, we separated a polypeptide that exhibited inhibitory activity on human liver cancer HepG2 cells, and named the polypeptide CPAP (C. pyrenoidosa antitumor polypeptide). Furthermore, the micro- and nanoencapsulation of CPAP were investigated by using two methods: complex coacervation and ionotropic gelation. The in vitro release tests revealed that CPAP was well preserved against gastric enzymatic degradation after micro/nanoencapsulation and the slowly controlled release in the intestine could be potentially achieved. These results suggest that CPAP may be a useful ingredient in food, nutraceutical, and pharmaceutical applications. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1724" xmlns="http://purl.org/rss/1.0/"><title>Hemorheological implications of perfluorocarbon based oxygen carrier interaction with colloid plasma expanders and blood</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1724</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Hemorheological implications of perfluorocarbon based oxygen carrier interaction with colloid plasma expanders and blood</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Diana M. Vásquez, Daniel Ortiz, Oscar A. Alvarez, Juan C. Briceño, Pedro Cabrales</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T08:45:59.493998-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1724</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1724</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1724</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Perfluorocarbon (PFC) emulsions used as artificial oxygen carriers lack colloid osmotic pressure (COP) and must be administered with colloid-based plasma expanders (PEs). Although PFC emulsions have been widely studied, there is limited information about PFC emulsion interaction with PEs and blood. Their interaction forms aggregates due to electrostatic and rheological phenomena, and change blood rheology and blood flow. This study analyzes the effects of the interaction between PFC emulsions with blood in the presence of clinically-used PEs. The rheological behavior of the mixtures was analyzed <em>in vitro</em> in parallel with in vivo analysis of blood flow in the microcirculation using intravital microscopy, when PEs were administered in a clinically relevant scenario. The interaction between the PFC emulsion and PE with blood produced PFC droplets and red blood cell (RBCs) aggregation and increased blood viscosity in a shear dependent fashion. The PFC droplets formed aggregates when mixed with PEs containing electrolytes, and the aggregation increased with the electrolyte concentration. Mixtures of PFC with PEs that produced PFC aggregates also induced RCBs aggregation when mixed with blood, increasing blood viscosity at low shear rates. The more viscous suspension at low shear rates produced a blunted blood flow velocity profile <em>in vivo</em> compared to nonaggregating mixtures of PFC and PEs. For the PEs evaluated, human serum albumin produced minimal to undetectable aggregation. PFC and PEs interaction with blood can affect sections of the microcirculation with low shear rates (e.g., arterioles, venules, and pulmonary circulation) when used in a clinical setting, because persistent aggregates could cause capillary occlusion, decreased perfusion, pulmonary emboli or focal ischemia. © 2013 <em>American Institute of Chemical Engineers Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Perfluorocarbon (PFC) emulsions used as artificial oxygen carriers lack colloid osmotic pressure (COP) and must be administered with colloid-based plasma expanders (PEs). Although PFC emulsions have been widely studied, there is limited information about PFC emulsion interaction with PEs and blood. Their interaction forms aggregates due to electrostatic and rheological phenomena, and change blood rheology and blood flow. This study analyzes the effects of the interaction between PFC emulsions with blood in the presence of clinically-used PEs. The rheological behavior of the mixtures was analyzed in vitro in parallel with in vivo analysis of blood flow in the microcirculation using intravital microscopy, when PEs were administered in a clinically relevant scenario. The interaction between the PFC emulsion and PE with blood produced PFC droplets and red blood cell (RBCs) aggregation and increased blood viscosity in a shear dependent fashion. The PFC droplets formed aggregates when mixed with PEs containing electrolytes, and the aggregation increased with the electrolyte concentration. Mixtures of PFC with PEs that produced PFC aggregates also induced RCBs aggregation when mixed with blood, increasing blood viscosity at low shear rates. The more viscous suspension at low shear rates produced a blunted blood flow velocity profile in vivo compared to nonaggregating mixtures of PFC and PEs. For the PEs evaluated, human serum albumin produced minimal to undetectable aggregation. PFC and PEs interaction with blood can affect sections of the microcirculation with low shear rates (e.g., arterioles, venules, and pulmonary circulation) when used in a clinical setting, because persistent aggregates could cause capillary occlusion, decreased perfusion, pulmonary emboli or focal ischemia. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1719" xmlns="http://purl.org/rss/1.0/"><title>Case Study: An accelerated 8-day monoclonal antibody production process based on high seeding densities</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1719</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Case Study: An accelerated 8-day monoclonal antibody production process based on high seeding densities</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ishai Padawer, Wai Lam W. Ling, Yunling Bai</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T00:29:34.686104-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1719</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1719</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1719</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This study describes the development work to shorten the monoclonal antibody (mAb) production time in CHO cell cultures from 14 days to 8 days without impacting mAb titer or product quality. The proposed process increases cell inoculation densities up to 25× higher than a typical seeding density in the final production bioreactor, with the implementation of an ATF™ perfusion system in the <em>N</em> − 1 stage. Similar antibody titer and N-glycosylation profiles were reached in 8 days using the 25× seed condition, as in 14 days using the 1× seed condition. Acidic variants in the 25× seed condition were 12–20% lower than the 1× seed condition. These results indicate that an accelerated 8-day antibody production process utilizing a 25× seeding strategy has the potential of achieving similar product quality and titer as the 1× seeding condition in a 14-day production process. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
This study describes the development work to shorten the monoclonal antibody (mAb) production time in CHO cell cultures from 14 days to 8 days without impacting mAb titer or product quality. The proposed process increases cell inoculation densities up to 25× higher than a typical seeding density in the final production bioreactor, with the implementation of an ATF™ perfusion system in the N − 1 stage. Similar antibody titer and N-glycosylation profiles were reached in 8 days using the 25× seed condition, as in 14 days using the 1× seed condition. Acidic variants in the 25× seed condition were 12–20% lower than the 1× seed condition. These results indicate that an accelerated 8-day antibody production process utilizing a 25× seeding strategy has the potential of achieving similar product quality and titer as the 1× seeding condition in a 14-day production process. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1718" xmlns="http://purl.org/rss/1.0/"><title>Multipronged approach to managing beta-glucan contaminants in the downstream process: Control of raw materials and filtration with charge-modified nylon 6,6 membrane filters</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1718</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multipronged approach to managing beta-glucan contaminants in the downstream process: Control of raw materials and filtration with charge-modified nylon 6,6 membrane filters</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eva Gefroh, Art Hewig, Ganesh Vedantham, Megan McClure, Alla Krivosheyeva, Ajay Lajmi, Yuefeng Lu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T00:29:25.362642-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1718</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1718</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1718</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>(1→3)-β-<span class="smallCaps">d</span>-Glucans (beta-glucans) have been found in raw materials used in the manufacture of recombinant therapeutics. Because of their biological activity, beta-glucans are considered process contaminants and consequently their level in the product needs to be controlled. Although beta-glucans introduced into the cell culture process can readily be removed by bind-and-elute chromatography process steps, beta-glucans can also be introduced into the purification process through raw materials containing beta-glucans as well as leachables from filters made from cellulose. This article reports a multipronged approach to managing the beta-glucan contamination in the downstream process. Raw material screening and selection can be used to effectively limit the level of beta-glucan introduced into the downstream process. Placement of a cellulosic filter upstream of the last bind-and-elute column step or effective preuse flushing can also limit the level of contaminant introduced. More importantly, this article reports the active removal of beta-glucan from the downstream process when necessary. It was discovered that the Posidyne<sup>®</sup> filter, a charge-modified nylon 6,6 membrane filter, was able to effectively remove beta-glucans from buffers at relatively low pH and salt concentrations. An approach of using low beta-glucan buffer components combined with filtration of the buffer with a Posidyne membrane has been successfully demonstrated at preparative scale. Additionally, the feasibility of active removal of beta-glucan from in-process product pools by Posidyne membrane filtration has also been demonstrated. Based on the data presented, a mechanism for binding is proposed, as well as a systematic approach for sizing of the Posidyne filter. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
(1→3)-β-d-Glucans (beta-glucans) have been found in raw materials used in the manufacture of recombinant therapeutics. Because of their biological activity, beta-glucans are considered process contaminants and consequently their level in the product needs to be controlled. Although beta-glucans introduced into the cell culture process can readily be removed by bind-and-elute chromatography process steps, beta-glucans can also be introduced into the purification process through raw materials containing beta-glucans as well as leachables from filters made from cellulose. This article reports a multipronged approach to managing the beta-glucan contamination in the downstream process. Raw material screening and selection can be used to effectively limit the level of beta-glucan introduced into the downstream process. Placement of a cellulosic filter upstream of the last bind-and-elute column step or effective preuse flushing can also limit the level of contaminant introduced. More importantly, this article reports the active removal of beta-glucan from the downstream process when necessary. It was discovered that the Posidyne® filter, a charge-modified nylon 6,6 membrane filter, was able to effectively remove beta-glucans from buffers at relatively low pH and salt concentrations. An approach of using low beta-glucan buffer components combined with filtration of the buffer with a Posidyne membrane has been successfully demonstrated at preparative scale. Additionally, the feasibility of active removal of beta-glucan from in-process product pools by Posidyne membrane filtration has also been demonstrated. Based on the data presented, a mechanism for binding is proposed, as well as a systematic approach for sizing of the Posidyne filter. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1716" xmlns="http://purl.org/rss/1.0/"><title>Use of perfluorocarbons to enhance the performance of perfused three-dimensional hepatic cultures</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1716</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Use of perfluorocarbons to enhance the performance of perfused three-dimensional hepatic cultures</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gengbei Shi, Robin N. Coger</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T00:28:57.410663-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1716</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1716</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1716</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Bioartificial liver devices (BALs) are extracorporeal systems designed to temporarily bridge patients until a suitable donated liver is available for transplantation and also have value for pharmaceutical testing applications. Yet critical issues exist that limit the functional performance of their current designs. One of these concerns scale up issues connected to oxygen (O<sub>2</sub>) delivery to the cells housed within their three-dimensional (3D) configurations, and its consequences to device performance. As primary blood substitute candidates with extraordinarily high O<sub>2</sub> capacity, perfluorocarbons (PFCs) offer hope as one strategy for addressing the O<sub>2</sub> delivery issue encountered when scaling up the tissue space of current BAL designs. This study utilizes a PFC-based second-generation O<sub>2</sub> carrier OXYCYTE®, as an additive to regular nutrient medium, for augmenting O<sub>2</sub> delivery in a customized 3D tissue assembly system. The results demonstrate that the addition of PFCs significantly increases the O<sub>2</sub> capacity of regular medium and that net cytochrome P450 activity levels are considerably increased under flow in PFC-treated systems, as compared to controls. This work thus clarifies the benefits of using PFCs to enhance the functional performance of 3D liver systems. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013</p></div>
]]></content:encoded><description>
Bioartificial liver devices (BALs) are extracorporeal systems designed to temporarily bridge patients until a suitable donated liver is available for transplantation and also have value for pharmaceutical testing applications. Yet critical issues exist that limit the functional performance of their current designs. One of these concerns scale up issues connected to oxygen (O2) delivery to the cells housed within their three-dimensional (3D) configurations, and its consequences to device performance. As primary blood substitute candidates with extraordinarily high O2 capacity, perfluorocarbons (PFCs) offer hope as one strategy for addressing the O2 delivery issue encountered when scaling up the tissue space of current BAL designs. This study utilizes a PFC-based second-generation O2 carrier OXYCYTE®, as an additive to regular nutrient medium, for augmenting O2 delivery in a customized 3D tissue assembly system. The results demonstrate that the addition of PFCs significantly increases the O2 capacity of regular medium and that net cytochrome P450 activity levels are considerably increased under flow in PFC-treated systems, as compared to controls. This work thus clarifies the benefits of using PFCs to enhance the functional performance of 3D liver systems. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1713" xmlns="http://purl.org/rss/1.0/"><title>Polyethylene glycol-based low generation dendrimers functionalized with β-cyclodextrin as cryo- and dehydro-protectant of catalase formulations</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1713</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Polyethylene glycol-based low generation dendrimers functionalized with β-cyclodextrin as cryo- and dehydro-protectant of catalase formulations</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Patricio R. Santagapita, M. Florencia Mazzobre, Ariel García Cruz, Horacio R. Corti, Reynaldo Villalonga, M. Pilar Buera</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T00:28:43.200384-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1713</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1713</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1713</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Polyethylene glycol (PEG)-based low generation dendrimers are analyzed as single excipient or combined with trehalose in relation to their structure and efficiency as enzyme stabilizers during freeze-thawing, freeze-drying, and thermal treatment. A novel functional dendrimer (DG<sub>o</sub>-CD) based on the known PEG's ability as cryo-protector and β-CD as supramolecular stabilizing agent is presented. During freeze-thawing, PEG and β-CD failed to prevent catalase denaturation, while dendrimers, and especially DG<sub>o</sub>-CD, offered the better protection to the enzyme. During freeze-drying, trehalose was the best protective additive but DG<sub>o</sub>-CD provided also an adequate catalase stability showing a synergistic behavior in comparison to the activities recovered employing PEG or β-CD as unique additives. Although all the studied dendrimers improved the enzyme remaining activity during thermal treatment of freeze-dried formulations, the presence of amorphous trehalose was critical to enhance enzyme stability. The crystallinity of the protective matrix, either of PEG derivatives or of trehalose, negatively affected catalase stability in the freeze-dried systems. When humidified at 52% of relative humidity, the dendrimers delayed trehalose crystallization in the combined matrices, allowing extending the protection at those conditions in which normally trehalose fails. The results show how a relatively simple covalent combination of a polymer such as PEG with β-CD could significantly affect the properties of the individual components. Also, the results provide further insights about the role played by polymer–enzyme supramolecular interactions (host–guest crosslink, hydrogen bonding, and hydrophobic interactions) on enzyme stability in dehydrated models, being the effect on the stabilization also influenced by the physical state of the matrix. © 2013 <em>American Institute of Chemical Engineers Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Polyethylene glycol (PEG)-based low generation dendrimers are analyzed as single excipient or combined with trehalose in relation to their structure and efficiency as enzyme stabilizers during freeze-thawing, freeze-drying, and thermal treatment. A novel functional dendrimer (DGo-CD) based on the known PEG's ability as cryo-protector and β-CD as supramolecular stabilizing agent is presented. During freeze-thawing, PEG and β-CD failed to prevent catalase denaturation, while dendrimers, and especially DGo-CD, offered the better protection to the enzyme. During freeze-drying, trehalose was the best protective additive but DGo-CD provided also an adequate catalase stability showing a synergistic behavior in comparison to the activities recovered employing PEG or β-CD as unique additives. Although all the studied dendrimers improved the enzyme remaining activity during thermal treatment of freeze-dried formulations, the presence of amorphous trehalose was critical to enhance enzyme stability. The crystallinity of the protective matrix, either of PEG derivatives or of trehalose, negatively affected catalase stability in the freeze-dried systems. When humidified at 52% of relative humidity, the dendrimers delayed trehalose crystallization in the combined matrices, allowing extending the protection at those conditions in which normally trehalose fails. The results show how a relatively simple covalent combination of a polymer such as PEG with β-CD could significantly affect the properties of the individual components. Also, the results provide further insights about the role played by polymer–enzyme supramolecular interactions (host–guest crosslink, hydrogen bonding, and hydrophobic interactions) on enzyme stability in dehydrated models, being the effect on the stabilization also influenced by the physical state of the matrix. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1702" xmlns="http://purl.org/rss/1.0/"><title>Loofa (Luffa cylindrica) sponge: Review of development of the biomatrix as a tool for biotechnological applications</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1702</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Loofa (Luffa cylindrica) sponge: Review of development of the biomatrix as a tool for biotechnological applications</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Asma Saeed, Muhammad Iqbal</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T00:28:31.496636-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1702</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1702</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1702</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The review discusses the development of loofa sponge (<em>Luffa cylindrica</em>) as a biotechnological tool and the diversity of applications in which it has been successfully used since it was first reported as a matrix for the immobilization of microbiological cells in 1993. The fibro-vascular reticulated structure, made up of an open network of random lattices of small cross-sections coupled with very high porosity (79–93%), having very low density (0.02–0.04 g/cm<sup>3</sup>), and high specific pore volume (21–29 cm<sup>3</sup>/g), has the characteristics of a carrier/scaffold well-suited for cell immobilization. This has been confirmed through the immobilization of cells of diverse types, including filamentous and microalgae, fungi, bacteria, yeasts, higher plants, and human and rat hepatocytes. The cells immobilized in loofa sponge have performed well and better than free suspended cells and those immobilized in conventionally used natural and synthetic polymeric materials for the production of ethanol, organic acids, enzymes, and secondary metabolites. The loofa-immobilized cell systems have been efficiently used for the treatment of wastewaters containing toxic metals, dyes, and chlorinated compounds, and the technology has been used to develop biofilms for the remediation of domestic and industrial wastewaters rich in inorganic and organic matter. In addition, three-dimensional loofa sponge scaffolds for hepatocyte culture have been suggested to have the potential for development into a bioartificial liver device. Loofa sponge is a cost-effective, eco-friendly, and easy to handle matrix that has been used successfully as a biotechnological tool in a variety of systems, purposes, and applications. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The review discusses the development of loofa sponge (Luffa cylindrica) as a biotechnological tool and the diversity of applications in which it has been successfully used since it was first reported as a matrix for the immobilization of microbiological cells in 1993. The fibro-vascular reticulated structure, made up of an open network of random lattices of small cross-sections coupled with very high porosity (79–93%), having very low density (0.02–0.04 g/cm3), and high specific pore volume (21–29 cm3/g), has the characteristics of a carrier/scaffold well-suited for cell immobilization. This has been confirmed through the immobilization of cells of diverse types, including filamentous and microalgae, fungi, bacteria, yeasts, higher plants, and human and rat hepatocytes. The cells immobilized in loofa sponge have performed well and better than free suspended cells and those immobilized in conventionally used natural and synthetic polymeric materials for the production of ethanol, organic acids, enzymes, and secondary metabolites. The loofa-immobilized cell systems have been efficiently used for the treatment of wastewaters containing toxic metals, dyes, and chlorinated compounds, and the technology has been used to develop biofilms for the remediation of domestic and industrial wastewaters rich in inorganic and organic matter. In addition, three-dimensional loofa sponge scaffolds for hepatocyte culture have been suggested to have the potential for development into a bioartificial liver device. Loofa sponge is a cost-effective, eco-friendly, and easy to handle matrix that has been used successfully as a biotechnological tool in a variety of systems, purposes, and applications. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1722" xmlns="http://purl.org/rss/1.0/"><title>Resilient immortals, characterizing and utilizing Bax/Bak deficient Chinese hamster ovary (CHO) cells for high titer antibody production</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1722</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Resilient immortals, characterizing and utilizing Bax/Bak deficient Chinese hamster ovary (CHO) cells for high titer antibody production</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shahram Misaghi, Yan Qu, Andrew Snowden, Jennifer Chang, Brad Snedecor</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T00:28:19.488174-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1722</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1722</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1722</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Cell death due to apoptosis is frequently observed in large-scale manufacturing of therapeutic proteins, and can reduce product accumulation in bioreactors. Several different strategies that involve overexpression of antiapoptotic or downregulation of proapoptotic proteins have been designed in attempt to curb this problem in Chinese hamster ovary (CHO) cell culture. However, each of these designs has their own shortcomings and limits, rendering them ineffective for large-scale protein production. Recently, we have reported generation of a Bax and Bak deficient dhfr<sup>−/−</sup> CHO cell line using zinc-finger nucleases. Here we demonstrate that puromycin, but not methotrexate, selection can be used to generate antibody-expressing Bax and Bak deficient clones that are not only resistant to apoptosis, but that can also achieve higher titers relative to parental CHO cells due to higher cell density. Additionally, we show that Bax and Bak deficient cells have more mitochondria with healthy membrane potential, an attribute that perhaps contributes to their more potent growth compared to parental cells. Bax and Bak deficient cells do not readily apoptose, as shown by the ability to withstand high concentrations of apoptosis inducing agents, such as sodium butyrate, without a reduction in viability, growth, or titer. These traits render Bax and Bak deficient cells a potentially attractive host for production of therapeutic proteins at industrial scale. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Cell death due to apoptosis is frequently observed in large-scale manufacturing of therapeutic proteins, and can reduce product accumulation in bioreactors. Several different strategies that involve overexpression of antiapoptotic or downregulation of proapoptotic proteins have been designed in attempt to curb this problem in Chinese hamster ovary (CHO) cell culture. However, each of these designs has their own shortcomings and limits, rendering them ineffective for large-scale protein production. Recently, we have reported generation of a Bax and Bak deficient dhfr−/− CHO cell line using zinc-finger nucleases. Here we demonstrate that puromycin, but not methotrexate, selection can be used to generate antibody-expressing Bax and Bak deficient clones that are not only resistant to apoptosis, but that can also achieve higher titers relative to parental CHO cells due to higher cell density. Additionally, we show that Bax and Bak deficient cells have more mitochondria with healthy membrane potential, an attribute that perhaps contributes to their more potent growth compared to parental cells. Bax and Bak deficient cells do not readily apoptose, as shown by the ability to withstand high concentrations of apoptosis inducing agents, such as sodium butyrate, without a reduction in viability, growth, or titer. These traits render Bax and Bak deficient cells a potentially attractive host for production of therapeutic proteins at industrial scale. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1715" xmlns="http://purl.org/rss/1.0/"><title>Production of humic acids from oil palm empty fruit bunch by submerged fermentation with Trichoderma viride: Cellulosic substrates and nitrogen sources</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1715</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Production of humic acids from oil palm empty fruit bunch by submerged fermentation with Trichoderma viride: Cellulosic substrates and nitrogen sources</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F L. Motta, M. H. A. Santana</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-08T02:38:20.40607-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1715</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1715</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1715</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The novelty of this study was to produce humic acids by submerged fermentation of empty fruit bunch (EFB) with <em>Trichoderma viride</em> and to investigate the effects of the cellulosic substrates and the organic sources of nitrogen on the biotechnological production of these acids. The results obtained indicate the potential application of EFB, a waste of oil palm processing, for humic acids production. Because EFB contains cellulose, hemicellulose and lignin, fermentations were also performed using these polymers as carbon sources, separately or in combination. After 120 h of fermentation, significant production of humic acids was observed only in cultures containing either EFB or a mixture of the three polymers. Use of either potato peptone or yeast extract as a nitrogen source yielded nearly identical patterns of fungal growth and production of humic acids. The data obtained from microscopic imaging of <em>T. viride</em> growth and sporulation in EFB, coupled with the determined rates of production of humic acids indicated that the production of these acids is related to <em>T. viride</em> sporulation. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The novelty of this study was to produce humic acids by submerged fermentation of empty fruit bunch (EFB) with Trichoderma viride and to investigate the effects of the cellulosic substrates and the organic sources of nitrogen on the biotechnological production of these acids. The results obtained indicate the potential application of EFB, a waste of oil palm processing, for humic acids production. Because EFB contains cellulose, hemicellulose and lignin, fermentations were also performed using these polymers as carbon sources, separately or in combination. After 120 h of fermentation, significant production of humic acids was observed only in cultures containing either EFB or a mixture of the three polymers. Use of either potato peptone or yeast extract as a nitrogen source yielded nearly identical patterns of fungal growth and production of humic acids. The data obtained from microscopic imaging of T. viride growth and sporulation in EFB, coupled with the determined rates of production of humic acids indicated that the production of these acids is related to T. viride sporulation. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1721" xmlns="http://purl.org/rss/1.0/"><title>Microplates as a microreactor platform for microalgae research</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1721</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Microplates as a microreactor platform for microalgae research</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adriana Pacheco, Ileana Hernández-Mireles, Cecilia García-Martínez, Mario M. Álvarez</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-08T01:49:45.954432-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1721</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1721</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1721</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Biocatalysts and Bioreactor Design</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>High-throughput platforms for microalgae screening are not yet commercially available. In this study, the feasibility of 96-well microplates was analyzed for microalgae research. Equivalence among wells, as culture microreactors, was investigated in controlled high CO<sub>2</sub> conditions. Specific growth rates of two microalgae species, <em>Scenedesmus</em> sp. UTEX1589 and an environmental isolate, were significantly higher in border wells than in internal positions. Furthermore, growth rate gradients analyzed as contours throughout the platform were observed for <em>Scenedesmus</em> sp. However, the output variable exhibited high precision associated with a low coefficient of variation (CV), between 6.8 and 7.8%. In a demonstrative experiment to determine the effect of culture media dilution on six microalgae species, treatments were randomized in the central subset of a microplate. Results were consistent and statistically sound (CV 9.4–12.9%), and showed that microalgae species could grow with no detrimental effect in 50% (v/v) dilution of the culture medium. Provided border wells exclusion and a randomized design, 96-well microplates are a practical and statistical robust platform for microalgae research. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
High-throughput platforms for microalgae screening are not yet commercially available. In this study, the feasibility of 96-well microplates was analyzed for microalgae research. Equivalence among wells, as culture microreactors, was investigated in controlled high CO2 conditions. Specific growth rates of two microalgae species, Scenedesmus sp. UTEX1589 and an environmental isolate, were significantly higher in border wells than in internal positions. Furthermore, growth rate gradients analyzed as contours throughout the platform were observed for Scenedesmus sp. However, the output variable exhibited high precision associated with a low coefficient of variation (CV), between 6.8 and 7.8%. In a demonstrative experiment to determine the effect of culture media dilution on six microalgae species, treatments were randomized in the central subset of a microplate. Results were consistent and statistically sound (CV 9.4–12.9%), and showed that microalgae species could grow with no detrimental effect in 50% (v/v) dilution of the culture medium. Provided border wells exclusion and a randomized design, 96-well microplates are a practical and statistical robust platform for microalgae research. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1720" xmlns="http://purl.org/rss/1.0/"><title>Improving of red colorants production by a new Penicillium purpurogenum strain in submerged culture and the effect of different parameters in their stability</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1720</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Improving of red colorants production by a new Penicillium purpurogenum strain in submerged culture and the effect of different parameters in their stability</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Valéria Carvalho Santos-Ebinuma, Inês Conceição Roberto, Maria Francisca Simas Teixeira, Adalberto Pessoa</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-01T02:49:53.596045-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1720</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1720</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1720</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>There is a worldwide interest in the development of processes for colorants production from natural sources such as microorganism. The aim of this study was to optimize red colorants production by <em>Penicillium purpurogenum</em> DPUA 1275 and to evaluate the effect of pH, temperature, salts and polymers on the stability of these colorants. Under optimized conditions, a 78% increase in red colorants production was achieved. The best pH and temperature conditions were obtained at pH 8.0 and 70°C, respectively. In the presence of salts NaCl and Na<sub>2</sub>SO<sub>4</sub>, both at concentrations of 0.1 and 0.5 M in Mcllvaine buffer (pH 8.0), the red colorants showed good stability. In the presence of both polymers polyethylene glycol and sodium polyacrylate, the red colorants kept their color intensity. Thus, this study presents characteristics of red colorants produced by <em>P. purpurogenum</em> that can be applied in different industries after toxicological examination. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
There is a worldwide interest in the development of processes for colorants production from natural sources such as microorganism. The aim of this study was to optimize red colorants production by Penicillium purpurogenum DPUA 1275 and to evaluate the effect of pH, temperature, salts and polymers on the stability of these colorants. Under optimized conditions, a 78% increase in red colorants production was achieved. The best pH and temperature conditions were obtained at pH 8.0 and 70°C, respectively. In the presence of salts NaCl and Na2SO4, both at concentrations of 0.1 and 0.5 M in Mcllvaine buffer (pH 8.0), the red colorants showed good stability. In the presence of both polymers polyethylene glycol and sodium polyacrylate, the red colorants kept their color intensity. Thus, this study presents characteristics of red colorants produced by P. purpurogenum that can be applied in different industries after toxicological examination. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1717" xmlns="http://purl.org/rss/1.0/"><title>Separation of nonfucosylated antibodies with immobilized FcγRIII receptors</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1717</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Separation of nonfucosylated antibodies with immobilized FcγRIII receptors</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Glen R. Bolton, Margaret E. Ackerman, Austin W. Boesch</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-01T02:49:42.814349-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1717</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1717</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1717</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Post-translational modifications can dramatically impact protein activity, but identifying such structure:function relationships, as well as capitalizing on functionally enhanced variants, is a significant challenge. Here, affinity chromatography resins that contained immobilized FcγRIII receptors were used to enrich nonfucosylated antibodies 6- to 9-fold, offering what may be a tractable method for both the identification of post-translational modifications that affect function, as well as a means to enrich variants with enhanced activity. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Post-translational modifications can dramatically impact protein activity, but identifying such structure:function relationships, as well as capitalizing on functionally enhanced variants, is a significant challenge. Here, affinity chromatography resins that contained immobilized FcγRIII receptors were used to enrich nonfucosylated antibodies 6- to 9-fold, offering what may be a tractable method for both the identification of post-translational modifications that affect function, as well as a means to enrich variants with enhanced activity. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1714" xmlns="http://purl.org/rss/1.0/"><title>Multispectral image analysis for algal biomass quantification</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1714</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multispectral image analysis for algal biomass quantification</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Thomas E. Murphy, Keith Macon, Halil Berberoglu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-01T02:49:29.320216-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1714</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1714</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1714</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This article reports a novel multispectral image processing technique for rapid, noninvasive quantification of biomass concentration in attached and suspended algae cultures. Monitoring the biomass concentration is critical for efficient production of biofuel feedstocks, food supplements, and bioactive chemicals. Particularly, noninvasive and rapid detection techniques can significantly aid in providing delay-free process control feedback in large-scale cultivation platforms. In this technique, three-band spectral images of Anabaena variabilis cultures were acquired and separated into their red, green, and blue components. A correlation between the magnitude of the green component and the areal biomass concentration was generated. The correlation predicted the biomass concentrations of independently prepared attached and suspended cultures with errors of 7 and 15%, respectively, and the effect of varying lighting conditions and background color were investigated. This method can provide necessary feedback for dilution and harvesting strategies to maximize photosynthetic conversion efficiency in large-scale operation. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
This article reports a novel multispectral image processing technique for rapid, noninvasive quantification of biomass concentration in attached and suspended algae cultures. Monitoring the biomass concentration is critical for efficient production of biofuel feedstocks, food supplements, and bioactive chemicals. Particularly, noninvasive and rapid detection techniques can significantly aid in providing delay-free process control feedback in large-scale cultivation platforms. In this technique, three-band spectral images of Anabaena variabilis cultures were acquired and separated into their red, green, and blue components. A correlation between the magnitude of the green component and the areal biomass concentration was generated. The correlation predicted the biomass concentrations of independently prepared attached and suspended cultures with errors of 7 and 15%, respectively, and the effect of varying lighting conditions and background color were investigated. This method can provide necessary feedback for dilution and harvesting strategies to maximize photosynthetic conversion efficiency in large-scale operation. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1710" xmlns="http://purl.org/rss/1.0/"><title>Rapid removal of glycerol from frozen-thawed red blood cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1710</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Rapid removal of glycerol from frozen-thawed red blood cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ratih E. Lusianti, James D. Benson, Jason P. Acker, Adam Z. Higgins</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T10:24:19.396314-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1710</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1710</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1710</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The storage of red blood cells (RBCs) in a refrigerated state allows a shelf life of a few weeks, whereas RBCs frozen in 40% glycerol have a shelf life of 10 years. Despite the clear logistical advantages of frozen blood, it is not widely used in transfusion medicine. One of the main reasons is that existing post-thaw washing methods to remove glycerol are prohibitively time consuming, requiring about an hour to remove glycerol from a single unit of blood. In this study, we have investigated the potential for more rapid removal of glycerol. Using published biophysical data for human RBCs, we mathematically optimized a three-step deglycerolization process, yielding a procedure that was less than 32 s long. This procedure was found to yield 70% hemolysis, a value that was much higher than expected. Consequently, we systematically evaluated three-step deglycerolization procedures, varying the solution composition and equilibration time in each step. Our best results consisted of less than 20% hemolysis for a deglycerolization time of 3 min, and it is expected that even further improvements could be made with a more thorough optimization and more reliable biophysical data. Our results demonstrate the potential for significantly reducing the deglycerolization time compared with existing methods. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The storage of red blood cells (RBCs) in a refrigerated state allows a shelf life of a few weeks, whereas RBCs frozen in 40% glycerol have a shelf life of 10 years. Despite the clear logistical advantages of frozen blood, it is not widely used in transfusion medicine. One of the main reasons is that existing post-thaw washing methods to remove glycerol are prohibitively time consuming, requiring about an hour to remove glycerol from a single unit of blood. In this study, we have investigated the potential for more rapid removal of glycerol. Using published biophysical data for human RBCs, we mathematically optimized a three-step deglycerolization process, yielding a procedure that was less than 32 s long. This procedure was found to yield 70% hemolysis, a value that was much higher than expected. Consequently, we systematically evaluated three-step deglycerolization procedures, varying the solution composition and equilibration time in each step. Our best results consisted of less than 20% hemolysis for a deglycerolization time of 3 min, and it is expected that even further improvements could be made with a more thorough optimization and more reliable biophysical data. Our results demonstrate the potential for significantly reducing the deglycerolization time compared with existing methods. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1712" xmlns="http://purl.org/rss/1.0/"><title>Quantification of protein mixture in chromatographic separation using multi-wavelength UV spectra</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1712</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Quantification of protein mixture in chromatographic separation using multi-wavelength UV spectra</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mark-Henry Kamga, Hae Woo Lee, Jay Liu, Seongkyu Yoon</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T10:24:07.763715-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1712</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1712</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1712</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In therapeutic protein production, the protein purification with chromatographic processes is of high importance in separating the qualified proteins from the impurities for consistent product quality. Therefore, to aid real-time monitoring of the protein purification processes, various kinds of methodologies have been proposed until now. However, the majority of them still rely on the use of a single ultraviolet (UV) absorbance or the utilization of expensive and time-consuming instruments, thus requiring a simple, fast, and cost-effective methodology for protein quantification. In this study, the feasibility of using multiwavelength UV spectroscopy was investigated as an alternative tool for the real-time monitoring of the protein mixtures in protein purification. To this end, three different proteins were selected as a model system for the protein mixture, and the multivariate UV spectra were analyzed to construct the reliable quantification models for different proteins of interest. By using various chemometrics tools, such as partial least squares (PLS), the validity of estimating the protein concentration from the UV spectra of the mixture samples was rigorously analyzed with their prediction performance, and the results indicated that the multiwavelength UV spectra had sufficient sensitivity and accuracy to estimate the protein concentrations in mixture, demonstrating its usefulness for the rapid quantification of the protein mixtures in protein purification. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
In therapeutic protein production, the protein purification with chromatographic processes is of high importance in separating the qualified proteins from the impurities for consistent product quality. Therefore, to aid real-time monitoring of the protein purification processes, various kinds of methodologies have been proposed until now. However, the majority of them still rely on the use of a single ultraviolet (UV) absorbance or the utilization of expensive and time-consuming instruments, thus requiring a simple, fast, and cost-effective methodology for protein quantification. In this study, the feasibility of using multiwavelength UV spectroscopy was investigated as an alternative tool for the real-time monitoring of the protein mixtures in protein purification. To this end, three different proteins were selected as a model system for the protein mixture, and the multivariate UV spectra were analyzed to construct the reliable quantification models for different proteins of interest. By using various chemometrics tools, such as partial least squares (PLS), the validity of estimating the protein concentration from the UV spectra of the mixture samples was rigorously analyzed with their prediction performance, and the results indicated that the multiwavelength UV spectra had sufficient sensitivity and accuracy to estimate the protein concentrations in mixture, demonstrating its usefulness for the rapid quantification of the protein mixtures in protein purification. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1708" xmlns="http://purl.org/rss/1.0/"><title>Aqueous biphasic systems composed of ionic liquids and sodium carbonate as enhanced routes for the extraction of tetracycline</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1708</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Aqueous biphasic systems composed of ionic liquids and sodium carbonate as enhanced routes for the extraction of tetracycline</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Carlos F. C. Marques, Teresa Mourão, Catarina M. S. S. Neves, Álvaro S. Lima, Isabel Boal-Palheiros, João A. P. Coutinho, Mara G. Freire</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T10:23:51.111956-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1708</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1708</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1708</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Aqueous biphasic systems (ABS) using ionic liquids (ILs) offer an alternative approach for the extraction, recovery, and purification of biomolecules through their partitioning between two aqueous liquid phases. In this work, the ability of a wide range of ILs to form ABS with aqueous solutions of Na<sub>2</sub>CO<sub>3</sub> was evaluated. The ABS formed by IL + water + Na<sub>2</sub>CO<sub>3</sub> were determined at 25°C, and the respective solubility curves, tie-lines, and tie-line lengths are reported. The studied ILs share the common chloride anion, allowing the IL cation core, the cation isomerism, the presence of functionalized groups, and alkyl side chain length effects to be evaluated. An increase in the cation side alkyl chain length leads to a higher ability for liquid–liquid demixing whereas different positional isomers and the presence of an allyl group have no major influence in the phase diagrams behavior. Quaternary phosphonium- and ammonium-based fluids are more able to form an ABS when compared with imidazolium-, pyridinium-, pyrrolidinium-, and piperidium-based ILs. Moreover, the presence of an aromatic cation core has no major contribution to the formation of ABS when compared to the respective nonaromatic counterparts. Finally, to appraise on the systems applicability in downstream processing, selected systems were used for the partitioning of tetracyclines (neutral and salt forms) — a class of antibiotics produced by bacteria fermentation. Single-step extraction efficiencies for the IL-rich phase were always higher than 99% and confirm the great potential of ILs to be applied in the biotechnological field. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Aqueous biphasic systems (ABS) using ionic liquids (ILs) offer an alternative approach for the extraction, recovery, and purification of biomolecules through their partitioning between two aqueous liquid phases. In this work, the ability of a wide range of ILs to form ABS with aqueous solutions of Na2CO3 was evaluated. The ABS formed by IL + water + Na2CO3 were determined at 25°C, and the respective solubility curves, tie-lines, and tie-line lengths are reported. The studied ILs share the common chloride anion, allowing the IL cation core, the cation isomerism, the presence of functionalized groups, and alkyl side chain length effects to be evaluated. An increase in the cation side alkyl chain length leads to a higher ability for liquid–liquid demixing whereas different positional isomers and the presence of an allyl group have no major influence in the phase diagrams behavior. Quaternary phosphonium- and ammonium-based fluids are more able to form an ABS when compared with imidazolium-, pyridinium-, pyrrolidinium-, and piperidium-based ILs. Moreover, the presence of an aromatic cation core has no major contribution to the formation of ABS when compared to the respective nonaromatic counterparts. Finally, to appraise on the systems applicability in downstream processing, selected systems were used for the partitioning of tetracyclines (neutral and salt forms) — a class of antibiotics produced by bacteria fermentation. Single-step extraction efficiencies for the IL-rich phase were always higher than 99% and confirm the great potential of ILs to be applied in the biotechnological field. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1709" xmlns="http://purl.org/rss/1.0/"><title>Intermolecular interactions during ultrafiltration of pegylated proteins</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1709</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Intermolecular interactions during ultrafiltration of pegylated proteins</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Krisada Ruanjaikaen, Andrew L. Zydney</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T10:23:42.297456-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1709</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1709</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1709</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Recent studies have demonstrated the feasibility of using membrane ultrafiltration for the purification of pegylated proteins; however, the separations have all been performed at relatively low protein concentrations where intermolecular interactions are unimportant. The objective of this study was to examine the behavior at higher PEG concentrations and to develop an appropriate theoretical framework to describe the effects of intermolecular interactions. Ultrafiltration experiments were performed using pegylated α-lactalbumin as a model protein with both neutral and charged composite regenerated cellulose membranes. The transmission of the pegylated α-lactalbumin, PEG, and α-lactalbumin all increase with increasing PEG concentration due to the increase in the solute partition coefficient arising from unfavorable intermolecular interactions in the bulk solution. The experimental results were in good agreement with a simple model that accounts for the change in Gibbs free energy associated with these intermolecular interactions, including the effects of concentration polarization on the local solute concentrations upstream of the membrane. These intermolecular interactions are shown to cause a greater than expected loss of pegylated product in a batch ultrafiltration system, and they alter the yield and purification factor that can be achieved during a diafiltration process to remove unreacted PEG. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Recent studies have demonstrated the feasibility of using membrane ultrafiltration for the purification of pegylated proteins; however, the separations have all been performed at relatively low protein concentrations where intermolecular interactions are unimportant. The objective of this study was to examine the behavior at higher PEG concentrations and to develop an appropriate theoretical framework to describe the effects of intermolecular interactions. Ultrafiltration experiments were performed using pegylated α-lactalbumin as a model protein with both neutral and charged composite regenerated cellulose membranes. The transmission of the pegylated α-lactalbumin, PEG, and α-lactalbumin all increase with increasing PEG concentration due to the increase in the solute partition coefficient arising from unfavorable intermolecular interactions in the bulk solution. The experimental results were in good agreement with a simple model that accounts for the change in Gibbs free energy associated with these intermolecular interactions, including the effects of concentration polarization on the local solute concentrations upstream of the membrane. These intermolecular interactions are shown to cause a greater than expected loss of pegylated product in a batch ultrafiltration system, and they alter the yield and purification factor that can be achieved during a diafiltration process to remove unreacted PEG. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1711" xmlns="http://purl.org/rss/1.0/"><title>Glassy State and Cryopreservation of Mint Shoot Tips</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1711</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Glassy State and Cryopreservation of Mint Shoot Tips</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aline S. Teixeira, M. Elena González-Benito, Antonio D. Molina-García</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-27T05:06:58.969225-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1711</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1711</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1711</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Vitrification refers to the physical process by which a liquid supercools to very low temperatures and finally solidifies into a metastable glass, without undergoing crystallization at a practical cooling rate. Thus, vitrification is an effective freeze-avoidance mechanism and living tissue cryopreservation is, in most cases, relying on it. As a glass is exceedingly viscous and stops all chemical reactions that require molecular diffusion, its formation leads to metabolic inactivity and stability over time. To investigate glassy state in cryopreserved plant material, mint shoot tips were submitted to the different stages of a frequently used cryopreservation protocol (droplet-vitrification) and evaluated for water content reduction and sucrose content, as determined by ion chromatography, frozen water fraction and glass transitions occurrence by differential scanning calorimetry, and investigated by low-temperature scanning electron microscopy, as a way to ascertain if their cellular content was vitrified. Results show how tissues at intermediate treatment steps develop ice crystals during liquid nitrogen cooling, while specimens whose treatment was completed become vitrified, with no evidence of ice formation. The agreement between calorimetric and microscopic observations was perfect. Besides finding a higher sucrose concentration in tissues at the more advanced protocol steps, this level was also higher in plants precultured at 25/−1°C than in plants cultivated at 25°C. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Vitrification refers to the physical process by which a liquid supercools to very low temperatures and finally solidifies into a metastable glass, without undergoing crystallization at a practical cooling rate. Thus, vitrification is an effective freeze-avoidance mechanism and living tissue cryopreservation is, in most cases, relying on it. As a glass is exceedingly viscous and stops all chemical reactions that require molecular diffusion, its formation leads to metabolic inactivity and stability over time. To investigate glassy state in cryopreserved plant material, mint shoot tips were submitted to the different stages of a frequently used cryopreservation protocol (droplet-vitrification) and evaluated for water content reduction and sucrose content, as determined by ion chromatography, frozen water fraction and glass transitions occurrence by differential scanning calorimetry, and investigated by low-temperature scanning electron microscopy, as a way to ascertain if their cellular content was vitrified. Results show how tissues at intermediate treatment steps develop ice crystals during liquid nitrogen cooling, while specimens whose treatment was completed become vitrified, with no evidence of ice formation. The agreement between calorimetric and microscopic observations was perfect. Besides finding a higher sucrose concentration in tissues at the more advanced protocol steps, this level was also higher in plants precultured at 25/−1°C than in plants cultivated at 25°C. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1706" xmlns="http://purl.org/rss/1.0/"><title>Cell-free protein synthesis and purification of human dopamine D2 receptor long isoform</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1706</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cell-free protein synthesis and purification of human dopamine D2 receptor long isoform</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dipannita Basu, Jessica M. Castellano, Nancy Thomas, Ram K. Mishra</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-27T05:06:49.934646-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1706</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1706</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1706</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The human dopamine D2 receptor long isoform (D2L) has significant implications in neurological and neuropsychiatric disorders such as Parkinson's disease and schizophrenia. Detailed structural knowledge of this receptor is limited owing to its highly hydrophobic nature, which leads to protein aggregation and host toxicity when expressed in cellular systems. The newly emerging field of cell-free protein expression presents numerous advantages to overcome these challenges. This system utilizes protein synthesis machinery and exogenous DNA to synthesize functional proteins outside of intact cells. This study utilizes two different cell-free systems for the synthesis of human dopamine D2L receptor. These include the Escherichia coli lysate-based system and the wheat-germ lysate-based system. The bacterial cell-free method used pET 100/D-TOPO vector to synthesize hexa-histidine-tagged D2L receptor using a dialysis bag system; the resulting protein was purified using nickel-nitrilotriacetic acid affinity resin. The wheat germ system used pEU–glutathione-S-transferase (GST) vector to synthesize GST-tagged D2L receptor using a bilayer translation method; the resulting protein was purified using a GST affinity resin. The presence and binding capacity of the synthesized D2L receptor was confirmed by immunoblotting and radioligand competition assays, respectively. Additionally, in-gel protein sequencing via Nano LC-MS/MS was used to confirm protein synthesis via the wheat germ system. The results showed both systems to synthesize microgram quantities of the receptor. Improved expression of this highly challenging protein can improve research and understanding of the human dopamine D2L receptor. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
The human dopamine D2 receptor long isoform (D2L) has significant implications in neurological and neuropsychiatric disorders such as Parkinson's disease and schizophrenia. Detailed structural knowledge of this receptor is limited owing to its highly hydrophobic nature, which leads to protein aggregation and host toxicity when expressed in cellular systems. The newly emerging field of cell-free protein expression presents numerous advantages to overcome these challenges. This system utilizes protein synthesis machinery and exogenous DNA to synthesize functional proteins outside of intact cells. This study utilizes two different cell-free systems for the synthesis of human dopamine D2L receptor. These include the Escherichia coli lysate-based system and the wheat-germ lysate-based system. The bacterial cell-free method used pET 100/D-TOPO vector to synthesize hexa-histidine-tagged D2L receptor using a dialysis bag system; the resulting protein was purified using nickel-nitrilotriacetic acid affinity resin. The wheat germ system used pEU–glutathione-S-transferase (GST) vector to synthesize GST-tagged D2L receptor using a bilayer translation method; the resulting protein was purified using a GST affinity resin. The presence and binding capacity of the synthesized D2L receptor was confirmed by immunoblotting and radioligand competition assays, respectively. Additionally, in-gel protein sequencing via Nano LC-MS/MS was used to confirm protein synthesis via the wheat germ system. The results showed both systems to synthesize microgram quantities of the receptor. Improved expression of this highly challenging protein can improve research and understanding of the human dopamine D2L receptor. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1693" xmlns="http://purl.org/rss/1.0/"><title>A CHO cell line engineered to express XBP1 and ERO1-Lα has increased levels of transient protein expression</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1693</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A CHO cell line engineered to express XBP1 and ERO1-Lα has increased levels of transient protein expression</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Katharine Cain, Shirley Peters, Hanna Hailu, Bernie Sweeney, Paul Stephens, James Heads, Kaushik Sarkar, Andy Ventom, Catherine Page, Alan Dickson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T01:59:39.431104-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1693</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1693</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1693</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Transient gene expression (TGE) systems currently provide rapid and scalable (up to 100 L) methods for generating multigram quantities of recombinant heterologous proteins. Product titers of up to 1 g/L have been demonstrated in HEK293 cells <a href="#btpr1693-bib-0001" rel="references:#btpr1693-bib-0001"/> but reported yields from Chinese hamster ovary (CHO) cells are lower at ∼300 mg/L.<a href="#btpr1693-bib-0002" rel="references:#btpr1693-bib-0002"/> We report on the establishment of an engineered CHOS cell line, which has been developed for TGE. This cell line has been engineered to express both X-box binding protein (XBP-1S) and endoplasmic reticulum oxidoreductase (ERO1-Lα) and has been named CHOS-XE. CHOS-XE cells produced increased antibody (MAb) yields (5.3– 6.2 fold) in comparison to CHOS cells. Product quality was unchanged as assessed by size, charge, propensity to aggregate, major glycosylation species, and thermal stability. To further develop and test this TGE system, five commercial media were assessed, and one was shown to offer the greatest increase in antibody yields. With the addition of a commercial feed, MAb titers reached 875 mg/L. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 2013</p></div>
]]></content:encoded><description>
Transient gene expression (TGE) systems currently provide rapid and scalable (up to 100 L) methods for generating multigram quantities of recombinant heterologous proteins. Product titers of up to 1 g/L have been demonstrated in HEK293 cells  but reported yields from Chinese hamster ovary (CHO) cells are lower at ∼300 mg/L. We report on the establishment of an engineered CHOS cell line, which has been developed for TGE. This cell line has been engineered to express both X-box binding protein (XBP-1S) and endoplasmic reticulum oxidoreductase (ERO1-Lα) and has been named CHOS-XE. CHOS-XE cells produced increased antibody (MAb) yields (5.3– 6.2 fold) in comparison to CHOS cells. Product quality was unchanged as assessed by size, charge, propensity to aggregate, major glycosylation species, and thermal stability. To further develop and test this TGE system, five commercial media were assessed, and one was shown to offer the greatest increase in antibody yields. With the addition of a commercial feed, MAb titers reached 875 mg/L. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1688" xmlns="http://purl.org/rss/1.0/"><title>Recent advancements in various steps of ethanol, butanol, and isobutanol productions from woody materials</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1688</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Recent advancements in various steps of ethanol, butanol, and isobutanol productions from woody materials</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pedram Fatehi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T07:35:48.696857-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1688</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1688</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1688</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">297</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">310</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In this review, the recent advancements and technical challenges associated with the production of ethanol, butanol, and isobutanol via bioconversion routes from celluloses of woody materials are reviewed. Physicochemical processes, e.g. steam explosion, seem to be the most viable process for pretreating woody materials. Although enzymatic hydrolysis is selective, it is rather a slow process. Acid hydrolysis is a relatively fast process with a high yield, but it produces inhibitory compounds of fermentation, which necessitates a detoxification process before the fermentation. Presently, the major challenges in the production of ethanol, butanol, and isobutanol via biological conversions are the rather low production yield and the sensitivity of microorganisms to the presence of inhibitors and products in fermentation media. In this study, the recent advancements in the applications of <em>Saccharomyces cerevisiae, Clostridium acetobutylicum,</em> and <em>Corynebacterium glutamicum</em>, the most promising microorganisms, for ethanol, butanol, and isobutanol production are also discussed. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 297–310, 2013</p></div>
]]></content:encoded><description>
In this review, the recent advancements and technical challenges associated with the production of ethanol, butanol, and isobutanol via bioconversion routes from celluloses of woody materials are reviewed. Physicochemical processes, e.g. steam explosion, seem to be the most viable process for pretreating woody materials. Although enzymatic hydrolysis is selective, it is rather a slow process. Acid hydrolysis is a relatively fast process with a high yield, but it produces inhibitory compounds of fermentation, which necessitates a detoxification process before the fermentation. Presently, the major challenges in the production of ethanol, butanol, and isobutanol via biological conversions are the rather low production yield and the sensitivity of microorganisms to the presence of inhibitors and products in fermentation media. In this study, the recent advancements in the applications of Saccharomyces cerevisiae, Clostridium acetobutylicum, and Corynebacterium glutamicum, the most promising microorganisms, for ethanol, butanol, and isobutanol production are also discussed. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 297–310, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1677" xmlns="http://purl.org/rss/1.0/"><title>Elicitation of galanthamine production by leucojum aestivum shoots grown in temporary immersion system</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1677</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Elicitation of galanthamine production by leucojum aestivum shoots grown in temporary immersion system</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anika Schumann, Laura Torras-Claveria, Strahil Berkov, Diana Claus, André Gerth, Jaume Bastida, Carles Codina</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-17T06:11:55.578004-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1677</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1677</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1677</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">311</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">318</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The influence of different elicitors (copper sulfate, silver nitrate, salicylic acid and methyl jasmonate), on both the growth and alkaloid production of Leucojum aestivum shoots grown in a temporary immersion system was studied. Seven Amaryllidaceae alkaloids and three protoalkaloids were quantitatively determined by GC-MS analysis in leaves and bulblets, separately. Methyl jasmonate was found to significantly improve the production of galanthamine (GAL) in both leaves and bulblets. The content of GAL released to the liquid nutrient medium was also measured. The release of GAL into the liquid medium took place mainly in the first 2 weeks determined by harvesting the liquid nutrient medium after 2 weeks and measuring the GAL content (1st subculturing step). © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 311–318, 2013</p></div>
]]></content:encoded><description>
The influence of different elicitors (copper sulfate, silver nitrate, salicylic acid and methyl jasmonate), on both the growth and alkaloid production of Leucojum aestivum shoots grown in a temporary immersion system was studied. Seven Amaryllidaceae alkaloids and three protoalkaloids were quantitatively determined by GC-MS analysis in leaves and bulblets, separately. Methyl jasmonate was found to significantly improve the production of galanthamine (GAL) in both leaves and bulblets. The content of GAL released to the liquid nutrient medium was also measured. The release of GAL into the liquid medium took place mainly in the first 2 weeks determined by harvesting the liquid nutrient medium after 2 weeks and measuring the GAL content (1st subculturing step). © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 311–318, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1690" xmlns="http://purl.org/rss/1.0/"><title>Efficiency of different heterologous promoters in the unicellular microalga Chlamydomonas reinhardtii</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1690</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Efficiency of different heterologous promoters in the unicellular microalga Chlamydomonas reinhardtii</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Encarnación Díaz-Santos, Marta Vega, Marta Vila, Javier Vigara, Rosa León</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T07:34:10.720563-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1690</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1690</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1690</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">319</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">328</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Despite the biotechnological interest of microalgae, no robust and stable methods for genetic transformation of most microalgal strains exist. The scanty and disperse data about the efficiency of heterologous promoters in microalgae and the use of different transformation methods, DNA quantities and reporter genes in the existing studies makes very difficult a real comparison of their efficiency. Using Chlamydomonas reinhardtii as a host, we have evaluated the efficiency of the heterologous promoters of cauliflower mosaic virus 35S (CaMV 35S) and Agrobacterium nopaline synthase (NOS) genes. These promoters were fused to the paromomycin conferring-resistance aminoglycoside 3′-phosphotransferase encoding gene (APHVIII), and C. reinhardtii was transformed by the glass beads agitation method. The transformation efficiency and the APHVIII transcript and protein levels were evaluated in a series of transformants for each promoter. The chimeric promoter HSP70A/RBCS2 and the promoter-less APHVIII marker gene were used for comparison. We found significantly higher transformation efficiencies and higher level of APHVIII expression in those transformants harboring the NOS promoter than in those transformed with CaMV 35S promoter. The NOS promoter, widely used for genetic manipulation of higher plants, has been very rarely used for the transformation of microalgae. The results shown here suggest the possibilities of this heterologous promoter as an efficient system for the genetic manipulation of microalgae. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 319–328, 2013</p></div>
]]></content:encoded><description>
Despite the biotechnological interest of microalgae, no robust and stable methods for genetic transformation of most microalgal strains exist. The scanty and disperse data about the efficiency of heterologous promoters in microalgae and the use of different transformation methods, DNA quantities and reporter genes in the existing studies makes very difficult a real comparison of their efficiency. Using Chlamydomonas reinhardtii as a host, we have evaluated the efficiency of the heterologous promoters of cauliflower mosaic virus 35S (CaMV 35S) and Agrobacterium nopaline synthase (NOS) genes. These promoters were fused to the paromomycin conferring-resistance aminoglycoside 3′-phosphotransferase encoding gene (APHVIII), and C. reinhardtii was transformed by the glass beads agitation method. The transformation efficiency and the APHVIII transcript and protein levels were evaluated in a series of transformants for each promoter. The chimeric promoter HSP70A/RBCS2 and the promoter-less APHVIII marker gene were used for comparison. We found significantly higher transformation efficiencies and higher level of APHVIII expression in those transformants harboring the NOS promoter than in those transformed with CaMV 35S promoter. The NOS promoter, widely used for genetic manipulation of higher plants, has been very rarely used for the transformation of microalgae. The results shown here suggest the possibilities of this heterologous promoter as an efficient system for the genetic manipulation of microalgae. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 319–328, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1679" xmlns="http://purl.org/rss/1.0/"><title>Impact of an acid fungal protease in high gravity fermentation for ethanol production using indian sorghum as a feedstock</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1679</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Impact of an acid fungal protease in high gravity fermentation for ethanol production using indian sorghum as a feedstock</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">V. Gohel, G. Duan, V. B. Maisuria</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-14T00:58:27.757479-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1679</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1679</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1679</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">329</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">336</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This study evaluated the conventional jet cooking liquefaction process followed by simultaneous saccharification and fermentation (SSF) at 30% and 35% dry solids (DS) concentration of Indian sorghum feedstock for ethanol production, with addition of acid fungal protease or urea. To evaluate the efficacy of thermostable α-amylase in liquefaction at 30% and 35% DS concentration of Indian sorghum, liquefact solubility, higher dextrins, and fermentable sugars were analyzed at the end of the process. The liquefact was further subjected to SSF using yeast. In comparison with urea, addition of an acid fungal protease during SSF process was observed to accelerate yeast growth (<em>μ</em>), substrate consumption (<em>Q</em><sub>s</sub>), ultimately ethanol yield based on substrate (<em>Y</em><sub>p/s</sub>) and ethanol productivity based on fermentation time (<em>Q</em><sub>p</sub>). The fermentation efficiency and ethanol recovery were determined for both concentrations of Indian sorghum and found to be increased with use of acid fungal protease in SSF process. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 329–336, 2013</p></div>
]]></content:encoded><description>
This study evaluated the conventional jet cooking liquefaction process followed by simultaneous saccharification and fermentation (SSF) at 30% and 35% dry solids (DS) concentration of Indian sorghum feedstock for ethanol production, with addition of acid fungal protease or urea. To evaluate the efficacy of thermostable α-amylase in liquefaction at 30% and 35% DS concentration of Indian sorghum, liquefact solubility, higher dextrins, and fermentable sugars were analyzed at the end of the process. The liquefact was further subjected to SSF using yeast. In comparison with urea, addition of an acid fungal protease during SSF process was observed to accelerate yeast growth (μ), substrate consumption (Qs), ultimately ethanol yield based on substrate (Yp/s) and ethanol productivity based on fermentation time (Qp). The fermentation efficiency and ethanol recovery were determined for both concentrations of Indian sorghum and found to be increased with use of acid fungal protease in SSF process. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 329–336, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1696" xmlns="http://purl.org/rss/1.0/"><title>Biotransformation and improved enzymatic extraction of chlorogenic acid from coffee pulp by filamentous fungi</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1696</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Biotransformation and improved enzymatic extraction of chlorogenic acid from coffee pulp by filamentous fungi</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">María Teresa Torres-Mancera, Itzamná Baqueiro-Peña, Arturo Figueroa-Montero, Gabriela Rodríguez-Serrano, Eduardo González-Zamora, Ernesto Favela-Torres, Gerardo Saucedo-Castañeda</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-07T07:35:48.917118-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1696</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1696</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1696</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">337</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">345</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The highest enzymatic extraction of covalent linked chlorogenic (36.1%) and caffeic (CA) (33%) acids from coffee pulp (CP) was achieved by solid-state fermentation with a mixture of three enzymatic extracts produced by <em>Aspergillus tamarii</em>, <em>Rhizomucor pusillus</em>, and <em>Trametes</em> sp. Enzyme extracts were produced in a practical inexpensive way. Synergistic effects on the extraction yield were observed when more than one enzyme extract was used. In addition, biotransformation of chlorogenic acid (ChA) by <em>Aspergillus niger</em> C23308 was studied. Equimolar transformation of ChA into CA and quinic acids (QA) was observed during the first 36 h in submerged culture. Subsequently, after 36 h, equimolar transformation of CA into protocatechuic acid was observed; this pathway is being reported for the first time for <em>A. niger</em>. QA was used as a carbon source by <em>A. niger</em> C23308. This study presents the potential of using CP to produce enzymes and compounds such as ChA with biological activities. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 337–345, 2013</p></div>
]]></content:encoded><description>
The highest enzymatic extraction of covalent linked chlorogenic (36.1%) and caffeic (CA) (33%) acids from coffee pulp (CP) was achieved by solid-state fermentation with a mixture of three enzymatic extracts produced by Aspergillus tamarii, Rhizomucor pusillus, and Trametes sp. Enzyme extracts were produced in a practical inexpensive way. Synergistic effects on the extraction yield were observed when more than one enzyme extract was used. In addition, biotransformation of chlorogenic acid (ChA) by Aspergillus niger C23308 was studied. Equimolar transformation of ChA into CA and quinic acids (QA) was observed during the first 36 h in submerged culture. Subsequently, after 36 h, equimolar transformation of CA into protocatechuic acid was observed; this pathway is being reported for the first time for A. niger. QA was used as a carbon source by A. niger C23308. This study presents the potential of using CP to produce enzymes and compounds such as ChA with biological activities. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 337–345, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1700" xmlns="http://purl.org/rss/1.0/"><title>Display of Clostridium cellulovorans xylose isomerase on the cell surface of Saccharomyces cerevisiae and its direct application to xylose fermentation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1700</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Display of Clostridium cellulovorans xylose isomerase on the cell surface of Saccharomyces cerevisiae and its direct application to xylose fermentation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Miki Ota, Hiroshi Sakuragi, Hironobu Morisaka, Kouichi Kuroda, Hideo Miyake, Yutaka Tamaru, Mitsuyoshi Ueda</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-07T07:36:18.589799-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1700</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1700</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1700</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">346</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">351</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Xylose isomerase (XI) is a key enzyme in the conversion of <span class="smallCaps">d</span>-xylose, which is a major component of lignocellulosic biomass, to <span class="smallCaps">d</span>-xylulose. Genomic analysis of the bacterium Clostridium cellulovorans revealed the presence of XI-related genes. In this study, XI derived from C. cellulovorans was produced and displayed using the yeast cell-surface display system, and the xylose assimilation and fermentation properties of this XI-displaying yeast were examined. XI-displaying yeast grew well in medium containing xylose as the sole carbon source and directly produced ethanol from xylose under anaerobic conditions. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 346–351, 2013</p></div>
]]></content:encoded><description>
Xylose isomerase (XI) is a key enzyme in the conversion of d-xylose, which is a major component of lignocellulosic biomass, to d-xylulose. Genomic analysis of the bacterium Clostridium cellulovorans revealed the presence of XI-related genes. In this study, XI derived from C. cellulovorans was produced and displayed using the yeast cell-surface display system, and the xylose assimilation and fermentation properties of this XI-displaying yeast were examined. XI-displaying yeast grew well in medium containing xylose as the sole carbon source and directly produced ethanol from xylose under anaerobic conditions. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 346–351, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1701" xmlns="http://purl.org/rss/1.0/"><title>Continuous rhamnolipid production using denitrifying Pseudomonas aeruginosa cells in hollow-fiber bioreactor</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1701</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Continuous rhamnolipid production using denitrifying Pseudomonas aeruginosa cells in hollow-fiber bioreactor</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Neissa M. Pinzon, Aaron G. Cook, Lu-Kwang Ju</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-07T07:36:23.863251-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1701</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1701</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1701</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Applied Cellular Physiology and Metabolic Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">352</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">358</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Rhamnolipids are high-value effective biosurfactants produced by <i>Pseudomonas aeruginosa</i>. Large-scale production of rhamnolipids is still challenging especially under free-cell aerobic conditions in which the highly foaming nature of the culture broth reduces the productivity of the process. Immobilized systems relying on oxygen as electron acceptor have been previously investigated but oxygen transfer limitation presents difficulties for continuous rhamnolipid production. A coupled system using immobilized cells and nitrate instead of oxygen as electron acceptor taking advantage of the ability of <i>P. aeruginosa</i> to perform nitrate respiration was evaluated. This denitrification-based immobilized approach based on a hollow-fiber setup eliminated the transfer limitation problems and was found suitable for continuous rhamnolipid production in a period longer than 1,500 h. It completely eliminated the foaming difficulties related to aerobic systems with a comparable specific productivity of 0.017 g/(g dry cells)-h and allowed easy recovery of rhamnolipids from the cell-free medium. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 346–351, 2013</p></div>
]]></content:encoded><description>
Rhamnolipids are high-value effective biosurfactants produced by Pseudomonas aeruginosa. Large-scale production of rhamnolipids is still challenging especially under free-cell aerobic conditions in which the highly foaming nature of the culture broth reduces the productivity of the process. Immobilized systems relying on oxygen as electron acceptor have been previously investigated but oxygen transfer limitation presents difficulties for continuous rhamnolipid production. A coupled system using immobilized cells and nitrate instead of oxygen as electron acceptor taking advantage of the ability of P. aeruginosa to perform nitrate respiration was evaluated. This denitrification-based immobilized approach based on a hollow-fiber setup eliminated the transfer limitation problems and was found suitable for continuous rhamnolipid production in a period longer than 1,500 h. It completely eliminated the foaming difficulties related to aerobic systems with a comparable specific productivity of 0.017 g/(g dry cells)-h and allowed easy recovery of rhamnolipids from the cell-free medium. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 346–351, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1676" xmlns="http://purl.org/rss/1.0/"><title>Fluid flow in a spiral device used for irradiation of biological fluids</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1676</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fluid flow in a spiral device used for irradiation of biological fluids</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Todd Nikolof, Mahesh Prakash, Paul W Cleary, Joseph Bertolini</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-13T07:03:07.511895-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1676</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1676</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1676</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">359</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">367</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The manufacture of plasma-derived therapeutics includes dedicated viral inactivation steps to minimize the risk of infection. Traditional viral inactivation methods are effective for the removal and inactivation of enveloped viruses, but less effective against small nonenveloped viruses. UV-C irradiation has been demonstrated to be an effective means of inactivating such viruses. The UVivatec lab system consists of a spiral tube around an UV-C irradiation source. Flow of a solution through the chamber generates and ensures controlled mixing and uniform exposure to irradiation. A detailed assessment of the effect of flow rate, alternate cross sectional design and scale up of the irradiation chamber on Dean vortices was performed using the smoothed particle hydrodynamics method. The aim was to provide a basis for setting flow rate limits and using a laboratory scale apparatus to model viral inactivation in larger manufacturing scale equipment. The effect of flow rate related changes on the fluence rate was also investigated through chemical actinometry studies. The data were consistent with the simulations indicating that Dean vortices were present at low flow rates, but dissipated at higher flow rates through the spiral chamber. Importantly, this work also allowed a correlation between the small system and large scale system to be established. This will greatly facilitate process development and viral validation studies. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 359–367, 2013</p></div>
]]></content:encoded><description>
The manufacture of plasma-derived therapeutics includes dedicated viral inactivation steps to minimize the risk of infection. Traditional viral inactivation methods are effective for the removal and inactivation of enveloped viruses, but less effective against small nonenveloped viruses. UV-C irradiation has been demonstrated to be an effective means of inactivating such viruses. The UVivatec lab system consists of a spiral tube around an UV-C irradiation source. Flow of a solution through the chamber generates and ensures controlled mixing and uniform exposure to irradiation. A detailed assessment of the effect of flow rate, alternate cross sectional design and scale up of the irradiation chamber on Dean vortices was performed using the smoothed particle hydrodynamics method. The aim was to provide a basis for setting flow rate limits and using a laboratory scale apparatus to model viral inactivation in larger manufacturing scale equipment. The effect of flow rate related changes on the fluence rate was also investigated through chemical actinometry studies. The data were consistent with the simulations indicating that Dean vortices were present at low flow rates, but dissipated at higher flow rates through the spiral chamber. Importantly, this work also allowed a correlation between the small system and large scale system to be established. This will greatly facilitate process development and viral validation studies. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 359–367, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1678" xmlns="http://purl.org/rss/1.0/"><title>Integration of stochastic simulation with multivariate analysis: Short-term facility fit prediction</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1678</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Integration of stochastic simulation with multivariate analysis: Short-term facility fit prediction</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adam Stonier, David Pain, Ashley Westlake, Nicholas Hutchinson, Nina F. Thornhill, Suzanne S. Farid</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T12:39:44.159507-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1678</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1678</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1678</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">368</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">377</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This article describes a decision-support tool to help pinpoint the potential root causes of sub-optimal short-term facility fit issues in biopharmaceutical facilities. This was achieved by creating a tool that integrated stochastic simulation with advanced multivariate statistical analysis. Process fluctuations in product titers in cell culture, step yields, and chromatography eluate volumes were mimicked using Monte Carlo simulation data derived using a stochastic discrete-event simulation model. The resulting stochastic datasets, with the computed consequences on key metrics such as product mass loss and cost of goods, were examined using advanced multivariate statistical techniques. Principal component analysis combined with clustering algorithms was used to analyze the complex datasets from complete industrial batch processes for biopharmaceuticals. The challenge of visualizing the multidimensional nature of the dataset was addressed using hierarchical and <em>k</em>-means clustering as well as stacked parallel co-ordinate plots to help identify process fingerprints and characteristics of clusters leading to sub-optimal facility fit issues. Industrially-relevant case studies are presented that focus on technology transfer challenges for therapeutic antibodies moving from early phase to late phase clinical trials. The case study details how sub-optimal facility fit can be alleviated by allocating alternative product pool tanks. The impact of this operational change is then assessed by reviewing an updated process fingerprint. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 368–377, 2013</p></div>
]]></content:encoded><description>
This article describes a decision-support tool to help pinpoint the potential root causes of sub-optimal short-term facility fit issues in biopharmaceutical facilities. This was achieved by creating a tool that integrated stochastic simulation with advanced multivariate statistical analysis. Process fluctuations in product titers in cell culture, step yields, and chromatography eluate volumes were mimicked using Monte Carlo simulation data derived using a stochastic discrete-event simulation model. The resulting stochastic datasets, with the computed consequences on key metrics such as product mass loss and cost of goods, were examined using advanced multivariate statistical techniques. Principal component analysis combined with clustering algorithms was used to analyze the complex datasets from complete industrial batch processes for biopharmaceuticals. The challenge of visualizing the multidimensional nature of the dataset was addressed using hierarchical and k-means clustering as well as stacked parallel co-ordinate plots to help identify process fingerprints and characteristics of clusters leading to sub-optimal facility fit issues. Industrially-relevant case studies are presented that focus on technology transfer challenges for therapeutic antibodies moving from early phase to late phase clinical trials. The case study details how sub-optimal facility fit can be alleviated by allocating alternative product pool tanks. The impact of this operational change is then assessed by reviewing an updated process fingerprint. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 368–377, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1684" xmlns="http://purl.org/rss/1.0/"><title>Effects of chemical modifications in the partition behavior of proteins in aqueous two-phase systems: A case study with RNase A</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1684</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effects of chemical modifications in the partition behavior of proteins in aqueous two-phase systems: A case study with RNase A</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">José González-Valdez, Marco Rito-Palomares, Jorge Benavides</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T07:36:18.197226-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1684</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1684</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1684</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">378</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">385</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Chemical modification of proteins is gaining importance due to the improvement in properties and the broader range of applications that these protein conjugates have. Once modified, several purification strategies need to be applied to isolate the conjugates of interest. Aqueous two-phase systems (ATPS) are an attractive alternative for the primary recovery of proteins and their conjugates. However, to better understand which biochemical parameters affect in greater degree the partition behavior of these modified proteins in ATPS, it becomes necessary to characterize the partition behavior of different species. In this work, ribonuclease A (RNase A) was selected as a model protein to address the partition behavior of chemically modified proteins in ATPS. Native, mono-PEGylated, Uniblue A, Dabsyl Chloride, and Direct Red 83 chemically modified RNase A's were partitioned in 16 different polyethylene glycol (PEG)–potassium phosphate ATPS. Results suggest that while the effects of system design parameters govern the partition of native RNase A, the behavior of the chemically modified species is more influenced by the physicochemical characteristics of the modifying molecules, that in most cases promote partition toward the top polymer-rich phase with recovery percentages as high as 86%. It has been found that both, the hydrophobicity and molecular weight of the modifying species play a preponderant role in conjugate partition behavior since as hydrophobicity increases partition is promoted towards the PEG-rich phase balancing the effect of the molecular weight of the modifying molecules that tends to shift partition towards the salt rich phase. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 378–385, 2013</p></div>
]]></content:encoded><description>
Chemical modification of proteins is gaining importance due to the improvement in properties and the broader range of applications that these protein conjugates have. Once modified, several purification strategies need to be applied to isolate the conjugates of interest. Aqueous two-phase systems (ATPS) are an attractive alternative for the primary recovery of proteins and their conjugates. However, to better understand which biochemical parameters affect in greater degree the partition behavior of these modified proteins in ATPS, it becomes necessary to characterize the partition behavior of different species. In this work, ribonuclease A (RNase A) was selected as a model protein to address the partition behavior of chemically modified proteins in ATPS. Native, mono-PEGylated, Uniblue A, Dabsyl Chloride, and Direct Red 83 chemically modified RNase A's were partitioned in 16 different polyethylene glycol (PEG)–potassium phosphate ATPS. Results suggest that while the effects of system design parameters govern the partition of native RNase A, the behavior of the chemically modified species is more influenced by the physicochemical characteristics of the modifying molecules, that in most cases promote partition toward the top polymer-rich phase with recovery percentages as high as 86%. It has been found that both, the hydrophobicity and molecular weight of the modifying species play a preponderant role in conjugate partition behavior since as hydrophobicity increases partition is promoted towards the PEG-rich phase balancing the effect of the molecular weight of the modifying molecules that tends to shift partition towards the salt rich phase. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 378–385, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1695" xmlns="http://purl.org/rss/1.0/"><title>Grafted megaporous materials as ion-exchangers for bioproduct adsorption</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1695</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Grafted megaporous materials as ion-exchangers for bioproduct adsorption</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Noor Shad Bibi, Marcelo Fernández-Lahore</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-07T07:35:38.645087-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1695</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1695</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1695</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">386</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">393</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Megaporous chromatographic materials were manufactured by a three-step procedure, including backbone synthesis, chemical grafting, and introduction of ion-exchange functionality. The backbone of the adsorbent cylindrical bodies was prepared by polymerization of methacrylic acid and poly(ethylene glycol) diacrylate at sub-zero temperatures. Grafting was performed employing glycidyl methacrylate and a chemical initiator, cerium ammonium nitrate. The degree of grafting was adjusted by modifying the concentration of the initiator in the reaction mixture to a range of values (23, 39, 62, 89, and 105%). Further, the pendant epoxy-groups generated by the previous step were reacted to cation- and anion-exchanging moieties utilizing known chemical routes. Infrared spectroscopy studies confirmed the incorporation of epoxy and ion-exchanger groups to the backbone material. Optimized materials were tested for chromatography applications with model proteins; the dynamic binding capacity, as recorded at 10% breakthrough and 2.0 × 10<sup>−4</sup> m/s superficial velocity, were 350 and 58 mg/g for the cation-exchanger and the anion-exchanger material, respectively. These results may indicate that long tentacle-type polymer brushes were formed during grafting therefore increasing the ability of the megaporous body to efficiently capture macromolecules. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 386–393, 2013</p></div>
]]></content:encoded><description>
Megaporous chromatographic materials were manufactured by a three-step procedure, including backbone synthesis, chemical grafting, and introduction of ion-exchange functionality. The backbone of the adsorbent cylindrical bodies was prepared by polymerization of methacrylic acid and poly(ethylene glycol) diacrylate at sub-zero temperatures. Grafting was performed employing glycidyl methacrylate and a chemical initiator, cerium ammonium nitrate. The degree of grafting was adjusted by modifying the concentration of the initiator in the reaction mixture to a range of values (23, 39, 62, 89, and 105%). Further, the pendant epoxy-groups generated by the previous step were reacted to cation- and anion-exchanging moieties utilizing known chemical routes. Infrared spectroscopy studies confirmed the incorporation of epoxy and ion-exchanger groups to the backbone material. Optimized materials were tested for chromatography applications with model proteins; the dynamic binding capacity, as recorded at 10% breakthrough and 2.0 × 10−4 m/s superficial velocity, were 350 and 58 mg/g for the cation-exchanger and the anion-exchanger material, respectively. These results may indicate that long tentacle-type polymer brushes were formed during grafting therefore increasing the ability of the megaporous body to efficiently capture macromolecules. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 386–393, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1680" xmlns="http://purl.org/rss/1.0/"><title>Chromatographic peak alignment using derivative dynamic time warping</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1680</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Chromatographic peak alignment using derivative dynamic time warping</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christopher Bork, Kenneth Ng, Yinhan Liu, Alex Yee, Michael Pohlscheidt</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-18T01:56:02.970449-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1680</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1680</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1680</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">394</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">402</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Chromatogram overlays are frequently used to monitor inter-batch performance of bioprocess purification steps. However, the objective analysis of chromatograms is difficult due to peak shifts caused by variable phase durations or unexpected process holds. Furthermore, synchronization of batch process data may also be required prior to performing multivariate analysis techniques. Dynamic time warping was originally developed as a method for spoken word recognition, but shows potential in the objective analysis of time variant signals, such as manufacturing data. In this work we will discuss the application of dynamic time warping with a derivative weighting function to align chromatograms to facilitate process monitoring and fault detection. In addition, we will demonstrate the utility of this method as a preprocessing step for multivariate model development. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 394–402, 2013</p></div>
]]></content:encoded><description>
Chromatogram overlays are frequently used to monitor inter-batch performance of bioprocess purification steps. However, the objective analysis of chromatograms is difficult due to peak shifts caused by variable phase durations or unexpected process holds. Furthermore, synchronization of batch process data may also be required prior to performing multivariate analysis techniques. Dynamic time warping was originally developed as a method for spoken word recognition, but shows potential in the objective analysis of time variant signals, such as manufacturing data. In this work we will discuss the application of dynamic time warping with a derivative weighting function to align chromatograms to facilitate process monitoring and fault detection. In addition, we will demonstrate the utility of this method as a preprocessing step for multivariate model development. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 394–402, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1705" xmlns="http://purl.org/rss/1.0/"><title>Chromatography process development in the quality by design paradigm I: Establishing a high-throughput process development platform as a tool for estimating “characterization space” for an ion exchange chromatography step</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1705</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Chromatography process development in the quality by design paradigm I: Establishing a high-throughput process development platform as a tool for estimating “characterization space” for an ion exchange chromatography step</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Bhambure, A. S. Rathore</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-27T05:57:52.309131-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1705</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1705</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1705</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">403</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">414</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This article describes the development of a high-throughput process development (HTPD) platform for developing chromatography steps. An assessment of the platform as a tool for establishing the “characterization space” for an ion exchange chromatography step has been performed by using design of experiments. Case studies involving use of a biotech therapeutic, granulocyte colony-stimulating factor have been used to demonstrate the performance of the platform. We discuss the various challenges that arise when working at such small volumes along with the solutions that we propose to alleviate these challenges to make the HTPD data suitable for empirical modeling. Further, we have also validated the scalability of this platform by comparing the results from the HTPD platform (2 and 6 μL resin volumes) against those obtained at the traditional laboratory scale (resin volume, 0.5 mL). We find that after integration of the proposed correction factors, the HTPD platform is capable of performing the process optimization studies at 170-fold higher productivity. The platform is capable of providing semi-quantitative assessment of the effects of the various input parameters under consideration. We think that platform such as the one presented is an excellent tool for examining the “characterization space” and reducing the extensive experimentation at the traditional lab scale that is otherwise required for establishing the “design space.” Thus, this platform will specifically aid in successful implementation of quality by design in biotech process development. This is especially significant in view of the constraints with respect to time and resources that the biopharma industry faces today. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 403–414, 2013</p></div>
]]></content:encoded><description>
This article describes the development of a high-throughput process development (HTPD) platform for developing chromatography steps. An assessment of the platform as a tool for establishing the “characterization space” for an ion exchange chromatography step has been performed by using design of experiments. Case studies involving use of a biotech therapeutic, granulocyte colony-stimulating factor have been used to demonstrate the performance of the platform. We discuss the various challenges that arise when working at such small volumes along with the solutions that we propose to alleviate these challenges to make the HTPD data suitable for empirical modeling. Further, we have also validated the scalability of this platform by comparing the results from the HTPD platform (2 and 6 μL resin volumes) against those obtained at the traditional laboratory scale (resin volume, 0.5 mL). We find that after integration of the proposed correction factors, the HTPD platform is capable of performing the process optimization studies at 170-fold higher productivity. The platform is capable of providing semi-quantitative assessment of the effects of the various input parameters under consideration. We think that platform such as the one presented is an excellent tool for examining the “characterization space” and reducing the extensive experimentation at the traditional lab scale that is otherwise required for establishing the “design space.” Thus, this platform will specifically aid in successful implementation of quality by design in biotech process development. This is especially significant in view of the constraints with respect to time and resources that the biopharma industry faces today. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 403–414, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1667" xmlns="http://purl.org/rss/1.0/"><title>Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1667</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Seshu Tummala, Michael Titus, Lee Wilson, Chunhua Wang, Carlo Ciatto, Greg Thill, Donald Foster, Chen Li, Zoltan Szabo, Andras Guttman, Brian Bettencourt, Muthuswamy Jayaraman, Jack Deroot, David Kocisko, Stuart Pollard, Klaus Charisse, Satya Kuchimanchi, Greg Hinkle, Stuart Milstein, Rachel Meyers, Shiaw-Lin Wu, Barry L. Karger, Anthony Rossomando</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-13T07:09:32.716309-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1667</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1667</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1667</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">415</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">424</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Traditional metabolic engineering approaches, including homologous recombination, zinc-finger nucleases, and short hairpin RNA, have previously been used to generate biologics with specific characteristics that improve efficacy, potency, and safety. An alternative approach is to exogenously add soluble small interfering RNA (siRNA) duplexes, formulated with a cationic lipid, directly to cells grown in shake flasks or bioreactors. This approach has the following potential advantages: no cell line development required, ability to tailor mRNA silencing by adjusting siRNA concentration, simultaneous silencing of multiple target genes, and potential temporal control of down regulation of target gene expression. In this study, we demonstrate proof of concept of the siRNA feeding approach as a metabolic engineering tool in the context of increasing monoclonal antibody (MAb) afucosylation. First, potent siRNA duplexes targeting fut8 and gmds were dosed into shake flasks with cells that express an anti-CD20 MAb. Dose response studies demonstrated the ability to titrate the silencing effect. Furthermore, siRNA addition resulted in no deleterious effects on cell growth, final protein titer, or specific productivity. In bioreactors, antibodies produced by cells following siRNA treatment exhibited improved functional characteristics compared to antibodies from untreated cells, including increased levels of afucosylation (63%), a 17-fold improvement in FCgRIIIa binding, and an increase in specific cell lysis by up to 30%, as determined in an Antibody-Dependent Cellular Cytoxicity (ADCC) assay. In addition, standard purification procedures effectively cleared the exogenously added siRNA and transfection agent. Moreover, no differences were observed when other key product quality structural attributes were compared to untreated controls. These results establish that exogenous addition of siRNA represents a potentially novel metabolic engineering tool to improve biopharmaceutical function and quality that can complement existing metabolic engineering methods. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 415–424, 2013</p></div>
]]></content:encoded><description>
Traditional metabolic engineering approaches, including homologous recombination, zinc-finger nucleases, and short hairpin RNA, have previously been used to generate biologics with specific characteristics that improve efficacy, potency, and safety. An alternative approach is to exogenously add soluble small interfering RNA (siRNA) duplexes, formulated with a cationic lipid, directly to cells grown in shake flasks or bioreactors. This approach has the following potential advantages: no cell line development required, ability to tailor mRNA silencing by adjusting siRNA concentration, simultaneous silencing of multiple target genes, and potential temporal control of down regulation of target gene expression. In this study, we demonstrate proof of concept of the siRNA feeding approach as a metabolic engineering tool in the context of increasing monoclonal antibody (MAb) afucosylation. First, potent siRNA duplexes targeting fut8 and gmds were dosed into shake flasks with cells that express an anti-CD20 MAb. Dose response studies demonstrated the ability to titrate the silencing effect. Furthermore, siRNA addition resulted in no deleterious effects on cell growth, final protein titer, or specific productivity. In bioreactors, antibodies produced by cells following siRNA treatment exhibited improved functional characteristics compared to antibodies from untreated cells, including increased levels of afucosylation (63%), a 17-fold improvement in FCgRIIIa binding, and an increase in specific cell lysis by up to 30%, as determined in an Antibody-Dependent Cellular Cytoxicity (ADCC) assay. In addition, standard purification procedures effectively cleared the exogenously added siRNA and transfection agent. Moreover, no differences were observed when other key product quality structural attributes were compared to untreated controls. These results establish that exogenous addition of siRNA represents a potentially novel metabolic engineering tool to improve biopharmaceutical function and quality that can complement existing metabolic engineering methods. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 415–424, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1681" xmlns="http://purl.org/rss/1.0/"><title>In vitro silencing of myostatin gene by shRNAs in chicken embryonic myoblast cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1681</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">In vitro silencing of myostatin gene by shRNAs in chicken embryonic myoblast cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ajai K. Tripathi, Mansi K. Aparnathi, Amrutlal K. Patel, Chaitanya G. Joshi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T12:39:47.910069-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1681</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1681</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1681</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">425</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">431</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>RNA interference represents one of the potential mechanisms of regulation of gene expression. Selective downregulation of myostatin (MSTN), a member of transforming growth factor-β (TGF-β) superfamily and a negative regulator of myogenesis, has been demonstrated to enhance skeletal muscle growth. In this study, we studied short hairpin RNA (shRNA)-induced myostatin gene silencing in chicken embryonic myoblast cells using seven different shRNA-expressing constructs by reverse transcription-quantitative real time PCR (RT-qPCR). Myostatin-silencing efficiency of all shRNA constructs were first evaluated in human embryonic kidney cell line 293T (HEK293T) cells, where we observed 30–75.6% reduction in myostatin expression, followed by chicken embryo myoblast cells that revealed up to 55% reduction in myostatin expression along with upregulation of MyoD by 4.65-folds. Consistent with the earlier observations, the transfection of cells with plasmids led to significant increase in interferon responsive genes OAS1 and IFN β (2–112-folds), independent of myostatin silencing in both HEK293T and chicken embryonic myoblast cells. Our study suggests that apart from shRNA sequences, cell type-specific factors may play a significant role in determining the knockdown efficiency of shRNAs. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 425–431, 2013</p></div>
]]></content:encoded><description>
RNA interference represents one of the potential mechanisms of regulation of gene expression. Selective downregulation of myostatin (MSTN), a member of transforming growth factor-β (TGF-β) superfamily and a negative regulator of myogenesis, has been demonstrated to enhance skeletal muscle growth. In this study, we studied short hairpin RNA (shRNA)-induced myostatin gene silencing in chicken embryonic myoblast cells using seven different shRNA-expressing constructs by reverse transcription-quantitative real time PCR (RT-qPCR). Myostatin-silencing efficiency of all shRNA constructs were first evaluated in human embryonic kidney cell line 293T (HEK293T) cells, where we observed 30–75.6% reduction in myostatin expression, followed by chicken embryo myoblast cells that revealed up to 55% reduction in myostatin expression along with upregulation of MyoD by 4.65-folds. Consistent with the earlier observations, the transfection of cells with plasmids led to significant increase in interferon responsive genes OAS1 and IFN β (2–112-folds), independent of myostatin silencing in both HEK293T and chicken embryonic myoblast cells. Our study suggests that apart from shRNA sequences, cell type-specific factors may play a significant role in determining the knockdown efficiency of shRNAs. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 425–431, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1685" xmlns="http://purl.org/rss/1.0/"><title>Application of a new human cell line, F2N78, in the transient and stable production of recombinant therapeutics</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1685</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Application of a new human cell line, F2N78, in the transient and stable production of recombinant therapeutics</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hyun-Joo Lee, MinSeok Chang, Jong-Mook Kim, HyeJin Hong, KiEun Maeng, Jane Koo, ShinJae Chang, Myung-Sam Cho</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T13:03:57.725694-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1685</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1685</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1685</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">432</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">440</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Host cell lines developed by genetic engineering sometimes show instabilities in maintaining their genetically acquired phenotypes. Previously, a hybrid host cell line, designated as hybrid of kidney and B cells (HKB), capable of retaining selected phenotypes originally existing in the parental cells was developed via fusion of 293 cells and HH514-16 cells. Although HKB did indeed successfully preserve several favorable phenotypes, the expression of Epstein-Barr virus (EBV) specific nuclear antigen 1 (EBNA1), which should be constitutively expressed for host cells to utilize oriP expression vector in transient production of therapeutic proteins, was observed to be unstable. Here, in an attempt to obtain stable expression of EBNA1, a cell type that contains an integrated EBV genome, rather than HH514-16 cells, which harbor an episomal EBV genome, was applied for fusion with 293 cells. Fusion of 293 cells with Namalwa cells led to the creation of a new type of hybrid, F2N, which was able to stably express EBNA1 while not producing EBV particles. One of the F2N clones, F2N78, was observed to maintain EBNA1 expression for more than 1 year under serum-free suspension culture conditions along with human specific glycosyl phenotypes observed previously in HKB. In addition, F2N78 was demonstrated to be an appropriate host cell line for both the transient and stable production of recombinant therapeutics with the features of safety expected of production cell lines for human use. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 432–440, 2013</p></div>
]]></content:encoded><description>
Host cell lines developed by genetic engineering sometimes show instabilities in maintaining their genetically acquired phenotypes. Previously, a hybrid host cell line, designated as hybrid of kidney and B cells (HKB), capable of retaining selected phenotypes originally existing in the parental cells was developed via fusion of 293 cells and HH514-16 cells. Although HKB did indeed successfully preserve several favorable phenotypes, the expression of Epstein-Barr virus (EBV) specific nuclear antigen 1 (EBNA1), which should be constitutively expressed for host cells to utilize oriP expression vector in transient production of therapeutic proteins, was observed to be unstable. Here, in an attempt to obtain stable expression of EBNA1, a cell type that contains an integrated EBV genome, rather than HH514-16 cells, which harbor an episomal EBV genome, was applied for fusion with 293 cells. Fusion of 293 cells with Namalwa cells led to the creation of a new type of hybrid, F2N, which was able to stably express EBNA1 while not producing EBV particles. One of the F2N clones, F2N78, was observed to maintain EBNA1 expression for more than 1 year under serum-free suspension culture conditions along with human specific glycosyl phenotypes observed previously in HKB. In addition, F2N78 was demonstrated to be an appropriate host cell line for both the transient and stable production of recombinant therapeutics with the features of safety expected of production cell lines for human use. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 432–440, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1686" xmlns="http://purl.org/rss/1.0/"><title>Endogenous extracellular matrices enhance human mesenchymal stem cell aggregate formation and survival</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1686</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Endogenous extracellular matrices enhance human mesenchymal stem cell aggregate formation and survival</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Junho Kim, Teng Ma</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T13:04:01.000234-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1686</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1686</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1686</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">441</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">451</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Human mesenchymal stem or stromal cell (hMSC) therapies have promise across a wide range of diseases. However, inefficient cell delivery and low cell survival at injury sites reduce efficacy and are the major barriers in hMSC-based therapy. Formation of three-dimensional (3D) hMSC aggregates has been found to activate hMSC functions from enhancing secretion of therapeutic factors for improving cell migration and survival. As the stromal cells in bone marrow, hMSCs are significant sources of extracellular matrix (ECM) proteins and growth factors, which form an interactive microenvironment to influence hMSC fate via paracrine and autocrine actions. To date, however, the impact of the extracellular microenvironment on hMSC properties in the aggregates remains unknown. In the present study, we investigated the role of endogenous ECM matrices on hMSC aggregate formation and survival under ischemic stress. The results demonstrated that the preservation of endogenous ECM in the aggregates formed by thermal lifting (termed TLAs) as opposed to the aggregates formed by enzymatically detached hMSCs (termed EDAs) enhanced cell proliferation, multilineage potential, and survival under ischemic stress. The improved cell proliferation and viability in the TLAs is attributed to the incorporation of endogenous ECM proteins in the TLAs and their promitotic and antioxidant properties. The results demonstrate a novel method for the formation of hMSC aggregates via thermal responsive surface and highlight the significant contribution of the ECM in preserving hMSC properties in the 3D aggregates. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 441–451, 2013</p></div>
]]></content:encoded><description>
Human mesenchymal stem or stromal cell (hMSC) therapies have promise across a wide range of diseases. However, inefficient cell delivery and low cell survival at injury sites reduce efficacy and are the major barriers in hMSC-based therapy. Formation of three-dimensional (3D) hMSC aggregates has been found to activate hMSC functions from enhancing secretion of therapeutic factors for improving cell migration and survival. As the stromal cells in bone marrow, hMSCs are significant sources of extracellular matrix (ECM) proteins and growth factors, which form an interactive microenvironment to influence hMSC fate via paracrine and autocrine actions. To date, however, the impact of the extracellular microenvironment on hMSC properties in the aggregates remains unknown. In the present study, we investigated the role of endogenous ECM matrices on hMSC aggregate formation and survival under ischemic stress. The results demonstrated that the preservation of endogenous ECM in the aggregates formed by thermal lifting (termed TLAs) as opposed to the aggregates formed by enzymatically detached hMSCs (termed EDAs) enhanced cell proliferation, multilineage potential, and survival under ischemic stress. The improved cell proliferation and viability in the TLAs is attributed to the incorporation of endogenous ECM proteins in the TLAs and their promitotic and antioxidant properties. The results demonstrate a novel method for the formation of hMSC aggregates via thermal responsive surface and highlight the significant contribution of the ECM in preserving hMSC properties in the 3D aggregates. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 441–451, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1687" xmlns="http://purl.org/rss/1.0/"><title>Computational modeling of nutrient utilization in engineered cartilage</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1687</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Computational modeling of nutrient utilization in engineered cartilage</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tze-Hung Lin, Han-Yun Jhang, Feng-Cheng Chu, C. A. Chung</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T13:04:05.483588-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1687</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1687</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1687</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">452</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">462</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This study presents a mathematical model for simulating cartilaginous culture of chondrocytes seeded in scaffolds and for investigating the effects of glucose and oxygen concentration and pH value on cell metabolic rates. The model can clearly interpret the unexplained experimental observation (Sengers BG, Heywood HK, Lee DA, Oomens CWJ, Bader DL. Nutrient utilization by bovine articular chondrocytes: A combined experimental and theoretical approach. J Biomech Eng. 2005;127:758–766.), which showed that the oxygen concentration within the scaffold may increase instead of continuously decreasing in static cartilaginous culture of chondrocytes. Results from simulation demonstrate that when cells metabolize glucose and form lactate under high glucose concentration conditions, the acidity in the culture environment increases, inhibiting cell metabolic rates in the process. Consequently, the rate of oxygen consumption decreases in later stages of cell culture. As oxygen can be replenished through the free surface of the culture medium, oxygen concentration within the scaffold increases rather than decreases over time in the acidic environment. Different initial glucose concentration yields different results. In low glucose concentration conditions, oxygen concentration basically keeps decreasing with culture time. This is because the pH in the environment does not significantly change because of slower glycolysis rate in low glucose concentration cases, forming less lactic acid. From the simulation results, additional information regarding in vitro culture of chondrocytes is obtained. The correlations between nutrient consumption, lactate secretion, and pH changes during cell culture are also understood and may serve as a reference for in vitro cell culture research of tissue engineering. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 452–462, 2013</p></div>
]]></content:encoded><description>
This study presents a mathematical model for simulating cartilaginous culture of chondrocytes seeded in scaffolds and for investigating the effects of glucose and oxygen concentration and pH value on cell metabolic rates. The model can clearly interpret the unexplained experimental observation (Sengers BG, Heywood HK, Lee DA, Oomens CWJ, Bader DL. Nutrient utilization by bovine articular chondrocytes: A combined experimental and theoretical approach. J Biomech Eng. 2005;127:758–766.), which showed that the oxygen concentration within the scaffold may increase instead of continuously decreasing in static cartilaginous culture of chondrocytes. Results from simulation demonstrate that when cells metabolize glucose and form lactate under high glucose concentration conditions, the acidity in the culture environment increases, inhibiting cell metabolic rates in the process. Consequently, the rate of oxygen consumption decreases in later stages of cell culture. As oxygen can be replenished through the free surface of the culture medium, oxygen concentration within the scaffold increases rather than decreases over time in the acidic environment. Different initial glucose concentration yields different results. In low glucose concentration conditions, oxygen concentration basically keeps decreasing with culture time. This is because the pH in the environment does not significantly change because of slower glycolysis rate in low glucose concentration cases, forming less lactic acid. From the simulation results, additional information regarding in vitro culture of chondrocytes is obtained. The correlations between nutrient consumption, lactate secretion, and pH changes during cell culture are also understood and may serve as a reference for in vitro cell culture research of tissue engineering. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 452–462, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1698" xmlns="http://purl.org/rss/1.0/"><title>Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1698</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Srinath Kasturirangan, Tim Reasoner, Philip Schulz, Shanta Boddapati, Sharareh Emadi, Jon Valla, Michael R. Sierks</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-07T07:36:04.190187-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1698</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1698</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1698</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">463</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">471</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>We developed atomic force microscope (AFM)-based protocols that enable isolation and characterization of antibody-based reagents that selectively bind target protein variants using low nanogram amounts or less of unpurified starting material. We isolated single-chain antibody fragments (scFvs) that specifically recognize an oligomeric beta-amyloid (Aβ) species correlated with Alzheimer's disease (AD) using only a few nanograms of an enriched but not purified sample obtained from human AD brain tissue. We used several subtractive panning steps to remove all phage binding nondesired antigens and then used a single positive panning step using minimal antigen. We also used AFM to characterize the specificity of the isolated clones, again using minimal material, selecting the C6 scFv based on expression levels. We show that C6 selectively binds cell and brain-derived oligomeric Aβ. The protocols described are readily adapted to isolating antibody-based reagents against other antigenic targets with limited availability. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 463–471, 2013</p></div>
]]></content:encoded><description>
We developed atomic force microscope (AFM)-based protocols that enable isolation and characterization of antibody-based reagents that selectively bind target protein variants using low nanogram amounts or less of unpurified starting material. We isolated single-chain antibody fragments (scFvs) that specifically recognize an oligomeric beta-amyloid (Aβ) species correlated with Alzheimer's disease (AD) using only a few nanograms of an enriched but not purified sample obtained from human AD brain tissue. We used several subtractive panning steps to remove all phage binding nondesired antigens and then used a single positive panning step using minimal antigen. We also used AFM to characterize the specificity of the isolated clones, again using minimal material, selecting the C6 scFv based on expression levels. We show that C6 selectively binds cell and brain-derived oligomeric Aβ. The protocols described are readily adapted to isolating antibody-based reagents against other antigenic targets with limited availability. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 463–471, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1674" xmlns="http://purl.org/rss/1.0/"><title>Novel nanoimaging approach: Antibodious polymeric nanolabel for intracellular alpha-fetoprotein targeted monitoring</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1674</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Novel nanoimaging approach: Antibodious polymeric nanolabel for intracellular alpha-fetoprotein targeted monitoring</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Özlem Biçen Ünlüer, Arzu Ersöz, Ridvan Say, Özlem Tomsuk, Hülya Sivas</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-17T06:20:26.429259-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1674</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1674</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1674</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">472</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">479</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This study describes preparation and use of novel labeled and antibodious polymeric nanolabels (anti-alpha fetoprotein cross-linked nanolabels) as an immunogenic and semisynthetic nanolabel with potential prognostic and therapeutic roles for hepatoma cancer. Specificity, uptake, and binding efficiencies of the nanolabel have been examined in a human hepatosarcoma cell line HepG2, a human colorectal cell line DLD-1, and a mouse myoblast cell line C2. Labeling of the cells has been performed by treating live and fixed cells with varying concentrations of the nanolabels and then, the cells have been examined under a fluorescence microscope. In addition, all cell lines have also been labeled using FITC-conjugated nanotrastuzumab to compare the results obtained with those of the binding of the FITC-nanoanti-alpha fetoprotein nanolabels. Results show that FITC-conjugated anti-alpha fetoprotein cross-linked nanolabels have been taken up by both live and fixed cells and have efficiently and specifically labeled HepG2 cells at a quite low concentration. Taken all together, the results indicate that the novel targeted nanoimaging tools and technique demonstrated their ability to detect the distribution of the nanolabels as probes in hepatoma cells. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 472–479, 2013</p></div>
]]></content:encoded><description>
This study describes preparation and use of novel labeled and antibodious polymeric nanolabels (anti-alpha fetoprotein cross-linked nanolabels) as an immunogenic and semisynthetic nanolabel with potential prognostic and therapeutic roles for hepatoma cancer. Specificity, uptake, and binding efficiencies of the nanolabel have been examined in a human hepatosarcoma cell line HepG2, a human colorectal cell line DLD-1, and a mouse myoblast cell line C2. Labeling of the cells has been performed by treating live and fixed cells with varying concentrations of the nanolabels and then, the cells have been examined under a fluorescence microscope. In addition, all cell lines have also been labeled using FITC-conjugated nanotrastuzumab to compare the results obtained with those of the binding of the FITC-nanoanti-alpha fetoprotein nanolabels. Results show that FITC-conjugated anti-alpha fetoprotein cross-linked nanolabels have been taken up by both live and fixed cells and have efficiently and specifically labeled HepG2 cells at a quite low concentration. Taken all together, the results indicate that the novel targeted nanoimaging tools and technique demonstrated their ability to detect the distribution of the nanolabels as probes in hepatoma cells. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 472–479, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1682" xmlns="http://purl.org/rss/1.0/"><title>Buffer capacity of biologics—from buffer salts to buffering by antibodies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1682</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Buffer capacity of biologics—from buffer salts to buffering by antibodies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anne R. Karow, Sven Bahrenburg, Patrick Garidel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-01T12:39:39.418545-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1682</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1682</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1682</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">480</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">492</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Controlling pH is essential for a variety of biopharmaceutical process steps. The chemical stability of biologics such as monoclonal antibodies is pH-dependent and slightly acidic conditions are favorable for stability in a number of cases. Since control of pH is widely provided by added buffer salts, the current study summarizes the buffer characteristics of acetate, citrate, histidine, succinate, and phosphate buffers. Experimentally derived values largely coincide with values calculated from a model that had been proposed in 1922 by van Slyke. As high concentrated protein formulations become more and more prevalent for biologics, the self-buffering potential of proteins becomes of relevance. The current study provides information on buffer characteristics for pH ranges down to 4.0 and up to 8.0 and shows that a monoclonal antibody at 50 mg/mL exhibits similar buffer capacity as 6 mM citrate or 14 mM histidine (pH 5.0–6.0). Buffer capacity of antibody solutions scales linearly with protein concentration up to more than 200 mg/mL. At a protein concentration of 220 mg/mL, the buffer capacity resembles the buffer capacity of 30 mM citrate or 50 mM histidine (pH 5.0–6.0). The buffer capacity of monoclonal antibodies is practically identical at the process relevant temperatures 5, 25, and 40°C. Changes in ionic strength of ΔI=0.15, in contrast, can alter the buffer capacity up to 35%. In conclusion, due to efficient self-buffering by antibodies in the pH range of favored chemical stability, conventional buffer excipients could be dispensable for pH stabilization of high concentrated protein solutions. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 480–492, 2013</p></div>
]]></content:encoded><description>
Controlling pH is essential for a variety of biopharmaceutical process steps. The chemical stability of biologics such as monoclonal antibodies is pH-dependent and slightly acidic conditions are favorable for stability in a number of cases. Since control of pH is widely provided by added buffer salts, the current study summarizes the buffer characteristics of acetate, citrate, histidine, succinate, and phosphate buffers. Experimentally derived values largely coincide with values calculated from a model that had been proposed in 1922 by van Slyke. As high concentrated protein formulations become more and more prevalent for biologics, the self-buffering potential of proteins becomes of relevance. The current study provides information on buffer characteristics for pH ranges down to 4.0 and up to 8.0 and shows that a monoclonal antibody at 50 mg/mL exhibits similar buffer capacity as 6 mM citrate or 14 mM histidine (pH 5.0–6.0). Buffer capacity of antibody solutions scales linearly with protein concentration up to more than 200 mg/mL. At a protein concentration of 220 mg/mL, the buffer capacity resembles the buffer capacity of 30 mM citrate or 50 mM histidine (pH 5.0–6.0). The buffer capacity of monoclonal antibodies is practically identical at the process relevant temperatures 5, 25, and 40°C. Changes in ionic strength of ΔI=0.15, in contrast, can alter the buffer capacity up to 35%. In conclusion, due to efficient self-buffering by antibodies in the pH range of favored chemical stability, conventional buffer excipients could be dispensable for pH stabilization of high concentrated protein solutions. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 480–492, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1689" xmlns="http://purl.org/rss/1.0/"><title>PEGylated human plasma fibronectin is proteolytically stable, supports cell adhesion, cell migration, focal adhesion assembly, and fibronectin fibrillogenesis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1689</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">PEGylated human plasma fibronectin is proteolytically stable, supports cell adhesion, cell migration, focal adhesion assembly, and fibronectin fibrillogenesis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chen Zhang, Sogol Hekmatfar, Anand Ramanathan, Nancy W. Karuri</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T07:35:40.71467-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1689</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1689</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1689</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">493</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">504</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Delayed wound healing in many chronic wounds has been linked to the degradation of fibronectin (FN) by abnormally high protease levels. We sought to develop a proteolytically stable and functionally active form of FN. For this purpose, we conjugated 3.35 kDa polyethylene glycol diacrylate (PEGDA) to human plasma fibronectin (HPFN). Conjugation of PEGDA to HPFN or HPFN PEGylation was characterized by an increase of approximately 16 kDa in the average molecular weight of PEGylated HPFN compared to native HPFN in SDS-PAGE gels. PEGylated HPFN was more resistant to α chymotrypsin or neutrophil elastase digestion than native HPFN: after 30 min incubation with α chymotrypsin, 56 and 90% of native and PEGylated HPFN respectively remained intact. PEGylated HPFN and native HPFN supported NIH 3T3 mouse fibroblast adhesion and spreading, migration and focal adhesion formation in a similar manner. Fluorescence microscopy showed that both native and PEGylated HPFN in the culture media were assembled into extracellular matrix (ECM) fibrils. Interestingly, when coated on surfaces, native but not PEGylated HPFN was assembled into the ECM of fibroblasts. The proteolytically stable PEGylated HPFN developed herein could be used to replenish FN levels in the chronic wound bed and promote tissue repair. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 493–504, 2013</p></div>
]]></content:encoded><description>
Delayed wound healing in many chronic wounds has been linked to the degradation of fibronectin (FN) by abnormally high protease levels. We sought to develop a proteolytically stable and functionally active form of FN. For this purpose, we conjugated 3.35 kDa polyethylene glycol diacrylate (PEGDA) to human plasma fibronectin (HPFN). Conjugation of PEGDA to HPFN or HPFN PEGylation was characterized by an increase of approximately 16 kDa in the average molecular weight of PEGylated HPFN compared to native HPFN in SDS-PAGE gels. PEGylated HPFN was more resistant to α chymotrypsin or neutrophil elastase digestion than native HPFN: after 30 min incubation with α chymotrypsin, 56 and 90% of native and PEGylated HPFN respectively remained intact. PEGylated HPFN and native HPFN supported NIH 3T3 mouse fibroblast adhesion and spreading, migration and focal adhesion formation in a similar manner. Fluorescence microscopy showed that both native and PEGylated HPFN in the culture media were assembled into extracellular matrix (ECM) fibrils. Interestingly, when coated on surfaces, native but not PEGylated HPFN was assembled into the ECM of fibroblasts. The proteolytically stable PEGylated HPFN developed herein could be used to replenish FN levels in the chronic wound bed and promote tissue repair. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 493–504, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1691" xmlns="http://purl.org/rss/1.0/"><title>A biomimetic chitosan composite with improved mechanical properties in wet conditions</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1691</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A biomimetic chitosan composite with improved mechanical properties in wet conditions</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dongyeop X. Oh, Dong Soo Hwang</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T07:34:04.030229-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1691</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1691</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1691</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">505</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">512</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Chitosan is one of the most widely used structural polymers for biomedical applications because it has many favorable properties. However, one of the most critical drawbacks regarding the use of chitosan as a biomedical material is its poor mechanical properties in wet conditions. Here, we designed a method to improve the mechanical properties of chitosan in wet conditions and minimized the swelling behavior of chitosan film due to water adsorption by mimicking the sclerotization of insect cuticles and squid beaks, that is, catechol-meditated crosslinking. The biomimetic chitosan composite film was prepared by mixing chitosan with <span class="smallCaps">l</span>-3,4-dihydroxyphenylalanine (DOPA) as a catecholic crosslinker and sodium periodate as an oxidant. The catechol-meditated crosslinking provided a sevenfold enhancement in the stiffness in wet conditions compared to pure chitosan films and reduced the swelling behavior of the chitosan film. This strategy expands the possible applications for the use of chitosan composites as load-bearing biomaterials. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 505–512, 2013</p></div>
]]></content:encoded><description>
Chitosan is one of the most widely used structural polymers for biomedical applications because it has many favorable properties. However, one of the most critical drawbacks regarding the use of chitosan as a biomedical material is its poor mechanical properties in wet conditions. Here, we designed a method to improve the mechanical properties of chitosan in wet conditions and minimized the swelling behavior of chitosan film due to water adsorption by mimicking the sclerotization of insect cuticles and squid beaks, that is, catechol-meditated crosslinking. The biomimetic chitosan composite film was prepared by mixing chitosan with l-3,4-dihydroxyphenylalanine (DOPA) as a catecholic crosslinker and sodium periodate as an oxidant. The catechol-meditated crosslinking provided a sevenfold enhancement in the stiffness in wet conditions compared to pure chitosan films and reduced the swelling behavior of the chitosan film. This strategy expands the possible applications for the use of chitosan composites as load-bearing biomaterials. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 505–512, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1692" xmlns="http://purl.org/rss/1.0/"><title>Bioinspired molecular adhesive for water-resistant oxygen indicator films</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1692</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Bioinspired molecular adhesive for water-resistant oxygen indicator films</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chau Hai Thai Vu, Keehoon Won</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T07:32:28.680054-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1692</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1692</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1692</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Formulation and Engineering of Biomaterials</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">513</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">519</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Mussels can attach themselves to nearly all types of hard surfaces in wet environments. Such attractive adhesive ability of mussels is believed to rely on the amino acid composition of proteins found near the plaque–substrate interface. Dopamine (DA) is identified as a simplified mimic of mussel proteins, which are rich in 3,4-dihydroxy-<span class="smallCaps">l</span>-phenylalanine and lysine, because it contains both catechol and amine functional groups. In this work, we have first applied this bioinspired adhesive to tackle a dye leaching problem of colorimetric oxygen indicator films, which are widely used to ensure the absence of oxygen inside the package of oxygen-sensitive materials. Simple immersion of packaging films into a DA solution resulted in poly(DA) deposition, decreasing the water contact angle of the films from 105° to 65°. The poly(DA) coating could reduce the thionine leakage of the UV-activated oxygen indicator film. The effects of poly(DA) coating were found to be dependent on the DA solution pH, the coating time, and the DA concentration. The film resistant to dye leaching lost its dye color by 5 min UVB irradiation and regained the color in the presence of oxygen, demonstrating that it functioned successfully as UV-activated oxygen indicators. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 513–519, 2013</p></div>
]]></content:encoded><description>
Mussels can attach themselves to nearly all types of hard surfaces in wet environments. Such attractive adhesive ability of mussels is believed to rely on the amino acid composition of proteins found near the plaque–substrate interface. Dopamine (DA) is identified as a simplified mimic of mussel proteins, which are rich in 3,4-dihydroxy-l-phenylalanine and lysine, because it contains both catechol and amine functional groups. In this work, we have first applied this bioinspired adhesive to tackle a dye leaching problem of colorimetric oxygen indicator films, which are widely used to ensure the absence of oxygen inside the package of oxygen-sensitive materials. Simple immersion of packaging films into a DA solution resulted in poly(DA) deposition, decreasing the water contact angle of the films from 105° to 65°. The poly(DA) coating could reduce the thionine leakage of the UV-activated oxygen indicator film. The effects of poly(DA) coating were found to be dependent on the DA solution pH, the coating time, and the DA concentration. The film resistant to dye leaching lost its dye color by 5 min UVB irradiation and regained the color in the presence of oxygen, demonstrating that it functioned successfully as UV-activated oxygen indicators. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 513–519, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1675" xmlns="http://purl.org/rss/1.0/"><title>A dynamic metabolic flux balance based model of fed-batch fermentation of bordetella pertussis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1675</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A dynamic metabolic flux balance based model of fed-batch fermentation of bordetella pertussis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hector Budman, Nilesh Patel, Melih Tamer, Walid Al-Gherwi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-17T06:15:33.738496-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1675</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1675</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1675</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">520</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">531</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A mathematical model based on a dynamic metabolic flux balance (DMFB) is developed for a process of fed-batch fermentation of <em>Bordetella pertussis</em>. The model is based on the maximization of growth rate at each time interval subject to stoichiometric constraints. The model is calibrated and verified with experimental data obtained in two different bioreactor experimental systems. It was found that the model calibration was mostly sensitive to the consumption or production rates of tyrosine and, for high supplementation rates, to the consumption rate of glutamate. Following this calibration the model correctly predicts biomass and by-products concentrations for different supplementation rates. Comparisons of model predictions to oxygen uptake and carbon emission rates measurements indicate that the TCA cycle is fully functional. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 520–531, 2013</p></div>
]]></content:encoded><description>
A mathematical model based on a dynamic metabolic flux balance (DMFB) is developed for a process of fed-batch fermentation of Bordetella pertussis. The model is based on the maximization of growth rate at each time interval subject to stoichiometric constraints. The model is calibrated and verified with experimental data obtained in two different bioreactor experimental systems. It was found that the model calibration was mostly sensitive to the consumption or production rates of tyrosine and, for high supplementation rates, to the consumption rate of glutamate. Following this calibration the model correctly predicts biomass and by-products concentrations for different supplementation rates. Comparisons of model predictions to oxygen uptake and carbon emission rates measurements indicate that the TCA cycle is fully functional. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 520–531, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1683" xmlns="http://purl.org/rss/1.0/"><title>Fabrication and characterization of tosyl-activated magnetic and nonmagnetic monodisperse microspheres for use in microfluic-based ferritin immunoassay</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1683</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fabrication and characterization of tosyl-activated magnetic and nonmagnetic monodisperse microspheres for use in microfluic-based ferritin immunoassay</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Frédéric Reymond, Christine Vollet, Zdeněk Plichta, Daniel Horák</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T07:36:59.648837-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1683</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1683</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1683</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">532</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">542</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>This article describes the preparation of tosyl-activated nonmagnetic poly(2-hydroxyethyl methacrylate-co-glycidyl methacrylate) [P(HEMA-GMA)] microspheres by dispersion polymerization and tosyl-activated magnetic poly(2-hydroxyethyl methacrylate-co-ethylene dimethacrylate) [P(HEMA-EDMA)] microspheres by multistep swelling polymerization method and precipitation of iron oxide inside the pores. These new approaches show that monodisperse microspheres, 2.3 µm, respectively 4.1 µm, in diameter can be produced in high yields avoiding aggregation and with the advantage of being free of aromatic moieties. To demonstrate their potential for diagnostic applications, both types of microparticles have been coated with capture and detection antibodies (DAs), respectively. Immunoassay protocols have then been developed for the dosage of ferritin using an automated affinity platform combining microchannel chips and electrochemical detection. The assay performance using the above magnetic microspheres has been compared with that obtained with commercial tosyl-activated beads. Finally, the possibility to combine functionalized magnetic and nonmagnetic microspheres has been evaluated in view of amplifying the number of enzymatic labels in the immuno-complex. At a ferritin concentration of 119.6 ng/mL, a signal-to-noise ratio of 150.5 is obtained using 0.2 mg/mL of anti-ferritin-coated P(HEMA-GMA)-DA microspheres against a value of 158.8 using free DA in solution. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 532–542, 2013</p></div>
]]></content:encoded><description>
This article describes the preparation of tosyl-activated nonmagnetic poly(2-hydroxyethyl methacrylate-co-glycidyl methacrylate) [P(HEMA-GMA)] microspheres by dispersion polymerization and tosyl-activated magnetic poly(2-hydroxyethyl methacrylate-co-ethylene dimethacrylate) [P(HEMA-EDMA)] microspheres by multistep swelling polymerization method and precipitation of iron oxide inside the pores. These new approaches show that monodisperse microspheres, 2.3 µm, respectively 4.1 µm, in diameter can be produced in high yields avoiding aggregation and with the advantage of being free of aromatic moieties. To demonstrate their potential for diagnostic applications, both types of microparticles have been coated with capture and detection antibodies (DAs), respectively. Immunoassay protocols have then been developed for the dosage of ferritin using an automated affinity platform combining microchannel chips and electrochemical detection. The assay performance using the above magnetic microspheres has been compared with that obtained with commercial tosyl-activated beads. Finally, the possibility to combine functionalized magnetic and nonmagnetic microspheres has been evaluated in view of amplifying the number of enzymatic labels in the immuno-complex. At a ferritin concentration of 119.6 ng/mL, a signal-to-noise ratio of 150.5 is obtained using 0.2 mg/mL of anti-ferritin-coated P(HEMA-GMA)-DA microspheres against a value of 158.8 using free DA in solution. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 532–542, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1699" xmlns="http://purl.org/rss/1.0/"><title>Optimizing microalgal production in raceway systems</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1699</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Optimizing microalgal production in raceway systems</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rafael Muñoz-Tamayo, Francis Mairet, Olivier Bernard</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-07T07:36:08.694646-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1699</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1699</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1699</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">543</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">552</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The industrial exploitation of microalgae is characterized by the production of high-value compounds. Optimization of the performance of microalgae culture systems is essential to render the process economically viable. For raceway systems, the optimization based on optimal control theory is rather challenging, because the process is by essence periodically forced and, as a consequence, optimization must be carried out in a periodic framework. In this article, we propose a simple operational criterion for raceway systems that when integrated in a strategy of closed-loop control allows attaining biomass productivities very near to the theoretical maximal productivities. The strategy developed was tested numerically using a mathematical model of microalgae growth in raceways. The model takes into account the temporal variation of the environmental variables temperature and light intensity and their influence on microalgae growth. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 543–552, 2013</p></div>
]]></content:encoded><description>
The industrial exploitation of microalgae is characterized by the production of high-value compounds. Optimization of the performance of microalgae culture systems is essential to render the process economically viable. For raceway systems, the optimization based on optimal control theory is rather challenging, because the process is by essence periodically forced and, as a consequence, optimization must be carried out in a periodic framework. In this article, we propose a simple operational criterion for raceway systems that when integrated in a strategy of closed-loop control allows attaining biomass productivities very near to the theoretical maximal productivities. The strategy developed was tested numerically using a mathematical model of microalgae growth in raceways. The model takes into account the temporal variation of the environmental variables temperature and light intensity and their influence on microalgae growth. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 543–552, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1694" xmlns="http://purl.org/rss/1.0/"><title>Design of growth-dependent biosensors based on destabilized GFP for the detection of physiological behavior of Escherichia coli in heterogeneous bioreactors</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1694</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Design of growth-dependent biosensors based on destabilized GFP for the detection of physiological behavior of Escherichia coli in heterogeneous bioreactors</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shanshan Han, Frank Delvigne, Alison Brognaux, Gitte E. Charbon, Søren J Sørensen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-18T01:45:43.525832-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1694</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1694</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1694</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Process Sensing and Control</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">553</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">563</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In this work, we present the design and characterization of Green Fluorescent Protein (GFP)-based reporter systems designed to describe cellular activity in “complex,” heterogeneous bioreactors. The reporter systems consist of Escherichia coli strains carrying growth dependent promoters fused to genes expressing stable and unstable variants of GFP, respectively. The response of Escherichia coli cells to transient exposure to glucose was studied in a two-compartment scale down bioreactor (SDR) consisting of a well-stirred tank reactor (STR) connected to a plug-flow reactor (PFR). Such a SDR system is employed to mimic the situation of high glucose concentration and oxygen limitation that often encountered in large-scale, fed-batch bioreactors and the response of E. coli was simulated by continuously pumping microbial cells from STR to the PFR. We found that repeated addition of concentrated glucose pulses with varied frequency at the entrance of the PFR had consequences on strain physiological behavior. The GFP expressions were significantly marked after 10 h of cultivation in STR (control reactor) and SDR, whereas, growth rates were rather similar. Additional experiments in chemostat with programmed glucose perturbation suggested that the activities of the promoters were linked with the substrate limitation signal. Taken together with immunoblot analysis, we suppose protein leakage is responsible for the overexpression of fis and the related promoters, such as rrnB in this case study, but additional works are required in order to confirm this relationship. This investigation is useful for a better understanding of the fast dynamic phenomena occurring in heterogeneous large-scale bioreactors. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 553–563, 2013</p></div>
]]></content:encoded><description>
In this work, we present the design and characterization of Green Fluorescent Protein (GFP)-based reporter systems designed to describe cellular activity in “complex,” heterogeneous bioreactors. The reporter systems consist of Escherichia coli strains carrying growth dependent promoters fused to genes expressing stable and unstable variants of GFP, respectively. The response of Escherichia coli cells to transient exposure to glucose was studied in a two-compartment scale down bioreactor (SDR) consisting of a well-stirred tank reactor (STR) connected to a plug-flow reactor (PFR). Such a SDR system is employed to mimic the situation of high glucose concentration and oxygen limitation that often encountered in large-scale, fed-batch bioreactors and the response of E. coli was simulated by continuously pumping microbial cells from STR to the PFR. We found that repeated addition of concentrated glucose pulses with varied frequency at the entrance of the PFR had consequences on strain physiological behavior. The GFP expressions were significantly marked after 10 h of cultivation in STR (control reactor) and SDR, whereas, growth rates were rather similar. Additional experiments in chemostat with programmed glucose perturbation suggested that the activities of the promoters were linked with the substrate limitation signal. Taken together with immunoblot analysis, we suppose protein leakage is responsible for the overexpression of fis and the related promoters, such as rrnB in this case study, but additional works are required in order to confirm this relationship. This investigation is useful for a better understanding of the fast dynamic phenomena occurring in heterogeneous large-scale bioreactors. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 553–563, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1697" xmlns="http://purl.org/rss/1.0/"><title>Purification of long helical capsid of newcastle disease virus from Escherichia coli using anion exchange chromatography</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1697</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Purification of long helical capsid of newcastle disease virus from Escherichia coli using anion exchange chromatography</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Chee Fai Yap, Wen Siang Tan, Chin Chin Sieo, Beng Ti Tey</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-07T07:35:54.456717-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1697</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1697</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1697</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Bioseparations and Downstream Processing</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">564</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">567</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>NP<sub>Δc375</sub> is a truncated version of the nucleocapsid protein of Newcastle disease virus (NDV) which self-assembles into a long helical structure. A packed bed anion exchange chromatography (PB-AEC), SepFastTM Supor Q pre-packed column, was used to purify NP<sub>Δc375</sub> from clarified feedstock. This PB-AEC column adsorbed 76.2% of NP<sub>Δc375</sub> from the clarified feedstock. About 67.5% of the adsorbed NP<sub>Δc375</sub> was successfully eluted from the column by applying 50 mM Tris-HCl elution buffer supplemented with 0.5 M NaCl at pH 7. Thus, a recovery yield of 51.4% with a purity of 76.7% which corresponds to a purification factor of 6.5 was achieved in this PB-AEC operation. Electron microscopic analysis revealed that the helical structure of the NP<sub>Δc375</sub> purified by SepFast<sup>TM</sup> Supor Q pre-packed column was as long as 490 nm and 22–24 nm in diameter. The antigenicity of the purified NP<sub>Δc375</sub> was confirmed by enzyme-linked immunosorbent assay. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 564–567, 2013</p></div>
]]></content:encoded><description>
NPΔc375 is a truncated version of the nucleocapsid protein of Newcastle disease virus (NDV) which self-assembles into a long helical structure. A packed bed anion exchange chromatography (PB-AEC), SepFastTM Supor Q pre-packed column, was used to purify NPΔc375 from clarified feedstock. This PB-AEC column adsorbed 76.2% of NPΔc375 from the clarified feedstock. About 67.5% of the adsorbed NPΔc375 was successfully eluted from the column by applying 50 mM Tris-HCl elution buffer supplemented with 0.5 M NaCl at pH 7. Thus, a recovery yield of 51.4% with a purity of 76.7% which corresponds to a purification factor of 6.5 was achieved in this PB-AEC operation. Electron microscopic analysis revealed that the helical structure of the NPΔc375 purified by SepFastTM Supor Q pre-packed column was as long as 490 nm and 22–24 nm in diameter. The antigenicity of the purified NPΔc375 was confirmed by enzyme-linked immunosorbent assay. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 564–567, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1707" xmlns="http://purl.org/rss/1.0/"><title>Efficient expansion of mesenchymal stromal cells in a disposable fixed bed culture system</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1707</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Efficient expansion of mesenchymal stromal cells in a disposable fixed bed culture system</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Amanda Mizukami, Maristela D. Orellana, Sâmia R. Caruso, Karen Lima Prata, Dimas T. Covas, Kamilla Swiech</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-21T07:13:47.195505-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/btpr.1707</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/btpr.1707</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fbtpr.1707</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cell Culture and Tissue Engineering</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">568</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">572</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>The need for efficient and reliable technologies for clinical-scale expansion of mesenchymal stromal cells (MSC) has led to the use of disposable bioreactors and culture systems. Here, we evaluate the expansion of cord blood-derived MSC in a disposable fixed bed culture system. Starting from an initial cell density of 6.0 × 10<sup>7</sup> cells, after 7 days of culture, it was possible to produce of 4.2(±0.8) × 10<sup>8</sup> cells, which represents a fold increase of 7.0 (±1.4). After enzymatic retrieval from Fibra-Cell disks, the cells were able to maintain their potential for differentiation into adipocytes and osteocytes and were positive for many markers common to MSC (CD73, CD90, and CD105). The results obtained in this study demonstrate that MSC can be efficiently expanded in the culture system. This novel approach presents several advantages over the current expansion systems, based on culture flasks or microcarrier-based spinner flasks and represents a key element for MSC cellular therapy according to GMP compliant clinical-scale production system. © 2013 American Institute of Chemical Engineers <em>Biotechnol. Prog</em>., 29: 568–572, 2013</p></div>
]]></content:encoded><description>
The need for efficient and reliable technologies for clinical-scale expansion of mesenchymal stromal cells (MSC) has led to the use of disposable bioreactors and culture systems. Here, we evaluate the expansion of cord blood-derived MSC in a disposable fixed bed culture system. Starting from an initial cell density of 6.0 × 107 cells, after 7 days of culture, it was possible to produce of 4.2(±0.8) × 108 cells, which represents a fold increase of 7.0 (±1.4). After enzymatic retrieval from Fibra-Cell disks, the cells were able to maintain their potential for differentiation into adipocytes and osteocytes and were positive for many markers common to MSC (CD73, CD90, and CD105). The results obtained in this study demonstrate that MSC can be efficiently expanded in the culture system. This novel approach presents several advantages over the current expansion systems, based on culture flasks or microcarrier-based spinner flasks and represents a key element for MSC cellular therapy according to GMP compliant clinical-scale production system. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29: 568–572, 2013
</description></item></rdf:RDF>